04 october 2012 ema/643088/2012 initial notices for ... · 04 october 2012 . ema/643088/2012 ......
TRANSCRIPT
7 Westferry Circus ● Canary Wharf ● London E14 4HB ● United Kingdom Telephone +44 (0)20 7418 8400 Facsimile +44 (0)20 7523 7051 E-mail [email protected] Website www.ema.europa.eu An agency of the European Union
© European Medicines Agency, 2012. Reproduction is authorised provided the source is acknowledged.
04 October 2012 EMA/643088/2012 Patient Health Protection
Initial Notices for Parallel Distribution –2011
Product name Parallel distributor
Date of notification
Strength Pharmaceutical dosage form
Pack size EU-number Member State(s) of Origin Member State(s) of Destination
Date of Notice letter
Abilify 2 Care 4 27/06/2011 10 mg Orodispersible tablet
28 x 1 EU/1/04/276/025 Austria, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 24/08/2011
Abilify 2 Care 4 27/06/2011 15 mg Orodispersible tablet
28 x 1 EU/1/04/276/028 Austria, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 24/08/2011
Abilify Abacus Medicine A/S
28/11/2011 10 mg Tablet 56 x 1 EU/1/04/276/009 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 16/12/2011
Abilify Abacus Medicine A/S
28/11/2011 30 mg Tablet 56 x 1 EU/1/04/276/019 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 16/12/2011
Abilify ADL Pharma GmbH
18/05/2011 5 mg Tablet 14 x 1 EU/1/04/276/001 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 01/06/2011
Abilify ADL Pharma GmbH
18/05/2011 5 mg Tablet 28 x 1 EU/1/04/276/002 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 01/06/2011
Abilify ADL Pharma GmbH
18/05/2011 5 mg Tablet 49 x 1 EU/1/04/276/003 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 01/06/2011
Abilify ADL Pharma GmbH
18/05/2011 5 mg Tablet 56 x 1 EU/1/04/276/004 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 01/06/2011
Abilify ADL Pharma GmbH
18/05/2011 5 mg Tablet 98 x 1 EU/1/04/276/005 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 01/06/2011
Abilify Axicorp Pharma GmbH
31/03/2011 5 mg Tablet 98 x 1 EU/1/04/276/005 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 19/04/2011
Abilify Axicorp Pharma GmbH
27/09/2011 30 mg Tablet 98 x 1 EU/1/04/276/020 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 04/10/2011
Abilify B&S Healthcare Ltd
10/08/2011 1 mg/ml Oral solution 1 bottle + 1 cup + 1 calibrated dropper
EU/1/04/276/034 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
12/08/2011
Abilify B2B Medical GmbH
06/12/2010 10 mg Tablet 49 x 1 EU/1/04/276/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 14/02/2011
Abilify B2B Medical GmbH
06/12/2010 10 mg Tablet 98 x 1 EU/1/04/276/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 14/02/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 2/255
Abilify B2B Medical GmbH
06/12/2010 15 mg Tablet 49 x 1 EU/1/04/276/013 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 14/02/2011
Abilify B2B Medical GmbH
06/12/2010 15 mg Tablet 98 x 1 EU/1/04/276/015 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 14/02/2011
Abilify B2B Medical GmbH
06/12/2010 30 mg Tablet 49 x 1 EU/1/04/276/018 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 14/02/2011
Abilify B2B Medical GmbH
06/12/2010 5 mg Tablet 49 x 1 EU/1/04/276/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 14/02/2011
Abilify B2B Medical GmbH
01/09/2011 10 mg Tablet 14 x 1 EU/1/04/276/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 16/09/2011
Abilify B2B Medical GmbH
01/09/2011 10 mg Tablet 28 x 1 EU/1/04/276/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 26/09/2011
Abilify B2B Medical GmbH
01/09/2011 15 mg Tablet 14 x 1 EU/1/04/276/011 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 16/09/2011
Abilify B2B Medical GmbH
01/09/2011 15 mg Tablet 28 x 1 EU/1/04/276/012 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 16/09/2011
Abilify B2B Medical GmbH
01/09/2011 30 mg Tablet 28 x 1 EU/1/04/276/017 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 26/09/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 3/255
Abilify B2B Medical GmbH
01/09/2011 30 mg Tablet 98 x 1 EU/1/04/276/020 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 26/09/2011
Abilify B2B Medical GmbH
01/09/2011 5 mg Tablet 14 x 1 EU/1/04/276/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 16/09/2011
Abilify B2B Medical GmbH
01/09/2011 5 mg Tablet 28 x 1 EU/1/04/276/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 26/09/2011
Abilify B2B Medical GmbH
01/09/2011 5 mg Tablet 98 x 1 EU/1/04/276/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 16/09/2011
Abilify BB Farma s.r.l.
04/05/2011 5 mg Tablet 49 x 1 EU/1/04/276/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Germany 11/05/2011
Abilify BB Farma s.r.l.
17/05/2011 30 mg Tablet 49 x 1 EU/1/04/276/018 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/05/2011
Abilify BB Farma s.r.l.
18/05/2011 10 mg Tablet 14 x 1 EU/1/04/276/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/05/2011
Abilify BB Farma s.r.l.
18/05/2011 10 mg Tablet 98 x 1 EU/1/04/276/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/05/2011
Abilify BB Farma s.r.l.
18/05/2011 10 mg Tablet 49 x 1 EU/1/04/276/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/05/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 4/255
Abilify BB Farma s.r.l.
01/06/2011 15 mg Tablet 14 x 1 EU/1/04/276/011 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Germany 09/06/2011
Abilify BB Farma s.r.l.
01/06/2011 15 mg Tablet 49 x 1 EU/1/04/276/013 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Germany 09/06/2011
Abilify BB Farma s.r.l.
01/06/2011 15 mg Tablet 98 x 1 EU/1/04/276/015 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Germany 09/06/2011
abilify Beragena Arzneimittel GmbH
30/03/2011 30 mg Tablet 98 x 1 EU/1/04/276/020 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 04/05/2011
Abilify Beragena Arzneimittel GmbH
30/03/2011 5 mg Tablet 98 x 1 EU/1/04/276/005 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 11/05/2011
Abilify Beragena Arzneimittel GmbH
09/11/2011 5 mg Tablet 14 x 1 EU/1/04/276/001 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 28/11/2011
Abilify Beragena Arzneimittel GmbH
09/11/2011 5 mg Tablet 28 x 1 EU/1/04/276/002 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 28/11/2011
Abilify Beragena Arzneimittel GmbH
09/11/2011 5 mg Tablet 56 x 1 EU/1/04/276/004 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 28/11/2011
Abilify BR Pharma International Ltd
25/01/2010 10 mg Tablet 49 x 1 EU/1/04/276/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 17/02/2011
Abilify BR Pharma International Ltd
25/01/2010 10 mg Tablet 98 x 1 EU/1/04/276/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 17/02/2011
Abilify BR Pharma International Ltd
10/02/2010 10 mg Tablet 14 x 1 EU/1/04/276/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 21/07/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 5/255
Abilify BR Pharma International Ltd
21/09/2010 10 mg Tablet 28 x 1 EU/1/04/276/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/01/2011
Abilify BR Pharma International Ltd
21/09/2010 15 mg Tablet 14 x 1 EU/1/04/276/011 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/01/2011
Abilify BR Pharma International Ltd
21/09/2010 15 mg Tablet 28 x 1 EU/1/04/276/012 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/01/2011
Abilify BR Pharma International Ltd
21/09/2010 15 mg Tablet 49 x 1 EU/1/04/276/013 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/01/2011
Abilify BR Pharma International Ltd
21/09/2010 15 mg Tablet 98 x 1 EU/1/04/276/015 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/01/2011
Abilify BR Pharma International Ltd
21/09/2010 5 mg Tablet 14 x 1 EU/1/04/276/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/01/2011
Abilify BR Pharma International Ltd
21/09/2010 5 mg Tablet 28 x 1 EU/1/04/276/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/01/2011
Abilify BR Pharma International Ltd
21/09/2010 5 mg Tablet 49 x 1 EU/1/04/276/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/01/2011
Abilify BR Pharma International Ltd
21/09/2010 5 mg Tablet 98 x 1 EU/1/04/276/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/01/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 6/255
Abilify BR Pharma International Ltd
21/02/2011 5 mg Tablet 56 x 1 EU/1/04/276/004 Austria, Belgium, Cyprus, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 27/05/2011
Abilify BR Pharma International Ltd
11/03/2011 10 mg Tablet 56 x 1 EU/1/04/276/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 27/05/2011
Abilify BR Pharma International Ltd
11/03/2011 15 mg Tablet 56 x 1 EU/1/04/276/014 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 27/05/2011
Abilify BR Pharma International Ltd
11/03/2011 30 mg Tablet 56 x 1 EU/1/04/276/019 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 27/05/2011
Abilify ChemVet Pharma ApS
17/02/2011 10 mg Tablet 28 x 1 EU/1/04/276/007 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 08/03/2011
Abilify ChemVet Pharma ApS
17/02/2011 15 mg Tablet 28 x 1 EU/1/04/276/012 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 08/03/2011
Abilify ChemVet Pharma ApS
04/11/2011 5 mg Tablet 28 x 1 EU/1/04/276/002 Austria, Belgium, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 10/11/2011
Abilify Docpharm GmbH&CoKGaA
14/06/2011 10 mg Orodispersible tablet
14 x 1 EU/1/04/276/024 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Spain, Sweden, The Netherlands, United Kingdom
Germany 27/06/2011
Abilify Docpharm GmbH&CoKGaA
14/06/2011 10 mg Orodispersible tablet
49 x 1 EU/1/04/276/026 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 27/06/2011
Abilify Emra-Med 27/09/2010 5 mg Tablet 98 x 1 EU/1/04/276/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 04/01/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 7/255
Abilify Emra-Med 27/09/2010 5 mg Tablet 28 x 1 EU/1/04/276/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 04/01/2011
Abilify Emra-Med 27/09/2010 5 mg Tablet 14 x 1 EU/1/04/276/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 04/01/2011
Abilify EuroPharma DK
08/06/2011 10 mg Tablet 14 x 1 EU/1/04/276/006 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 27/06/2011
Abilify EuroPharma DK
08/06/2011 10 mg Tablet 28 x 1 EU/1/04/276/007 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 27/06/2011
Abilify EuroPharma DK
08/06/2011 10 mg Tablet 56 x 1 EU/1/04/276/009 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 27/06/2011
Abilify EuroPharma DK
08/06/2011 15 mg Tablet 28 x 1 EU/1/04/276/012 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 27/06/2011
Abilify EuroPharma DK
08/06/2011 15 mg Tablet 56 x 1 EU/1/04/276/014 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 27/06/2011
Abilify EuroPharma DK
22/07/2011 1 mg/ml Oral solution 1 bottle + 1 cup + 1 calibrated dropper
EU/1/04/276/034 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 01/08/2011
Abilify Europharma Sverige AB
16/08/2011 10 mg Orodispersible tablet
28 x 1 EU/1/04/276/025 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 01/09/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 8/255
Abilify Europharma Sverige AB
16/08/2011 15 mg Orodispersible tablet
28 x 1 EU/1/04/276/028 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 01/09/2011
Abilify G-Pharma Ltd 22/03/2011 10 mg Tablet 56 x 1 EU/1/04/276/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
31/03/2011
Abilify Interport Ltd 07/08/2011 10 mg Orodispersible tablet
28 x 1 EU/1/04/276/025 Austria, Belgium, Denmark, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands
United Kingdom
12/08/2011
Abilify Kohlpharma GmbH
07/04/2011 5 mg Tablet 98 x 1 EU/1/04/276/005 Austria, France, Ireland, Italy, Norway, Spain, United Kingdom
Germany 19/04/2011
Abilify Kohlpharma GmbH
07/06/2011 30 mg Tablet 98 x 1 EU/1/04/276/020 Belgium, Greece, United Kingdom Germany 13/07/2011
Abilify Kohlpharma GmbH
25/08/2011 5 mg Tablet 28 x 1 EU/1/04/276/002 Austria, France, Ireland, Italy, Spain, United Kingdom
Germany 25/08/2011
Abilify Kosei Pharma UK Limited
27/05/2011 15 mg Tablet 28 x 1 EU/1/04/276/012 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Luxembourg, Malta, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
21/06/2011
Abilify Medartuum AB 02/11/2011 30 mg Tablet 56 x 1 EU/1/04/276/019 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Spain, The Netherlands, United Kingdom
Sweden 09/11/2011
Abilify Medartuum AB 24/11/2011 10 mg Tablet 28 x 1 EU/1/04/276/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Spain, The Netherlands, United Kingdom
Sweden 02/12/2011
Abilify Medartuum AB 24/11/2011 5 mg Tablet 28 x 1 EU/1/04/276/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Spain, The Netherlands, United Kingdom
Sweden 29/11/2011
Abilify MedicoPharm AG
18/03/2011 10 mg Tablet 49 x 1 EU/1/04/276/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 28/03/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 9/255
Abilify MedicoPharm AG
18/03/2011 10 mg Tablet 98 x 1 EU/1/04/276/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 28/03/2011
Abilify MedicoPharm AG
18/03/2011 15 mg Tablet 49 x 1 EU/1/04/276/013 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 28/03/2011
Abilify MedicoPharm AG
18/03/2011 15 mg Tablet 98 x 1 EU/1/04/276/015 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 28/03/2011
Abilify MedicoPharm AG
18/03/2011 5 mg Tablet 49 x 1 EU/1/04/276/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 28/03/2011
Abilify MedicoPharm AG
21/03/2011 10 mg Orodispersible tablet
49 x 1 EU/1/04/276/026 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 28/03/2011
Abilify MedicoPharm AG
21/03/2011 15 mg Orodispersible tablet
49 x 1 EU/1/04/276/029 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 28/03/2011
Abilify Omnia Läkemedel AB
04/03/2011 30 mg Tablet 56 x 1 EU/1/04/276/019 Belgium, France, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom
Sweden 08/04/2011
Abilify Omnia Läkemedel AB
07/03/2011 10 mg Tablet 56 x 1 EU/1/04/276/009 Belgium, France, Greece, Italy, Portugal, Romania, Spain, The Netherlands, United Kingdom
Sweden 08/04/2011
Abilify Omnia Läkemedel AB
08/06/2011 15 mg Tablet 56 x 1 EU/1/04/276/014 France, Greece, Italy, Romania, Spain, The Netherlands, United Kingdom
Sweden 11/08/2011
Abilify Orifarm AS 16/11/2011 1 mg/ml Oral solution 1 bottle + 1 cup + 1 calibrated dropper
EU/1/04/276/034 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 22/11/2011
Abilify Paranova Danmark AS
13/04/2010 30 mg Tablet 56 x 1 EU/1/04/276/019 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 11/01/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 10/255
Abilify Paranova Danmark AS
11/11/2011 1 mg/ml Oral solution 1 bottle + 1 cup + 1 calibrated dropper
EU/1/04/276/034 Austria, Belgium, Bulgaria, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 16/11/2011
Abilify Paranova Läkemedel AB
19/08/2011 5 mg Tablet 56 x 1 EU/1/04/276/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 22/08/2011
Abilify Paranova Läkemedel AB
19/08/2011 5 mg Tablet 28 x 1 EU/1/04/276/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 22/08/2011
Abilify Paranova Läkemedel AB
02/12/2011 1 mg/ml Oral solution 1 bottle + 1 cup + 1 calibrated dropper
EU/1/04/276/034 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 19/12/2011
Abilify Pharma Westen GmbH
07/04/2011 30 mg Tablet 98 x 1 EU/1/04/276/020 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 26/04/2011
Abilify S.C. HC PHARMA STORE s.r.l.
12/09/2011 10 mg Tablet 49 x 1 EU/1/04/276/008 Romania, Spain Germany 27/10/2011
Abilify S.C. HC PHARMA STORE s.r.l.
12/09/2011 10 mg Tablet 98 x 1 EU/1/04/276/010 Romania, Spain Germany 27/10/2011
Aclasta Haemato Pharm AG
04/04/2011 5 mg/100 ml Solution for infusion
1 bottle EU/1/05/308/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 14/04/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 11/255
Aclasta Medartuum AB 08/02/2011 5 mg/100 ml Solution for infusion
1 bottle EU/1/05/308/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 17/02/2011
Aclasta Omnia Läkemedel AB
06/09/2011 5 mg/100 ml Solution for infusion
1 bottle EU/1/05/308/001 Austria, Belgium, Bulgaria, France, Germany, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom
Sweden 15/09/2011
Aclasta Paranova Läkemedel AB
25/02/2011 5 mg/100 ml Solution for infusion
1 bottle EU/1/05/308/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 05/04/2011
Aclasta Veron Pharma Vertriebs GmbH
31/01/2011 5 mg/100 ml Solution for infusion
1 bottle EU/1/05/308/001 Austria, Belgium, Finland, France, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom
Germany 03/03/2011
Actos BR Pharma International Ltd
14/12/2011 45 mg Tablet 112 EU/1/00/150/029 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 22/12/2011
Actos CC Pharma 25/08/2011 30 mg Tablet 112 EU/1/00/150/027 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 31/08/2011
Actos CC Pharma 25/08/2011 30 mg Tablet 196 EU/1/00/150/028 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 31/08/2011
Actos Docpharm GmbH&CoKGaA
02/08/2011 15 mg Tablet 112 EU/1/00/150/025 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 04/08/2011
Actos Docpharm GmbH&CoKGaA
02/08/2011 30 mg Tablet 112 EU/1/00/150/027 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 04/08/2011
Actos Docpharm GmbH&CoKGaA
02/08/2011 45 mg Tablet 112 EU/1/00/150/029 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 04/08/2011
Actos Docpharm GmbH&CoKGaA
28/09/2011 15 mg Tablet 196 EU/1/00/150/026 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 14/10/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 12/255
Actos Docpharm GmbH&CoKGaA
28/09/2011 30 mg Tablet 196 EU/1/00/150/028 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/10/2011
Actos Docpharm GmbH&CoKGaA
28/09/2011 45 mg Tablet 196 EU/1/00/150/030 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 13/10/2011
Actos Emra-Med 11/03/2011 15 mg Tablet 112 EU/1/00/150/025 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/03/2011
Actos Emra-Med 20/06/2011 30 mg Tablet 112 EU/1/00/150/027 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 21/06/2011
Actos Emra-Med 27/10/2011 45 mg Tablet 112 EU/1/00/150/029 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 03/11/2011
Actos Eureco-Pharma B.V.
15/12/2010 30 mg Tablet 84 EU/1/00/150/020 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
31/01/2011
Actos Euro Registratie Collectief BV
08/02/2011 30 mg Tablet 84 EU/1/00/150/020 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
21/02/2011
Actos Kohlpharma GmbH
02/12/2011 30 mg Tablet 112 EU/1/00/150/027 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 13/12/2011
Actos Medartuum AB 09/12/2011 15 mg Tablet 98 EU/1/00/150/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 15/12/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 13/255
Actos Medartuum AB 09/12/2011 45 mg Tablet 98 EU/1/00/150/015 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 14/12/2011
Actos MPT Pharma 24/01/2011 15 mg Tablet 196 EU/1/00/150/026 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
18/02/2011
Actos MPT Pharma 24/01/2011 15 mg Tablet 112 EU/1/00/150/025 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
18/02/2011
Actos MPT Pharma 24/01/2011 15 mg Tablet 98 EU/1/00/150/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
18/02/2011
Actos MPT Pharma 24/01/2011 15 mg Tablet 84 EU/1/00/150/017 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
18/02/2011
Actos MPT Pharma 24/01/2011 15 mg Tablet 56 EU/1/00/150/009 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
18/02/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 14/255
Actos MPT Pharma 24/01/2011 15 mg Tablet 28 EU/1/00/150/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
18/02/2011
Actos MPT Pharma 11/04/2011 15 mg Tablet 50 EU/1/00/150/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
15/04/2011
Actos MPT Pharma 11/04/2011 15 mg Tablet 30 EU/1/00/150/016 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
15/04/2011
Actos O.P.D. Laboratories Ltd
23/07/2001 30 mg Tablet 28 EU/1/00/150/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands
United Kingdom
12/09/2011
Actos O.P.D. Laboratories Ltd
07/06/2010 45 mg Tablet 28 EU/1/00/150/012 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands
Ireland, United Kingdom
06/01/2011
Actos Pharma Westen GmbH
06/01/2011 30 mg Tablet 112 EU/1/00/150/027 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 10/01/2011
Actos Pharma Westen GmbH
06/01/2011 45 mg Tablet 112 EU/1/00/150/029 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 10/01/2011
Actos Pharma Westen GmbH
20/01/2011 15 mg Tablet 112 EU/1/00/150/025 Austria, Belgium, Denmark, Estonia, Finland, France, Greece, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/01/2011
Actos Swingward Ltd TA Medihealth
13/09/2010 15 mg Tablet 98 EU/1/00/150/003 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands
United Kingdom
08/03/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 15/255
Actrapid CC Pharma 27/05/2011 100 IU/ml Solution for injection
5 pre-filled pens
EU/1/02/230/008 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 28/06/2011
Actrapid EuroPharma DK
24/03/2011 100 IU/ml Solution for injection
5 pre-filled pens
EU/1/02/230/008 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 31/03/2011
Adcirca Haemato Pharm AG
23/05/2011 20 mg Film-coated tablet 56 EU/1/08/476/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Austria, Germany
10/06/2011
Adcirca Haemato Pharm AG
24/05/2011 20 mg Film-coated tablet 56 EU/1/08/476/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 10/06/2011
Adrovance Euro Registratie Collectief BV
08/02/2011 70 mg/2800 IU
Tablet 4 EU/1/06/364/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
10/03/2011
Advagraf 2 Care 4 13/05/2011 3 mg Prolonged-release capsules, hard
50 EU/1/07/387/012 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Denmark 16/05/2011
Advagraf BR Pharma International Ltd
14/09/2011 3 mg Prolonged-release capsules, hard
100 x 1 EU/1/07/387/023 Belgium Germany 28/09/2011
Advagraf BR Pharma International Ltd
14/10/2011 1 mg Prolonged-release capsules, hard
100 x 1 EU/1/07/387/020 Belgium Germany 29/11/2011
Advagraf CC Pharma 29/08/2011 3 mg Prolonged-release capsules, hard
100 x 1 EU/1/07/387/023 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 05/09/2011
Advagraf Euro Registratie Collectief BV
13/10/2011 1 mg Prolonged-release capsules, hard
50 EU/1/07/387/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
03/11/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 16/255
Advagraf Euro Registratie Collectief BV
24/11/2011 1 mg Prolonged-release capsules, hard
60 x 1 EU/1/07/387/019 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
21/12/2011
Advagraf Euro Registratie Collectief BV
24/11/2011 5 mg Prolonged-release capsules, hard
30 x 1 EU/1/07/387/024 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
21/12/2011
Advagraf Kohlpharma GmbH
01/12/2009 3 mg Prolonged-release capsules, hard
100 EU/1/07/387/013 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 09/06/2011
Advagraf Medcor Pharmaceuticals BV
08/04/2011 5 mg Prolonged-release capsules, hard
50 EU/1/07/387/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
11/04/2011
Advagraf Medcor Pharmaceuticals BV
16/08/2011 3 mg Prolonged-release capsules, hard
50 EU/1/07/387/012 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
17/08/2011
Advagraf NewNeopharm BV
05/05/2011 3 mg Prolonged-release capsules, hard
30 EU/1/07/387/011 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 18/05/2011
Advagraf NewNeopharm BV
05/05/2011 5 mg Prolonged-release capsules, hard
30 EU/1/07/387/007 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 18/05/2011
Advagraf Omnia Läkemedel AB
10/05/2011 0.5 mg Prolonged-release capsules, hard
50 EU/1/07/387/002 France, Italy, Portugal, Romania, Spain, The Netherlands, United Kingdom
Sweden 22/06/2011
Advagraf Omnia Läkemedel AB
10/05/2011 1 mg Prolonged-release capsules, hard
50 EU/1/07/387/004 France, Italy, Portugal, Romania, Spain, The Netherlands, United Kingdom
Sweden 22/06/2011
Advagraf Omnia Läkemedel AB
10/05/2011 3 mg Prolonged-release capsules, hard
50 EU/1/07/387/012 France, Italy, Portugal, Spain, The Netherlands, United Kingdom
Sweden 22/06/2011
Advagraf Omnia Läkemedel AB
10/05/2011 5 mg Prolonged-release capsules, hard
50 EU/1/07/387/008 France, Italy, Portugal, Romania, Spain, The Netherlands, United Kingdom
Sweden 22/06/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 17/255
Advagraf Orifarm AB 21/09/2011 0.5 mg Prolonged-release capsules, hard
50 EU/1/07/387/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Spain, The Netherlands, United Kingdom
Sweden 03/10/2011
Advagraf Orifarm AB 21/09/2011 3 mg Prolonged-release capsules, hard
50 EU/1/07/387/012 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Spain, The Netherlands, United Kingdom
Sweden 03/10/2011
Advagraf Orifarm AS 11/05/2011 0.5 mg Prolonged-release capsules, hard
50 EU/1/07/387/002 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 27/05/2011
Advagraf Paranova Läkemedel AB
14/10/2011 3 mg Prolonged-release capsules, hard
50 EU/1/07/387/012 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 09/12/2011
Advagraf Paranova Läkemedel AB
14/10/2011 5 mg Prolonged-release capsules, hard
50 EU/1/07/387/008 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 09/12/2011
Advagraf Paranova Läkemedel AB
22/11/2011 1 mg Prolonged-release capsules, hard
50 EU/1/07/387/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 09/12/2011
Aerius 2 Care 4 22/11/2010 5 mg Film-coated tablet 30 EU/1/00/160/011 Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 12/01/2011
Aerius 2 Care 4 22/11/2010 5 mg Film-coated tablet 100 EU/1/00/160/013 Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 14/01/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 18/255
Aerius Cross Pharma AB
08/03/2011 5 mg Film-coated tablet 30 EU/1/00/160/011 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Spain, The Netherlands, United Kingdom
Sweden 14/03/2011
Aerius Cross Pharma AB
11/03/2011 5 mg Film-coated tablet 100 EU/1/00/160/013 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Spain, The Netherlands, United Kingdom
Sweden 14/03/2011
Aerius Cross Pharma AB
29/11/2011 5 mg Film-coated tablet 90 EU/1/00/160/036 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 05/12/2011
Aerius EU-Pharma BV 14/06/2011 5 mg Film-coated tablet 90 EU/1/00/160/036 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, United Kingdom
The Netherlands
27/06/2011
Aerius EU-Pharma BV 15/08/2011 0.5 mg/ml Oral solution 1 bottle EU/1/00/160/066 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
16/08/2011
Aerius Ichem SpZoo 08/11/2011 0.5 mg/ml Oral solution 1 bottle EU/1/00/160/069 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Poland 21/12/2011
Aerius Medartuum AB 22/02/2011 5 mg Film-coated tablet 100 EU/1/00/160/013 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 15/03/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 19/255
Aerius Paranova Läkemedel AB
25/11/2011 5 mg Film-coated tablet 30 EU/1/00/160/011 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 21/12/2011
Aerius Paranova Läkemedel AB
25/11/2011 5 mg Film-coated tablet 100 EU/1/00/160/013 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 21/12/2011
Aerius S.C. Farmastore Prest S.R.L.
04/02/2011 5 mg Film-coated tablet 10 EU/1/00/160/006 Austria, Belgium, France, Germany, Greece, Italy, Portugal, Spain, United Kingdom
Romania 22/02/2011
Afinitor Orifarm AB 23/08/2011 10 mg Tablet 30 EU/1/09/538/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 26/08/2011
Aldara Cross Pharma AB
17/11/2011 5% w/w Cream 12 sachets EU/1/98/080/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 16/12/2011
Alimta AXicorp Pharma GmbH
04/10/2011 500 mg Powder for concentrate for solution for infusion
1 vial EU/1/04/290/001 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 13/10/2011
Alimta mibe GmbH Arzneimittel
27/05/2011 500 mg Powder for concentrate for solution for infusion
1 vial EU/1/04/290/001 Greece Germany 16/06/2011
Alimta Orifarm OY 10/02/2011 100 mg Powder for concentrate for solution for infusion
1 vial EU/1/04/290/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Finland 29/03/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 20/255
Alimta Orifarm OY 16/03/2011 500 mg Powder for concentrate for solution for infusion
1 vial EU/1/04/290/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Finland 29/03/2011
Alimta Veron Pharma Vertriebs GmbH
31/03/2011 500 mg Powder for concentrate for solution for infusion
1 vial EU/1/04/290/001 Austria, Belgium, France, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom
Germany 17/06/2011
alli CC Pharma 24/05/2011 60 mg Capsule, hard 120 EU/1/07/401/011 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 08/06/2011
Altargo Pharmachim AB
30/05/2011 1 % Ointment 1 tube EU/1/07/390/002 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Latvia, Malta, Norway, Portugal, Romania, Spain, The Netherlands, United Kingdom
Sweden 10/06/2011
Angiox Orifarm AB 23/05/2011 250 mg Powder for concentrate for solution for injection or infusion
10 vials EU/1/04/289/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 26/05/2011
Apidra Axicorp Pharma GmbH
18/08/2011 100 Units/ml Solution for injection
5 cartridges EU/1/04/285/008 Austria, Belgium, Denmark, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Germany 08/09/2011
Apidra Axicorp Pharma GmbH
18/08/2011 100 Units/ml Solution for injection
10 cartridges
EU/1/04/285/012 Austria, Belgium, Denmark, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Germany 09/09/2011
Apidra CC Pharma 26/11/2010 100 Units/ml Solution for injection
5 cartridges EU/1/04/285/008 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Germany 13/01/2011
Apidra CC Pharma 07/12/2010 100 Units/ml Solution for injection
10 cartridges
EU/1/04/285/012 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Germany 13/01/2011
Apidra CC Pharma 13/10/2011 100 Units/ml Solution for injection
5 pre-filled pens
EU/1/04/285/016 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 16/11/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 21/255
Apidra CC Pharma 13/10/2011 100 Units/ml Solution for injection
10 pre-filled pens
EU/1/04/285/020 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 11/11/2011
Apidra Dr Fisher Farma BV
01/06/2011 100 Units/ml Solution for injection
5 pre-filled pens
EU/1/04/285/016 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
15/06/2011
Apidra Emra-Med 19/01/2010 100 Units/ml Solution for injection
5 vials EU/1/04/285/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 18/03/2011
Apidra Eureco-Pharma B.V.
03/01/2011 100 Units/ml Solution for injection
5 cartridges EU/1/04/285/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
21/02/2011
Apidra Euro Registratie Collectief BV
07/06/2011 100 Units/ml Solution for injection
5 cartridges EU/1/04/285/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
27/06/2011
Apidra Kohlpharma GmbH
25/10/2010 100 Units/ml Solution for injection
5 pre-filled pens
EU/1/04/285/032 Austria, Belgium, France, Greece, Italy, Norway, United Kingdom
Germany 25/01/2011
Apidra Kohlpharma GmbH
25/10/2010 100 Units/ml Solution for injection
5 pre-filled pens
EU/1/04/285/016 Austria, Greece, Italy Germany 25/01/2011
Apidra Kohlpharma GmbH
25/10/2010 100 Units/ml Solution for injection
10 pre-filled pens
EU/1/04/285/020 Austria, Greece, Italy Germany 25/01/2011
Apidra Kohlpharma GmbH
25/10/2010 100 Units/ml Solution for injection
5 cartridges EU/1/04/285/008 Austria, France, Greece, Italy, Romania Germany 25/01/2011
Apidra Kohlpharma GmbH
25/10/2010 100 Units/ml Solution for injection
10 cartridges
EU/1/04/285/012 Austria, France, Greece, Italy, Romania Germany 25/01/2011
Apidra Orifarm AB 02/02/2011 100 Units/ml Solution for injection
5 pre-filled pens
EU/1/04/285/032 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 03/03/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 22/255
Apidra (SoloStar) Beragena Arzneimittel GmbH
19/04/2011 100 Units/ml Solution for injection
10 pre-filled pens
EU/1/04/285/036 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 10/05/2011
Apidra (SoloStar) Beragena Arzneimittel GmbH
19/04/2011 100 Units/ml Solution for injection
5 pre-filled pens
EU/1/04/285/032 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 10/05/2011
Apidra Optiset Emra-Med 10/12/2010 100 Units/ml Solution for injection
5 pre-filled pens
EU/1/04/285/016 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/02/2011
Apidra Optiset Emra-Med 10/12/2010 100 Units/ml Solution for injection
10 pre-filled pens
EU/1/04/285/020 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/02/2011
Apidra SoloStar Axicorp Pharma GmbH
18/08/2011 100 Units/ml Solution for injection
5 pre-filled pens
EU/1/04/285/032 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Germany 08/09/2011
Apidra SoloStar Axicorp Pharma GmbH
18/08/2011 100 Units/ml Solution for injection
10 pre-filled pens
EU/1/04/285/036 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Germany 09/09/2011
Apidra Solostar CC Pharma 26/11/2010 100 Units/ml Solution for injection
5 pre-filled pens
EU/1/04/285/032 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Germany 13/01/2011
Apidra Solostar CC Pharma 07/12/2010 100 Units/ml Solution for injection
10 pre-filled pens
EU/1/04/285/036 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Germany 13/01/2011
Apidra Solostar Kohlpharma GmbH
25/10/2010 100 Units/ml Solution for injection
10 pre-filled pens
EU/1/04/285/036 Austria, Belgium, France, Greece, Italy, Norway, United Kingdom
Germany 25/01/2011
Aprovel CC Pharma 21/12/2010 75 mg Film-coated tablet 28 EU/1/97/046/017 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 13/01/2011
Aprovel CC Pharma 21/12/2010 75 mg Film-coated tablet 56 EU/1/97/046/018 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 13/01/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 23/255
Aprovel CC Pharma 22/12/2010 75 mg Film-coated tablet 98 EU/1/97/046/020 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 13/01/2011
Aprovel CC Pharma 17/02/2011 300 mg Film-coated tablet 56 EU/1/97/046/028 Austria, Belgium, France, Greece, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 24/03/2011
Aprovel EU-Pharma BV 03/05/2011 150 mg Film-coated tablet 28 EU/1/97/046/022 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
10/05/2011
Aprovel EU-Pharma BV 17/05/2011 150 mg Tablet 28 EU/1/97/046/004 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
18/05/2011
Aranesp Axicorp Pharma GmbH
22/07/2011 500 µg Solution for injection
1 pre-filled syringe with needle guard
EU/1/01/185/098 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 06/09/2011
Aranesp Beragena Arzneimittel GmbH
17/03/2011 100 µg Solution for injection
4 pre-filled syringes
EU/1/01/185/018 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 26/04/2011
Aranesp Beragena Arzneimittel GmbH
17/03/2011 150 µg Solution for injection
4 pre-filled syringes
EU/1/01/185/020 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 19/04/2011
Aranesp Beragena Arzneimittel GmbH
17/03/2011 500 µg Solution for injection
1 pre-filled syringe with needle guard
EU/1/01/185/098 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 26/04/2011
Aranesp Beragena Arzneimittel GmbH
17/03/2011 500 µg Solution for injection
1 pre-filled syringe
EU/1/01/185/031 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 26/04/2011
Aranesp Beragena Arzneimittel GmbH
19/04/2011 100 µg Solution for injection
4 pre-filled syringes with needle guard
EU/1/01/185/091 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 27/04/2011
Aranesp Beragena Arzneimittel GmbH
19/04/2011 150 µg Solution for injection
4 pre-filled syringes with needle guard
EU/1/01/185/095 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 27/04/2011
Aranesp Beragena Arzneimittel GmbH
25/05/2011 60 µg Solution for injection
4 pre-filled syringe
EU/1/01/185/014 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 08/07/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 24/255
Aranesp Beragena Arzneimittel GmbH
25/05/2011 80 µg Solution for injection
4 pre-filled syringes
EU/1/01/185/016 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 08/07/2011
Aranesp Beragena Arzneimittel GmbH
21/09/2011 30 µg Solution for injection
4 pre-filled syringes with needle guard
EU/1/01/185/081 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 28/09/2011
Aranesp Beragena Arzneimittel GmbH
21/09/2011 40 µg Solution for injection
4 pre-filled syringes with needle guard
EU/1/01/185/083 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 28/09/2011
Aranesp Beragena Arzneimittel GmbH
21/09/2011 60 µg Solution for injection
4 pre-filled syringe with needle guard
EU/1/01/185/087 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 28/09/2011
Aranesp Beragena Arzneimittel GmbH
21/09/2011 80 µg Solution for injection
4 pre-filled syringes with needle guard
EU/1/01/185/089 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 28/09/2011
Aranesp Beragena Arzneimittel GmbH
12/10/2011 20 µg Solution for injection
4 pre-filled syringes
EU/1/01/185/006 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 04/11/2011
Aranesp Beragena Arzneimittel GmbH
12/10/2011 30 µg Solution for injection
4 pre-filled syringes
EU/1/01/185/008 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 04/11/2011
Aranesp Beragena Arzneimittel GmbH
12/10/2011 40 µg Solution for injection
4 pre-filled syringes
EU/1/01/185/010 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 04/11/2011
Aranesp Beragena Arzneimittel GmbH
12/10/2011 50 µg Solution for injection
4 pre-filled syringes
EU/1/01/185/012 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 04/11/2011
Aranesp Beragena Arzneimittel GmbH
07/11/2011 50 µg Solution for injection
4 pre-filled syringes with needle guard
EU/1/01/185/085 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 14/11/2011
Aranesp CC Pharma 04/01/2011 15 µg Solution for injection
4 pre-filled syringes with needle guards
EU/1/01/185/077 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 18/01/2011
Aranesp CC Pharma 22/03/2011 50 µg Solution for injection
4 pre-filled syringes with needle guard
EU/1/01/185/085 Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 18/04/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 25/255
Aranesp CC Pharma 04/05/2011 150 µg Solution for injection
4 pre-filled syringes with needle guard
EU/1/01/185/095 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 17/05/2011
Aranesp CC Pharma 23/05/2011 100 µg Solution for injection
4 pre-filled syringes with needle guard
EU/1/01/185/091 Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 10/06/2011
Aranesp CC Pharma 23/05/2011 300 µg Solution for injection
1 pre-filled syringe with needle guard
EU/1/01/185/096 Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 10/06/2011
Aranesp CC Pharma 23/05/2011 500 µg Solution for injection
1 pre-filled syringe with needle guard
EU/1/01/185/098 Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 10/06/2011
Aranesp Emra-Med 04/11/2010 300 µg Solution for injection
1 pre-filled syringe (non-blister)
EU/1/01/185/043 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 10/02/2011
Aranesp Emra-Med 04/11/2010 500 µg Solution for injection
1 pre-filled syringe (non-blister)
EU/1/01/185/044 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 10/02/2011
Aranesp Emra-Med 01/02/2011 150 µg Solution for injection
4 pre-filled syringes with needle guard
EU/1/01/185/095 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 04/02/2011
Aranesp Emra-Med 01/02/2011 300 µg Solution for injection
1 pre-filled syringe with needle guard
EU/1/01/185/096 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 09/02/2011
Aranesp Emra-Med 01/02/2011 50 µg Solution for injection
4 pre-filled syringes with needle guard
EU/1/01/185/085 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 04/02/2011
Aranesp Emra-Med 01/02/2011 500 µg Solution for injection
1 pre-filled syringe with needle guard
EU/1/01/185/098 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 09/02/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 26/255
Aranesp Euro Registratie Collectief BV
25/02/2011 20 µg Solution for injection
1 pre-filled syringe with needle guard
EU/1/01/185/078 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
14/06/2011
Aranesp Haemato Pharm AG
06/04/2011 100 µg Solution for injection
4 pre-filled syringes
EU/1/01/185/018 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 14/04/2011
Aranesp Haemato Pharm AG
06/04/2011 150 µg Solution for injection
4 pre-filled syringes
EU/1/01/185/020 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 14/04/2011
Aranesp Haemato Pharm AG
06/04/2011 300 µg Solution for injection
1 pre-filled syringe
EU/1/01/185/021 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 14/04/2011
Aranesp Haemato Pharm AG
06/04/2011 500 µg Solution for injection
1 pre-filled syringe
EU/1/01/185/031 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 14/04/2011
Aranesp Haemato Pharm AG
06/04/2011 80 µg Solution for injection
4 pre-filled syringes
EU/1/01/185/016 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 14/04/2011
Aranesp Haemato Pharm AG
26/04/2011 10 µg Solution for injection
4 pre-filled syringes
EU/1/01/185/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 12/05/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 27/255
Aranesp Haemato Pharm AG
26/04/2011 20 µg Solution for injection
4 pre-filled syringes with needle guard
EU/1/01/185/079 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 12/05/2011
Aranesp Haemato Pharm AG
26/04/2011 30 µg Solution for injection
4 pre-filled syringes with needle guard
EU/1/01/185/081 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 12/05/2011
Aranesp Haemato Pharm AG
27/04/2011 130 µg Solution for injection
4 pre-filled syringes with needle guard
EU/1/01/185/093 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 12/05/2011
Aranesp Haemato Pharm AG
27/04/2011 300 µg Solution for injection
1 pre-filled syringe with needle guard
EU/1/01/185/096 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 12/05/2011
Aranesp Haemato Pharm AG
27/04/2011 40 µg Solution for injection
4 pre-filled syringes with needle guard
EU/1/01/185/083 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 12/05/2011
Aranesp Haemato Pharm AG
27/04/2011 50 µg Solution for injection
4 pre-filled syringes with needle guard
EU/1/01/185/085 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 12/05/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 28/255
Aranesp Haemato Pharm AG
27/04/2011 500 µg Solution for injection
1 pre-filled syringe with needle guard
EU/1/01/185/098 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 12/05/2011
Aranesp Haemato Pharm AG
27/04/2011 60 µg Solution for injection
4 pre-filled syringe with needle guard
EU/1/01/185/087 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 12/05/2011
Aranesp Haemato Pharm AG
07/06/2011 100 µg Solution for injection
4 pre-filled syringes with needle guard
EU/1/01/185/091 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 20/06/2011
Aranesp Haemato Pharm AG
07/06/2011 150 µg Solution for injection
4 pre-filled syringes with needle guard
EU/1/01/185/095 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 20/06/2011
Aranesp Haemato Pharm AG
08/06/2011 80 µg Solution for injection
4 pre-filled syringes with needle guard
EU/1/01/185/089 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 21/06/2011
Aranesp Medcor Pharmaceuticals BV
01/03/2011 300 µg Solution for injection
1 pre-filled syringe with needle guard
EU/1/01/185/096 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
15/03/2011
Aranesp Medcor Pharmaceuticals BV
01/07/2011 500 µg Solution for injection
1 pre-filled syringe with needle guard
EU/1/01/185/098 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
04/07/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 29/255
Aranesp Medcor Pharmaceuticals BV
16/08/2011 20 µg Solution for injection
4 pre-filled syringes with needle guard
EU/1/01/185/079 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
23/08/2011
Aranesp Medcor Pharmaceuticals BV
16/08/2011 30 µg Solution for injection
4 pre-filled syringes with needle guard
EU/1/01/185/081 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
23/08/2011
Aranesp Medcor Pharmaceuticals BV
16/08/2011 40 µg Solution for injection
4 pre-filled syringes with needle guard
EU/1/01/185/083 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
23/08/2011
Aranesp Medcor Pharmaceuticals BV
16/08/2011 60 µg Solution for injection
4 pre-filled syringe with needle guard
EU/1/01/185/087 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
23/08/2011
Aranesp Medcor Pharmaceuticals BV
16/08/2011 80 µg Solution for injection
4 pre-filled syringes with needle guard
EU/1/01/185/089 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
23/08/2011
Aranesp Medcor Pharmaceuticals BV
05/09/2011 100 µg Solution for injection
4 pre-filled syringes with needle guard
EU/1/01/185/091 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
07/09/2011
Aranesp Orifarm AS 16/03/2011 150 µg Solution for injection
1 pre-filled pen
EU/1/01/185/054 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 20/04/2011
Aranesp Orifarm AS 12/07/2011 20 µg Solution for injection
1 pre-filled pen
EU/1/01/185/047 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Denmark 19/07/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 30/255
Aranesp Orifarm AS 12/07/2011 40 µg Solution for injection
1 pre-filled pen
EU/1/01/185/049 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Denmark 19/07/2011
Aranesp Paranova Läkemedel AB
17/11/2011 300 µg Solution for injection
1 pre-filled syringe with needle guard
EU/1/01/185/096 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 23/11/2011
Aranesp Pharma Westen GmbH
04/11/2011 100 µg Solution for injection
4 pre-filled syringes with needle guard
EU/1/01/185/091 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 11/11/2011
Aranesp (SureClick)
Paranova OY 30/08/2011 500 µg Solution for injection
1 pre-filled pen
EU/1/01/185/056 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Finland 04/10/2011
Arava ADL Pharma GmbH
31/01/2011 10 mg Film-coated tablet 30 EU/1/99/118/003 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 19/04/2011
Arava ADL Pharma GmbH
31/01/2011 10 mg Film-coated tablet 100 EU/1/99/118/004 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/07/2011
Arava ADL Pharma GmbH
30/06/2011 20 mg Film-coated tablet 30 EU/1/99/118/007 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 13/07/2011
Arava ADL Pharma GmbH
30/06/2011 20 mg Film-coated tablet 100 EU/1/99/118/008 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 13/07/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 31/255
Arava BB Farma s.r.l.
18/08/2011 10 mg Film-coated tablet 30 EU/1/99/118/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 06/09/2011
Arava BB Farma s.r.l.
18/08/2011 20 mg Film-coated tablet 30 EU/1/99/118/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 06/09/2011
Arava CC Pharma 18/07/2011 10 mg Film-coated tablet 30 EU/1/99/118/003 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Lithuania, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 23/08/2011
Arava Haemato Pharm AG
15/04/2011 10 mg Film-coated tablet 100 EU/1/99/118/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 20/04/2011
Arava Haemato Pharm AG
15/04/2011 20 mg Film-coated tablet 100 EU/1/99/118/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 02/05/2011
Arava MPT Pharma 16/11/2010 10 mg Film-coated tablet 30 EU/1/99/118/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
26/01/2011
Arava MPT Pharma 16/11/2010 10 mg Film-coated tablet 100 EU/1/99/118/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
26/01/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 32/255
Arava MPT Pharma 14/03/2011 20 mg Film-coated tablet 30 EU/1/99/118/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
31/03/2011
Arava Propharmed GmbH
24/02/2011 20 mg Film-coated tablet 100 EU/1/99/118/008 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 02/03/2011
Arixtra 2 Care 4 22/06/2011 1.5 mg/0.3 ml Solution for injection
7 pre-filled syringes
EU/1/02/206/006 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 10/08/2011
Arixtra 2 Care 4 22/06/2011 10 mg/0.8 ml Solution for injection
10 pre-filled syringes
EU/1/02/206/017 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 10/08/2011
Arixtra 2 Care 4 22/06/2011 2.5 mg/0.5 ml Solution for injection
20 pre-filled syringes
EU/1/02/206/004 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 10/08/2011
Arixtra 2 Care 4 22/06/2011 5 mg/0.4 ml Solution for injection
10 pre-filled syringes
EU/1/02/206/011 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 10/08/2011
Arixtra 2 Care 4 22/06/2011 7.5 mg/0.6 ml Solution for injection
10 pre-filled syringes
EU/1/02/206/014 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 10/08/2011
Arixtra Axicorp Pharma GmbH
15/03/2011 2.5 mg/0.5 ml Solution for injection
20 pre-filled syringes
EU/1/02/206/004 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 29/03/2011
Arixtra Elpis Ltd. 22/12/2009 2.5 mg/0.5 ml Solution for injection
7 pre-filled syringes
EU/1/02/206/002 Austria, Belgium, Bulgaria, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Liechtenstein, Lithuania, Luxembourg, Malta, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Latvia 11/03/2011
Arixtra Emra-Med 03/01/2011 1.5 mg/0.3 ml Solution for injection
7 pre-filled syringes
EU/1/02/206/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 14/01/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 33/255
Arixtra Orifarm AS 03/01/2011 7.5 mg/0.6 ml Solution for injection
10 pre-filled syringes
EU/1/02/206/014 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 03/03/2011
Arixtra Orifarm AS 03/08/2011 1.5 mg/0.3 ml Solution for injection
7 pre-filled syringes
EU/1/02/206/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 09/08/2011
Arixtra Orifarm AS 03/08/2011 10 mg/0.8 ml Solution for injection
10 pre-filled syringes
EU/1/02/206/017 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 09/08/2011
Arixtra Orifarm AS 03/08/2011 5 mg/0.4 ml Solution for injection
10 pre-filled syringes
EU/1/02/206/011 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 09/08/2011
atriance Haemato Pharm AG
04/04/2011 5 mg/ml Solution for infusion
6 vials EU/1/07/403/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 19/04/2011
Atripla Delphi Pharmaceuticals BV
23/02/2011 -- Film-coated tablet 30 EU/1/07/430/001 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Luxembourg, Portugal, Spain, United Kingdom
The Netherlands
27/04/2011
Atripla EU-Pharma BV 26/04/2011 -- Film-coated tablet 30 EU/1/07/430/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, United Kingdom
The Netherlands
03/05/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 34/255
Atripla Haemato Pharm AG
21/04/2011 -- Film-coated tablet 30 EU/1/07/430/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 29/04/2011
Atripla Medartuum AB 10/05/2011 -- Film-coated tablet 30 EU/1/07/430/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 16/05/2011
Atripla NewNeopharm BV
28/10/2010 -- Film-coated tablet 30 EU/1/07/430/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 07/01/2011
Atripla Orifarm AB 03/08/2011 -- Film-coated tablet 30 EU/1/07/430/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 22/08/2011
Atripla Orifarm OY 15/03/2011 -- Film-coated tablet 30 EU/1/07/430/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Finland 28/03/2011
Atripla Paranova Läkemedel AB
29/08/2011 -- Film-coated tablet 30 EU/1/07/430/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 15/11/2011
Atripla Paranova OY 10/03/2011 -- Film-coated tablet 30 EU/1/07/430/001 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Finland 14/04/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 35/255
Atripla Pharmachim AB
23/11/2011 -- Film-coated tablet 30 EU/1/07/430/001 Austria, Belgium, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Malta, Norway, Poland, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 29/11/2011
Avamys Clear Pharmacy
15/07/2011 27.5 micrograms/ spray
Nasal spray, suspension
1 bottle EU/1/07/434/003 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Malta, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
21/07/2011
Avamys EU-Pharma BV 14/07/2011 27.5 micrograms/ spray
Nasal spray, suspension
1 bottle EU/1/07/434/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, United Kingdom
The Netherlands
20/07/2011
Avamys Imed Healthcare Ltd
11/08/2011 27.5 micrograms/ spray
Nasal spray, suspension
1 bottle EU/1/07/434/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
12/08/2011
Avamys Mediwin Ltd 20/06/2011 27.5 micrograms/ spray
Nasal spray, suspension
1 bottle EU/1/07/434/003 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Poland, Portugal, Sweden, The Netherlands, United Kingdom
Spain 19/07/2011
Avamys Mediwin Ltd 20/06/2011 27.5 micrograms/ spray
Nasal spray, suspension
1 bottle EU/1/07/434/003 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Ireland, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Italy 19/07/2011
Avamys PCO Manufacturing
28/04/2010 27.5 micrograms/ spray
Nasal spray, suspension
1 bottle EU/1/07/434/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
12/01/2011
Avamys Pharmachim AB
26/09/2011 27.5 micrograms/ spray
Nasal spray, suspension
1 bottle EU/1/07/434/003 Austria, Belgium, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 17/10/2011
Avandamet Emra-Med 16/04/2010 4 mg/1000 mg Film-coated tablet 56 EU/1/03/258/012 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 07/01/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 36/255
Avandia Cross Pharma AB
04/05/2010 4 mg Film-coated tablet 28 EU/1/00/137/006 Austria, Belgium, Bulgaria, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Sweden 12/01/2011
Avastin Dr Fisher Farma BV
08/02/2011 25 mg/ml Concentrate for solution for infusion
1 vial EU/1/04/300/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
21/03/2011
Avastin Orifarm AB 31/03/2011 25 mg/ml Concentrate for solution for infusion
1 vial EU/1/04/300/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 06/04/2011
Avastin Orifarm AB 31/03/2011 25 mg/ml Concentrate for solution for infusion
1 vial EU/1/04/300/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 06/04/2011
Avastin Orifarm OY 17/02/2011 25 mg/ml Concentrate for solution for infusion
1 vial EU/1/04/300/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Finland 07/03/2011
Avastin Orifarm OY 17/02/2011 25 mg/ml Concentrate for solution for infusion
1 vial EU/1/04/300/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Finland 07/03/2011
Avonex CC Pharma 14/10/2011 30 µg/0.5 ml (6 million IU)
Solution for injection
4 pre-filled pens
EU/1/97/033/005 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 05/12/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 37/255
Avonex Emra-Med 05/09/2011 30 µg/0.5 ml (6 million IU)
Solution for injection
12 pre-filled syringes + 12 needles
EU/1/97/033/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 28/09/2011
Avonex Inopha GmbH 22/03/2011 30 µg/0.5 ml (6 million IU)
Solution for injection
4 pre-filled syringes + 4 needles
EU/1/97/033/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, United Kingdom
The Netherlands
28/03/2011
Avonex Pharma Westen GmbH
15/11/2011 30 µg/0.5 ml (6 million IU)
Solution for injection
4 pre-filled pens
EU/1/97/033/005 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 12/12/2011
Avonex Veron Pharma Vertriebs GmbH
13/12/2010 30 µg/0.5 ml (6 million IU)
Solution for injection
4 pre-filled syringes + 4 needles
EU/1/97/033/003 Austria, Belgium, France, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom
Germany 09/02/2011
Axura 2 Care 4 30/11/2011 10 mg Film-coated tablet 28 EU/1/02/218/007 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 16/12/2011
Axura 2 Care 4 30/11/2011 10 mg Film-coated tablet 56 EU/1/02/218/008 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 16/12/2011
Axura 2 Care 4 02/12/2011 10 mg Film-coated tablet 98 EU/1/02/218/014 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 21/12/2011
Axura 2 Care 4 02/12/2011 10 mg Film-coated tablet 112 EU/1/02/218/009 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 21/12/2011
Axura CC Pharma 04/07/2011 5 mg + 10 mg + 15 mg + 20 mg
Film-coated tablet 7 x 5 mg + 7 x 10 mg +7 x 15 mg +7 x 20 mg
EU/1/02/218/016 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 08/09/2011
Axura Ethigen Limited
04/10/2011 10 mg Film-coated tablet 28 EU/1/02/218/007 Germany United Kingdom
27/10/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 38/255
Axura Omnia Läkemedel AB
11/08/2011 10 mg Film-coated tablet 98 EU/1/02/218/014 Bulgaria, Germany, Portugal Sweden 16/08/2011
Axura Pharma Westen GmbH
21/04/2011 10 mg Film-coated tablet 98 EU/1/02/218/014 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 29/04/2011
Azarga B&S Healthcare Ltd
15/11/2011 10 mg/ml / 5 mg/ml
Eye drops, suspension
1 bottle EU/1/08/482/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
02/12/2011
Azarga CC Pharma 07/12/2010 10 mg/ml / 5 mg/ml
Eye drops, suspension
1 bottle EU/1/08/482/001 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 05/01/2011
Azarga CC Pharma 07/12/2010 10 mg/ml / 5 mg/ml
Eye drops, suspension
3 bottles EU/1/08/482/002 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 06/01/2011
Azarga Mevita HandelsGmbH
02/12/2011 10 mg/ml / 5 mg/ml
Eye drops, suspension
1 bottle EU/1/08/482/001 Austria, Belgium, France, Greece, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 14/12/2011
Azarga Mevita HandelsGmbH
02/12/2011 10 mg/ml / 5 mg/ml
Eye drops, suspension
3 bottles EU/1/08/482/002 Austria, Belgium, France, Greece, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 14/12/2011
Azarga Orifarm AB 12/10/2011 10 mg/ml / 5 mg/ml
Eye drops, suspension
3 bottles EU/1/08/482/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 22/11/2011
Azarga Paranova Läkemedel AB
02/12/2011 10 mg/ml / 5 mg/ml
Eye drops, suspension
1 bottle EU/1/08/482/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 21/12/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 39/255
Azarga Paranova Läkemedel AB
02/12/2011 10 mg/ml / 5 mg/ml
Eye drops, suspension
3 bottles EU/1/08/482/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 21/12/2011
Azarga Swingward Ltd TA Medihealth
26/08/2009 10 mg/ml / 5 mg/ml
Eye drops, suspension
1 bottle EU/1/08/482/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands
United Kingdom
06/01/2011
Azilect Abacus Medicine A/S
20/04/2011 1 mg Tablet 112 EU/1/04/304/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 27/04/2011
Azilect Abacus Medicine A/S
20/04/2011 1 mg Tablet 28 EU/1/04/304/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 27/04/2011
AZILECT BR Pharma International Ltd
04/04/2011 1 mg Tablet 28 EU/1/04/304/003 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Italy, Liechtenstein, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands
Ireland, Malta, United Kingdom
13/04/2011
AZILECT Clear Pharmacy
31/03/2011 1 mg Tablet 28 EU/1/04/304/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Malta, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
07/04/2011
AZILECT Dr Fisher Farma BV
12/07/2011 1 mg Tablet 28 EU/1/04/304/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
20/07/2011
AZILECT EuroPharma DK
13/01/2011 1 mg Tablet 28 EU/1/04/304/003 Austria, Belgium, Cyprus, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 17/01/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 40/255
AZILECT EuroPharma DK
13/01/2011 1 mg Tablet 112 EU/1/04/304/006 Austria, Belgium, Cyprus, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 17/01/2011
AZILECT Interport Ltd 29/07/2011 1 mg Tablet 28 EU/1/04/304/003 Austria, Belgium, Bulgaria, Czech Republic, France, Germany, Greece, Hungary, Italy, Latvia, Lithuania, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands
United Kingdom
12/08/2011
AZILECT Omnia Läkemedel AB
09/08/2011 1 mg Tablet 112 EU/1/04/304/006 Belgium, Czech Republic, France, Germany, Greece, Italy, Norway, Poland, Portugal, Spain, United Kingdom
Sweden 15/08/2011
AZILECT Orifarm AS 11/05/2011 1 mg Tablet 30 EU/1/04/304/004 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 13/05/2011
AZILECT Paranova Danmark AS
09/03/2011 1 mg Tablet 112 EU/1/04/304/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 16/05/2011
Azopt Medartuum AB 31/03/2011 10 mg/ml Eye drops, suspension
3 bottles EU/1/00/129/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 13/04/2011
Azopt Mevita HandelsGmbH
07/10/2011 10 mg/ml Eye drops, suspension
1 bottle EU/1/00/129/001 Austria, Belgium, France, Greece, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 26/10/2011
Azopt Mevita HandelsGmbH
07/10/2011 10 mg/ml Eye drops, suspension
3 bottles EU/1/00/129/003 Austria, Belgium, France, Greece, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 26/10/2011
Baraclude CC Pharma 22/03/2011 0.05 mg/ml Oral solution 1 bottle + 1 measuring spoon
EU/1/06/343/005 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 15/04/2011
Baraclude Combiphar Europe BV
08/10/2009 0.5 mg Film-coated tablet 30 x 1 EU/1/06/343/003 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
12/09/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 41/255
Baraclude Haemato Pharm AG
15/04/2011 0.5 mg Film-coated tablet 30 x 1 EU/1/06/343/003 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Denmark 20/04/2011
Baraclude Omnia Läkemedel AB
16/09/2011 0.5 mg Film-coated tablet 30 x 1 EU/1/06/343/003 Austria, Belgium, Bulgaria, France, Germany, Greece, Italy, Portugal, Romania, Spain, The Netherlands, United Kingdom
Sweden 26/09/2011
Baraclude Paranova Läkemedel AB
21/06/2011 0.5 mg Film-coated tablet 30 x 1 EU/1/06/343/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 25/07/2011
Benlysta Emra-Med 18/11/2011 120 mg Powder for concentrate for solution for infusion
1 vial EU/1/11/700/001 Austria, Belgium, Ireland, Malta, The Netherlands, United Kingdom
Germany 21/12/2011
Benlysta Emra-Med 18/11/2011 400 mg Powder for concentrate for solution for infusion
1 vial EU/1/11/700/002 Austria, Belgium, Ireland, Malta, The Netherlands, United Kingdom
Germany 21/12/2011
Benlysta Haemato Pharm AG
19/09/2011 120 mg Powder for concentrate for solution for infusion
1 vial EU/1/11/700/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 29/09/2011
Benlysta Haemato Pharm AG
19/09/2011 400 mg Powder for concentrate for solution for infusion
1 vial EU/1/11/700/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 29/09/2011
Betaferon Axicorp Pharma B.V.
23/08/2011 0.25 mg/ml Powder and solvent for solution for injection
3 x 14 x (1 vial + 1 pre-filled syringe + 1 vial adapter with needle + 2 alcohol wipes)
EU/1/95/003/010 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Germany 02/09/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 42/255
Betaferon Axicorp Pharma B.V.
24/08/2011 0.25 mg/ml Powder and solvent for solution for injection
3 x 15 x (1 vial + 1 pre-filled syringe + 1 vial adapter with needle + 2 alcohol wipes)
EU/1/95/003/007 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Germany 15/09/2011
Betaferon Axicorp Pharma B.V.
07/12/2011 0.25 mg/ml Powder and solvent for solution for injection
14 x (1 vial + 1 pre-filled syringe + 1 vial adapter with needle + 2 alcohol wipes)
EU/1/95/003/009 Austria, Belgium, Bulgaria, Czech Republic, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Spain, The Netherlands, United Kingdom
Germany 16/12/2011
Betaferon Emra-Med 04/01/2010 0.25 mg/ml Powder and solvent for solution for injection
3 x 14 x (1 vial + 1 pre-filled syringe + 1 vial adapter with needle + 2 alcohol wipes)
EU/1/95/003/010 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 03/05/2011
Betaferon EVE Packs GmbH
16/02/2011 0.25 mg/ml Powder and solvent for solution for injection
3 x 14 x (1 vial + 1 pre-filled syringe + 1 vial adapter with needle + 2 alcohol wipes)
EU/1/95/003/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 27/05/2011
Betaferon Haemato Pharm AG
14/03/2011 0.25 mg/ml Powder and solvent for solution for injection
15 x (1 vial + 1 pre-filled syringe + 1 vial adapter with needle + 2 alcohol wipes)
EU/1/95/003/005 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 13/04/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 43/255
Betaferon Medartuum AB 13/07/2011 0.25 mg/ml Powder and solvent for solution for injection
15 x (1 vial + 1 pre-filled syringe + 1 vial adapter with needle + 2 alcohol wipes)
EU/1/95/003/005 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 15/09/2011
Betaferon Omnia Läkemedel AB
13/07/2011 0.25 mg/ml Powder and solvent for solution for injection
15 x (1 vial + 1 pre-filled syringe + 1 vial adapter with needle + 2 alcohol wipes)
EU/1/95/003/005 Belgium, Bulgaria, France, Greece, Italy, Lithuania, Poland, Portugal, Romania, Spain, The Netherlands, United Kingdom
Sweden 08/09/2011
Betaferon Orifarm AB 17/05/2011 0.25 mg/ml Powder and solvent for solution for injection
15 x (1 vial + 1 pre-filled syringe + 1 vial adapter with needle + 2 alcohol wipes)
EU/1/95/003/005 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 11/07/2011
Betaferon Orifarm OY 13/09/2011 0.25 mg/ml Powder and solvent for solution for injection
15 x (1 vial + 1 pre-filled syringe + 1 vial adapter with needle + 2 alcohol wipes)
EU/1/95/003/005 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Finland 20/10/2011
Betaferon Paranova OY 25/08/2011 0.25 mg/ml Powder and solvent for solutionfor injection
15 x (1 vial + 1 pre-filled syringe + 1 vial adapter with needle + 2 alcohol wipes)
EU/1/95/003/005 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Finland 11/11/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 44/255
Betaferon Pharma Westen GmbH
21/01/2010 0.25 mg/ml Powder and solvent for solution for injection
14 x (1 vial + 1 pre-filled syringe + 1 vial adapter with needle + 2 alcohol wipes)
EU/1/95/003/009 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 16/12/2011
Betaferon Pharma Westen GmbH
21/01/2010 0.25 mg/ml Powder and solvent for solution for injection
3 x 14 x (1 vial + 1 pre-filled syringe + 1 vial adapter with needle + 2 alcohol wipes)
EU/1/95/003/010 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 16/12/2011
Betaferon Pharma Westen GmbH
07/10/2010 0.25 mg/ml Powder and solvent for solution for injection
5 x (1 vial + 1 pre-filled syringe + 1 vial adapter with needle + 2 alcohol wipes)
EU/1/95/003/006 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 16/12/2011
Betaferon Pharmachim AB
20/10/2011 0.25 mg/ml Powder and solvent for solution for injection
15 x (1 vial + 1 pre-filled syringe + 1 vial adapter with needle + 2 alcohol wipes)
EU/1/95/003/005 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Malta, Norway, Poland, Portugal, Spain, The Netherlands, United Kingdom
Sweden 13/12/2011
Bondronat Kohlpharma GmbH
18/10/2011 6 mg/6 ml Concentrate for solution for infusion
5 vials EU/1/96/012/012 Czech Republic, Greece, Romania Germany 03/11/2011
Bonviva Abacus Medicine A/S
03/03/2011 150 mg Film-coated tablet 1 EU/1/03/265/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 08/03/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 45/255
Bonviva MPT Pharma 26/07/2011 150 mg Film-coated tablet 1 EU/1/03/265/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
03/08/2011
Bonviva MPT Pharma 26/07/2011 150 mg Film-coated tablet 3 EU/1/03/265/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
03/08/2011
Bridion Orifarm AB 12/05/2011 100 mg/ml Solution for injection
10 vials EU/1/08/466/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 18/05/2011
Brilique CC Pharma 24/05/2011 90 mg Film-coated tablet 56 EU/1/10/655/004 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 28/06/2011
Brilique CC Pharma 24/05/2011 90 mg Film-coated tablet 100 x 1 EU/1/10/655/006 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 28/06/2011
Brilique Doncaster Pharmaceuticals Group Ltd
30/08/2011 90 mg Film-coated tablet 56 EU/1/10/655/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
14/09/2011
BYETTA CC Pharma 30/09/2010 10 micrograms
Solution for injection
1 pre-filled pen
EU/1/06/362/003 Austria, Belgium, France, Greece, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 18/05/2011
BYETTA Orifarm AB 07/04/2011 10 micrograms
Solution for injection
1 pre-filled pen
EU/1/06/362/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 19/04/2011
BYETTA PCO Manufacturing
18/03/2011 5 micrograms Solution for injection
1 pre-filled pen
EU/1/06/362/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
10/06/2011
Caelyx Euro Registratie Collectief BV
24/02/2011 2.0 mg/ml Concentrate for solution for infusion
1 vial EU/1/96/011/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
03/03/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 46/255
Caelyx Euro Registratie Collectief BV
24/02/2011 2.0 mg/ml Concentrate for solution for infusion
1 vial EU/1/96/011/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
03/03/2011
Caelyx Inopha GmbH 16/03/2011 2.0 mg/ml Concentrate for solution for infusion
1 vial EU/1/96/011/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, United Kingdom
The Netherlands
23/03/2011
Caelyx Inopha GmbH 16/03/2011 2.0 mg/ml Concentrate for solution for infusion
1 vial EU/1/96/011/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, United Kingdom
The Netherlands
23/03/2011
Caelyx InPharm Spzoo
25/08/2011 2.0 mg/ml Concentrate for solution for infusion
1 vial EU/1/96/011/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Poland 04/10/2011
Caelyx Orifarm AB 29/11/2010 2.0 mg/ml Concentrate for solution for infusion
1 vial EU/1/96/011/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 19/01/2011
Caelyx Pharmachim AB
04/03/2011 2.0 mg/ml Concentrate for solution for infusion
1 vial EU/1/96/011/001 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 28/03/2011
Caelyx Pharmachim AB
07/03/2011 2.0 mg/ml Concentrate for solution for infusion
1 vial EU/1/96/011/003 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 28/03/2011
Cancidas Emra-Med 15/03/2011 50 mg Powder for concentrate for solution for infusion
1 vial EU/1/01/196/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 31/03/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 47/255
Cancidas Haemato Pharm AG
27/04/2011 50 mg Powder for concentrate for solution for infusion
1 vial EU/1/01/196/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 16/05/2011
Cancidas Haemato Pharm AG
27/04/2011 70 mg Powder for concentrate for solution for infusion
1 vial EU/1/01/196/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 16/05/2011
Cancidas InPharm Spzoo
22/07/2011 50 mg Powder for concentrate for solution for infusion
1 vial EU/1/01/196/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Poland 15/09/2011
Cancidas InPharm Spzoo
22/07/2011 70 mg Powder for concentrate for solution for infusion
1 vial EU/1/01/196/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Poland 15/09/2011
Cancidas Paranova Läkemedel AB
28/04/2011 50 mg Powder for concentrate for solution for infusion
1 vial EU/1/01/196/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 17/05/2011
Cancidas Paranova Läkemedel AB
28/04/2011 70 mg Powder for concentrate for solution for infusion
1 vial EU/1/01/196/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 17/05/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 48/255
Cancidas Pharmachim AB
21/01/2011 50 mg Powder for concentrate for solution for infusion
1 vial EU/1/01/196/001 Austria, Belgium, Bulgaria, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, Portugal, Romania, Spain, The Netherlands, United Kingdom
Sweden 21/02/2011
Cancidas Pharmachim AB
21/01/2011 70 mg Powder for concentrate for solution for infusion
1 vial EU/1/01/196/003 Austria, Belgium, Bulgaria, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, Portugal, Romania, Spain, The Netherlands, United Kingdom
Sweden 21/02/2011
CellCept BB Farma s.r.l.
05/10/2011 250 mg Capsule, hard 300 EU/1/96/005/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 07/11/2011
CellCept BB Farma s.r.l.
05/10/2011 250 mg Capsule, hard 100 EU/1/96/005/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 07/11/2011
CellCept BB Farma s.r.l.
05/10/2011 500 mg Film-coated tablet 50 EU/1/96/005/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 10/11/2011
CellCept BB Farma s.r.l.
05/10/2011 500 mg Film-coated tablet 150 EU/1/96/005/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 07/11/2011
CellCept EU-Pharma BV 07/12/2011 500 mg Film-coated tablet 150 EU/1/96/005/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
19/12/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 49/255
CellCept EuroPharma DK
16/02/2011 250 mg Capsule, hard 100 EU/1/96/005/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Denmark 04/03/2011
CellCept EuroPharma DK
16/02/2011 250 mg Capsule, hard 300 EU/1/96/005/003 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Denmark 31/03/2011
CellCept Europharma Sverige AB
06/07/2011 250 mg Capsule, hard 100 EU/1/96/005/001 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Norway, Poland, Portugal, Slovak Republic, Spain, The Netherlands, United Kingdom
Sweden 18/07/2011
CellCept Europharma Sverige AB
06/07/2011 500 mg Film-coated tablet 50 EU/1/96/005/002 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Norway, Poland, Portugal, Slovak Republic, Spain, The Netherlands, United Kingdom
Sweden 18/07/2011
CellCept Haemato Pharm AG
27/04/2011 500 mg Film-coated tablet 150 EU/1/96/005/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 18/05/2011
CellCept MPT Pharma 04/01/2011 500 mg Film-coated tablet 50 EU/1/96/005/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
13/01/2011
CellCept MPT Pharma 04/01/2011 500 mg Film-coated tablet 150 EU/1/96/005/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
13/01/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 50/255
Cellcept MPT Pharma 10/06/2011 250 mg Capsule, hard 100 EU/1/96/005/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
28/06/2011
CellCept Orifarm AS 27/09/2011 1 g/5 ml Powder for oral suspension
1 bottle EU/1/96/005/006 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 19/10/2011
Celsentri Haemato Pharm AG
04/04/2011 150 mg Film-coated tablet 60 EU/1/07/418/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 13/04/2011
Celsentri Haemato Pharm AG
04/04/2011 300 mg Film-coated tablet 60 EU/1/07/418/008 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 13/04/2011
Celsentri MedicoPharm AG
03/08/2011 150 mg Film-coated tablet 60 EU/1/07/418/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 10/08/2011
Celsentri MedicoPharm AG
03/08/2011 300 mg Film-coated tablet 60 EU/1/07/418/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 10/08/2011
Celsentri Orifarm AS 23/11/2011 150 mg Film-coated tablet 60 EU/1/07/418/003 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 23/11/2011
Celsentri Orifarm AS 23/11/2011 300 mg Film-coated tablet 60 EU/1/07/418/008 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 23/11/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 51/255
Celsentri Paranova Danmark AS
28/10/2011 300 mg Film-coated tablet 60 EU/1/07/418/008 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 05/12/2011
Cerezyme Medartuum AB 20/06/2011 400 U Powder for concentrate for solution for infusion
1 vial EU/1/97/053/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 30/06/2011
Cervarix Axicorp Pharma GmbH
20/06/2011 - - Suspension for injection
1 pre-filled syringe + 1 needle
EU/1/07/419/004 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 04/07/2011
Cervarix CC Pharma 18/05/2011 - - Suspension for injection
1 pre-filled syringe + 1 needle
EU/1/07/419/004 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Germany 22/06/2011
Cetrotide Axicorp Pharma GmbH
17/08/2011 0.25 mg Powder and solvent for solution for injection
1 vial + 1 pre-filled syringe + 2 injection needles + 2 alcohol swabs
EU/1/99/100/001 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 26/08/2011
Cetrotide CC Pharma 15/03/2011 0.25 mg Powder and solvent for solution for injection
7 vials + 7 pre-filled syringes + 14 injection needles + 14 alcohol swabs
EU/1/99/100/002 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 14/04/2011
Cetrotide CC Pharma 15/03/2011 3 mg Powder and solvent for solution for injection
1 vial + 1 pre-filled syringe + 2 injection needles + 2 alcohol swabs
EU/1/99/100/003 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 14/04/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 52/255
Cetrotide Dr Fisher Farma BV
22/09/2010 0.25 mg Powder and solvent for solution for injection
1 vial + 1 pre-filled syringe + 2 injection needles + 2 alcohol swabs
EU/1/99/100/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
25/02/2011
Cetrotide Emra-Med 18/07/2011 0.25 mg Powder and solvent for solution for injection
7 vials + 7 pre-filled syringes + 14 injection needles + 14 alcohol swabs
EU/1/99/100/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 06/09/2011
Cetrotide Emra-Med 18/07/2011 3 mg Powder and solvent for solution for injection
1 vial + 1 pre-filled syringe + 2 injection needles + 2 alcohol swabs
EU/1/99/100/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 06/09/2011
Champix EU-Pharma BV 06/09/2011 1.0 mg Film-coated tablet 28 EU/1/06/360/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
14/09/2011
Champix Imed Healthcare Ltd
07/07/2011 1.0 mg Film-coated tablet 56 EU/1/06/360/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
28/07/2011
Champix Omnia Läkemedel AB
08/06/2011 1.0 mg Film-coated tablet 112 EU/1/06/360/011 Belgium, France, Greece, Italy, Poland, Portugal, Spain, The Netherlands, United Kingdom
Sweden 02/08/2011
Champix Paranova Danmark AS
10/05/2011 1.0 mg Film-coated tablet 56 EU/1/06/360/005 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 18/07/2011
Cholestagel CC Pharma 15/03/2010 625 mg Film-coated tablet 180 EU/1/03/268/004 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 01/12/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 53/255
Cialis 2 Care 4 22/07/2010 5 mg Film-coated tablet 28 EU/1/02/237/008 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 21/02/2011
Cialis Abacus Medicine A/S
27/09/2011 10 mg Film-coated tablet 4 EU/1/02/237/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 26/10/2011
Cialis Abacus Medicine A/S
27/09/2011 5 mg Film-coated tablet 28 EU/1/02/237/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 26/10/2011
Cialis ABACUS MEDICINE A/S
19/12/2011 20 mg Film-coated tablet 4 EU/1/02/237/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 22/12/2011
Cialis Beragena Arzneimittel GmbH
06/09/2011 5 mg Film-coated tablet 28 EU/1/02/237/008 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 28/09/2011
Cialis CC Pharma 08/02/2011 10 mg Film-coated tablet 4 EU/1/02/237/001 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Germany 07/03/2011
Cialis CC Pharma 08/11/2011 20 mg Film-coated tablet 12 EU/1/02/237/005 Austria, Belgium, Bulgaria, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Germany 02/12/2011
Cialis ChemVet Pharma ApS
07/04/2011 20 mg Film-coated tablet 4 EU/1/02/237/003 Austria, Belgium, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 10/05/2011
Cialis ChemVet Pharma ApS
07/04/2011 5 mg Film-coated tablet 28 EU/1/02/237/008 Austria, Belgium, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 10/05/2011
Cialis Docpharm GmbH&CoKGaA
19/01/2011 5 mg Film-coated tablet 28 EU/1/02/237/008 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 28/01/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 54/255
Cialis Emra-Med 25/11/2011 5 mg Film-coated tablet 14 EU/1/02/237/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 13/12/2011
Cialis Euro Registratie Collectief BV
20/06/2011 5 mg Film-coated tablet 28 EU/1/02/237/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
27/06/2011
Cialis EuroPharma DK
14/01/2011 10 mg Film-coated tablet 4 EU/1/02/237/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 08/02/2011
Cialis Kohlpharma GmbH
21/11/2011 5 mg Film-coated tablet 14 EU/1/02/237/007 France, The Netherlands, United Kingdom Germany 30/11/2011
Cialis MedicoPharm AG
03/02/2011 20 mg Film-coated tablet 8 EU/1/02/237/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 18/02/2011
Cialis Mevita HandelsGmbH
08/11/2010 20 mg Film-coated tablet 8 EU/1/02/237/004 Austria, Belgium, France, Greece, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 07/06/2011
Cialis Mevita HandelsGmbH
08/11/2010 20 mg Film-coated tablet 4 EU/1/02/237/003 Austria, Belgium, France, Greece, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 07/06/2011
Cialis Singad Pharma ApS
03/08/2011 5 mg Film-coated tablet 28 EU/1/02/237/008 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 15/08/2011
Cialis Singad Pharma ApS
04/08/2011 10 mg Film-coated tablet 4 EU/1/02/237/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 16/08/2011
Cimzia Axicorp Pharma GmbH
26/10/2011 200 mg Solution for injection
2 pre-filled syringes + 2 alcohol swabs
EU/1/09/544/001 Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 21/11/2011
Cimzia CC Pharma 13/04/2011 200 mg Solution for injection
6 (3 x 2) pre-filled syringes + 6 (3 x 2) alcohol swabs
EU/1/09/544/002 Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 20/04/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 55/255
Cimzia Dr Fisher Farma BV
26/07/2011 200 mg Solution for injection
2 pre-filled syringes + 2 alcohol swabs
EU/1/09/544/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
20/09/2011
Cimzia Euro Registratie Collectief BV
18/03/2011 200 mg Solution for injection
2 pre-filled syringes + 2 alcohol swabs
EU/1/09/544/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
10/05/2011
Cimzia Kohlpharma GmbH
26/07/2011 200 mg Solution for injection
6 (3 x 2) pre-filled syringes + 6 (3 x 2) alcohol swabs
EU/1/09/544/002 Austria, Belgium, France, Sweden, United Kingdom
Germany 05/09/2011
Cimzia Orifarm AB 12/10/2011 200 mg Solution for injection
2 pre-filled syringes + 2 alcohol swabs
EU/1/09/544/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 25/10/2011
Cimzia Orifarm AS 06/05/2011 200 mg Solution for injection
2 pre-filled syringes + 2 alcohol swabs
EU/1/09/544/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 25/05/2011
Cimzia Pharma Westen GmbH
07/12/2010 200 mg Solution for injection
2 pre-filled syringes + 2 alcohol swabs
EU/1/09/544/001 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 02/02/2011
Cimzia Pharma Westen GmbH
13/01/2011 200 mg Solution for injection
6 (3 x 2) pre-filled syringes + 6 (3 x 2) alcohol swabs
EU/1/09/544/002 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 03/02/2011
Circadin Dr Fisher Farma BV
26/09/2011 2 mg Prolonged-release tablet
21 EU/1/07/392/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
12/10/2011
Circadin Euro Registratie Collectief BV
07/03/2011 2 mg Prolonged-release tablet
21 EU/1/07/392/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
09/03/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 56/255
circadin Ginova Ltd 18/04/2011 2 mg Prolonged-release tablet
21 EU/1/07/392/001 Austria, Belgium, Cyprus, Denmark, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands
Ireland, United Kingdom
20/04/2011
Circadin Pharmachim AB
10/08/2011 2 mg Prolonged-release tablet
21 EU/1/07/392/001 Austria, Belgium, Czech Republic, France, Germany, Greece, Ireland, Italy, Norway, Portugal, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 08/09/2011
Clopidogrel Mylan Euromedicines, S.L.
12/07/2010 75 mg Film-coated tablet 28 EU/1/09/559/014 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Poland, Portugal, Romania, Slovak Republic, Slovenia, Sweden, The Netherlands, United Kingdom
Spain 15/03/2011
Clopidogrel Teva Delfarma SpZoo
25/10/2011 75 mg Film-coated tablet 28 x 1 EU/1/09/540/011 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Poland 08/12/2011
CoAprovel B&S Healthcare
05/09/2011 300 mg/ 25 mg
Film-coated tablet 28 EU/1/98/086/024 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
04/10/2011
CoAprovel CC Pharma 04/11/2011 150 mg/ 12.50 mg
Film-coated tablet 56 x 1 EU/1/98/086/014 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 13/12/2011
CoAprovel Chemilines Ltd 18/10/2011 300 mg/ 25 mg
Film-coated tablet 28 EU/1/98/086/024 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands
United Kingdom
15/11/2011
CoAprovel Dr Fisher Farma BV
05/07/2011 300 mg/ 25 mg
Film-coated tablet 28 EU/1/98/086/024 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
14/07/2011
CoAprovel Emra-Med 11/07/2011 300 mg/ 12.50 mg
Film-coated tablet 28 EU/1/98/086/017 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/08/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 57/255
CoAprovel Emra-Med 11/07/2011 300 mg/ 12.50 mg
Film-coated tablet 98 EU/1/98/086/020 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/08/2011
CoAprovel Emra-Med 11/07/2011 300 mg/ 12.50 mg
Film-coated tablet 56 EU/1/98/086/018 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/08/2011
CoAprovel EU-Pharma BV 20/07/2011 150 mg/ 12.50 mg
Tablet 28 EU/1/98/086/001 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, United Kingdom
The Netherlands
26/07/2011
CoAprovel EU-Pharma BV 27/07/2011 150 mg/ 12.50 mg
Film-coated tablet 28 EU/1/98/086/012 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, United Kingdom
The Netherlands
08/08/2011
CoAprovel Orifarm AB 12/05/2011 300 mg/ 25 mg
Film-coated tablet 98 EU/1/98/086/027 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 19/05/2011
Combivir Docpharm GmbH&CoKGaA
26/01/2011 150 mg/ 300 mg
Film-coated tablet 60 EU/1/98/058/001 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 08/02/2011
Combivir Medartuum AB 27/09/2011 150 mg/ 300 mg
Film-coated tablet 60 EU/1/98/058/001 Austria, Belgium, Bulgaria, Cyprus, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Spain, The Netherlands, United Kingdom
Sweden 03/10/2011
Competact Chemilines Ltd 20/06/2011 15 mg/ 850 mg
Film-coated tablet 60 EU/1/06/354/006 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands
United Kingdom
13/09/2011
Competact Docpharm GmbH&CoKGaA
15/02/2011 15 mg/ 850 mg
Film-coated tablet 112 EU/1/06/354/010 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 16/03/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 58/255
Competact Docpharm GmbH&CoKGaA
15/02/2011 15 mg/ 850 mg
Film-coated tablet 196 (2 x 98)
EU/1/06/354/011 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 16/03/2011
Competact Kohlpharma GmbH
07/06/2011 15 mg/ 850 mg
Film-coated tablet 112 EU/1/06/354/010 France Germany 30/06/2011
Comtess Docpharm GmbH&CoKGaA
15/11/2011 200 mg Film-coated tablet 30 EU/1/98/082/001 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 17/11/2011
Comtess EuroPharma DK
22/07/2011 200 mg Film-coated tablet 100 EU/1/98/082/003 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 01/08/2011
Comtess Paranova Läkemedel AB
05/08/2011 200 mg Film-coated tablet 100 EU/1/98/082/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 11/08/2011
Cubicin CC Pharma 02/05/2011 350 mg Powder for solution for injection or infusion
1 vial EU/1/05/328/001 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 11/05/2011
Cubicin CC Pharma 02/05/2011 500 mg Powder for solution for injection or infusion
1 vial EU/1/05/328/002 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 11/05/2011
Cymbalta Abacus Medicine A/S
23/11/2011 30 mg Gastro-resistant capsule, hard
28 EU/1/04/296/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 09/12/2011
Cymbalta Abacus Medicine A/S
23/11/2011 30 mg Gastro-resistant capsule, hard
98 EU/1/04/296/009 Austria, Belgium, Cyprus, Finland, France, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 09/12/2011
Cymbalta Abacus Medicine A/S
23/11/2011 60 mg Gastro-resistant capsule, hard
28 EU/1/04/296/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 09/12/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 59/255
Cymbalta Abacus Medicine A/S
23/11/2011 60 mg Gastro-resistant capsule, hard
98 EU/1/04/296/004 Austria, Belgium, Cyprus, Finland, France, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 09/12/2011
Cymbalta B2B Medical GmbH
16/04/2011 30 mg Gastro-resistant capsule, hard
98 EU/1/04/296/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 03/05/2011
Cymbalta B2B Medical GmbH
16/04/2011 60 mg Gastro-resistant capsule, hard
98 EU/1/04/296/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 03/05/2011
Cymbalta BB Farma s.r.l.
17/05/2011 30 mg Gastro-resistant capsule, hard
28 EU/1/04/296/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 30/05/2011
Cymbalta BB Farma s.r.l.
17/05/2011 30 mg Gastro-resistant capsule, hard
98 EU/1/04/296/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 30/05/2011
Cymbalta BB Farma s.r.l.
09/06/2011 60 mg Gastro-resistant capsule, hard
28 EU/1/04/296/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 23/06/2011
Cymbalta BB Farma s.r.l.
09/06/2011 60 mg Gastro-resistant capsule, hard
98 EU/1/04/296/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 22/06/2011
Cymbalta Cross Healthcare Ltd
10/12/2010 30 mg Gastro-resistant capsule, hard
7 EU/1/04/296/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
17/02/2011
Cymbalta Haemato Pharm AG
12/04/2011 30 mg Gastro-resistant capsule, hard
28 EU/1/04/296/001 Austria, Belgium, Cyprus, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 28/04/2011
Cymbalta Haemato Pharm AG
12/04/2011 60 mg Gastro-resistant capsule, hard
28 EU/1/04/296/002 Austria, Belgium, Cyprus, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 28/04/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 60/255
Cymbalta Haemato Pharm AG
13/04/2011 60 mg Gastro-resistant capsule, hard
98 EU/1/04/296/004 Austria, Belgium, Cyprus, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 28/04/2011
Cymbalta Pharmachim AB
16/09/2011 60 mg Gastro-resistant capsule, hard
28 EU/1/04/296/002 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 11/10/2011
Cymbalta Propharmed GmbH
15/03/2011 30 mg Gastro-resistant capsule, hard
98 EU/1/04/296/009 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 30/03/2011
Cymbalta Propharmed GmbH
15/03/2011 60 mg Gastro-resistant capsule, hard
98 EU/1/04/296/004 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 30/03/2011
Cymbalta Propharmed GmbH
16/03/2011 60 mg Gastro-resistant capsule, hard
28 EU/1/04/296/002 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 30/03/2011
Cymbalta Veron Pharma Vertriebs GmbH
09/06/2011 30 mg Gastro-resistant capsule, hard
98 EU/1/04/296/009 Austria, Belgium, Finland, France, Greece, Italy, Portugal, Sweden, The Netherlands, United Kingdom
Germany 13/07/2011
Cystagon CC Pharma 21/04/2011 150 mg Capsule, hard 100 EU/1/97/039/003 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 06/05/2011
Cystagon CC Pharma 21/04/2011 50 mg Capsule, hard 100 EU/1/97/039/001 Austria, Belgium, Denmark, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 06/05/2011
Dukoral Omnia Läkemedel AB
08/02/2011 - - Suspension of vaccine and effervescent granules for oral solution
2 x 1 dose EU/1/03/263/002 Belgium, France, Italy, Poland, Spain, The Netherlands, United Kingdom
Sweden 22/02/2011
DuoPlavin BR Pharma International Ltd
11/05/2011 75 mg/100 mg Film-coated tablet 28 EU/1/10/619/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 27/05/2011
DuoPlavin BR Pharma International Ltd
19/10/2011 75 mg/100 mg Film-coated tablet 100 x 1 EU/1/10/619/014 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 15/11/2011
DuoPlavin CC Pharma 21/04/2011 75 mg/100 mg Film-coated tablet 28 EU/1/10/619/009 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 06/05/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 61/255
DuoPlavin Docpharm GmbH&CoKGaA
02/02/2011 75 mg/100 mg Film-coated tablet 100 x 1 EU/1/10/619/014 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 13/04/2011
DuoPlavin Docpharm GmbH&CoKGaA
02/02/2011 75 mg/100 mg Film-coated tablet 28 EU/1/10/619/009 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 08/04/2011
DuoPlavin Doncaster Pharmaceuticals Group Ltd
18/02/2011 75 mg/100 mg Film-coated tablet 28 EU/1/10/619/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
16/03/2011
DuoPlavin Dr Fisher Farma BV
02/02/2011 75 mg/100 mg Film-coated tablet 28 EU/1/10/619/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
19/04/2011
DuoPlavin Emra-Med 22/06/2011 75 mg/100 mg Film-coated tablet 100 x 1 EU/1/10/619/014 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 12/08/2011
DuoPlavin Kohlpharma GmbH
13/04/2011 75 mg/100 mg Film-coated tablet 28 EU/1/10/619/009 France, Italy, Spain Germany 24/05/2011
DuoPlavin Kohlpharma GmbH
13/04/2011 75 mg/100 mg Film-coated tablet 100 x 1 EU/1/10/619/014 France, Italy, Spain Germany 09/08/2011
DuoPlavin Medcor Pharmaceuticals BV
25/02/2011 75 mg/100 mg Film-coated tablet 28 EU/1/10/619/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
15/03/2011
DuoPlavin Pharma Westen GmbH
08/03/2011 75 mg/100 mg Film-coated tablet 28 EU/1/10/619/009 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 28/03/2011
DuoPlavin Veron Pharma Vertriebs GmbH
19/10/2011 75 mg/100 mg Film-coated tablet 28 EU/1/10/619/009 Austria, Belgium, France, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom
Germany 15/11/2011
DuoPlavin Veron Pharma Vertriebs GmbH
19/10/2011 75 mg/100 mg Film-coated tablet 100 x 1 EU/1/10/619/014 Austria, Belgium, France, Germany, Italy, Portugal, Spain, The Netherlands, United Kingdom
Germany 15/11/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 62/255
DuoTrav 2 Care 4 07/07/2010 40 µg /ml + 5 mg/ml
Eye drops, solution 3 bottles EU/1/06/338/002 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 10/01/2011
DuoTrav 2 Care 4 07/07/2010 40 µg /ml + 5 mg/ml
Eye drops, solution 1 bottle EU/1/06/338/001 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 10/01/2011
DuoTrav Abacus Medicine A/S
25/08/2011 40 µg /ml + 5 mg/ml
Eye drops, solution 3 bottles EU/1/06/338/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 26/08/2011
DuoTrav Abacus Medicine A/S
25/08/2011 40 µg /ml + 5 mg/ml
Eye drops, solution 1 bottle EU/1/06/338/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 26/08/2011
DuoTrav Cross Pharma AB
24/01/2011 40 µg /ml + 5 mg/ml
Eye drops, solution 3 bottles EU/1/06/338/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 08/02/2011
DuoTrav Doncaster Pharmaceuticals Group Ltd
01/09/2011 40 µg /ml + 5 mg/ml
Eye drops, solution 1 bottle EU/1/06/338/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
29/09/2011
DuoTrav Parallell Pharma AB
15/08/2011 40 µg /ml + 5 mg/ml
Eye drops, solution 1 bottle EU/1/06/338/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Poland, Portugal, Spain, The Netherlands, United Kingdom
Sweden 05/09/2011
DuoTrav Parallell Pharma AB
15/08/2011 40 µg /ml + 5 mg/ml
Eye drops, solution 3 bottles EU/1/06/338/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Poland, Portugal, Spain, The Netherlands, United Kingdom
Sweden 05/09/2011
DuoTrav Singad Pharma ApS
15/08/2011 40 µg /ml + 5 mg/ml
Eye drops, solution 1 bottle EU/1/06/338/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 12/09/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 63/255
DuoTrav Singad Pharma ApS
15/08/2011 40 µg /ml + 5 mg/ml
Eye drops, solution 3 bottles EU/1/06/338/002 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 12/09/2011
Dynastat Pharmachim AB
28/07/2011 40 mg Powder and solvent for solution for injection
5 vials + 5 ampoules
EU/1/02/209/008 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 12/08/2011
Ebixa Beragena Arzneimittel GmbH
11/10/2011 10 mg Film-coated tablet 42 EU/1/02/219/017 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 17/11/2011
Ebixa Beragena Arzneimittel GmbH
11/10/2011 10 mg Film-coated tablet 98 EU/1/02/219/020 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 17/11/2011
Ebixa Dr Fisher Farma BV
21/06/2011 10 mg Film-coated tablet 42 EU/1/02/219/017 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
27/06/2011
Ebixa Euro Registratie Collectief BV
20/09/2011 20 mg Film-coated tablet 28 EU/1/02/219/024 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
22/09/2011
Ebixa EuroPharma DK
29/03/2011 20 mg Film-coated tablet 28 EU/1/02/219/024 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 10/05/2011
Ebixa EuroPharma DK
29/03/2011 20 mg Film-coated tablet 98 EU/1/02/219/031 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 10/05/2011
Ebixa Medartuum AB 13/10/2011 20 mg Film-coated tablet 98 EU/1/02/219/045 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 25/11/2011
Ebixa Medcor Pharmaceuticals BV
03/01/2011 10 mg Film-coated tablet 42 EU/1/02/219/017 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
10/01/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 64/255
Ebixa Medcor Pharmaceuticals BV
13/05/2011 10 mg Film-coated tablet 98 EU/1/02/219/020 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
16/05/2011
Ebixa Medcor Pharmaceuticals BV
02/09/2011 20 mg Film-coated tablet 98 EU/1/02/219/031 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
07/09/2011
Ebixa MTK Pharma GmbH
07/04/2011 10 mg Film-coated tablet 42 EU/1/02/219/017 Poland Germany 22/06/2011
Ebixa Omnia Läkemedel AB
30/11/2011 10 mg Film-coated tablet 100 EU/1/02/219/003 Germany, Greece, Italy, Spain, The Netherlands, United Kingdom
Sweden 07/12/2011
Ebixa Orifarm AB 24/01/2011 20 mg Film-coated tablet 98 EU/1/02/219/031 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 31/01/2011
Ebixa Orifarm AS 24/01/2011 20 mg Film-coated tablet 28 EU/1/02/219/024 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 28/02/2011
Ebixa Orifarm AS 24/01/2011 20 mg Film-coated tablet 98 EU/1/02/219/031 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 31/01/2011
Ebixa Paranova Danmark AS
05/04/2011 10 mg Film-coated tablet 56 EU/1/02/219/008 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 19/05/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 65/255
Ebixa Paranova Danmark AS
05/04/2011 10 mg Film-coated tablet 28 EU/1/02/219/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, TheNetherlands, United Kingdom
Denmark 19/05/2011
Ebixa Paranova Danmark AS
29/06/2011 10 mg Film-coated tablet 112 EU/1/02/219/009 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 13/07/2011
Ebixa Paranova Läkemedel AB
13/10/2011 20 mg Film-coated tablet 28 EU/1/02/219/024 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 01/12/2011
Ebixa Paranova Läkemedel AB
13/10/2011 20 mg Film-coated tablet 98 EU/1/02/219/045 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 01/12/2011
Ebixa PCO Manufacturing
17/06/2011 10 mg Film-coated tablet 30 EU/1/02/219/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands
Ireland, United Kingdom
06/07/2011
Ebixa Pharmachim AB
06/06/2011 10 mg Film-coated tablet 30 EU/1/02/219/001 Austria, Belgium, Denmark, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 16/06/2011
Ebixa Pharmachim AB
06/06/2011 10 mg Film-coated tablet 100 EU/1/02/219/003 Austria, Belgium, Denmark, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 16/06/2011
Ebixa Pharmachim AB
28/07/2011 10 mg Film-coated tablet 28 EU/1/02/219/007 Austria, Belgium, Denmark, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 27/10/2011
Ebixa Pharmachim AB
28/07/2011 10 mg Film-coated tablet 56 EU/1/02/219/008 Austria, Belgium, Denmark, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 11/08/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 66/255
Ebixa Pharmachim AB
28/07/2011 10 mg Film-coated tablet 98 EU/1/02/219/020 Austria, Belgium, Denmark, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 11/08/2011
Ebixa Pharmacodane Aps
07/06/2011 20 mg Film-coated tablet 98 EU/1/02/219/031 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 24/06/2011
Ebixa Pharmacodane Aps
07/06/2011 20 mg Film-coated tablet 28 EU/1/02/219/024 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 23/06/2011
ECALTA Orifarm AB 08/11/2011 100 mg Powder for concentrate for solution for infusion
1 vial EU/1/07/416/002 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 10/11/2011
ECALTA Orifarm AS 04/07/2011 100 mg Powder for concentrate for solution for infusion
1 vial EU/1/07/416/002 Austria, Belgium, Cyprus, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 02/08/2011
Efient Amimed Direct Ltd
27/10/2010 10 mg Film-coated tablet 28 EU/1/08/503/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands
Ireland, United Kingdom
05/07/2011
Efient Amimed Direct Ltd
27/10/2010 5 mg Film-coated tablet 28 EU/1/08/503/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands
Ireland, United Kingdom
10/01/2011
Efient Emra-Med 13/09/2011 10 mg Film-coated tablet 28 EU/1/08/503/009 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 23/09/2011
Efient Emra-Med 13/09/2011 10 mg Film-coated tablet 98 EU/1/08/503/014 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 23/09/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 67/255
Efient EuroPharma DK
22/07/2011 10 mg Film-coated tablet 28 EU/1/08/503/009 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 02/08/2011
Efient EuroPharma DK
22/07/2011 10 mg Film-coated tablet 56 EU/1/08/503/011 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 01/08/2011
Efient EuroPharma DK
22/07/2011 10 mg Film-coated tablet 84 EU/1/08/503/012 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 01/08/2011
Efient EuroPharma DK
22/07/2011 10 mg Film-coated tablet 98 EU/1/08/503/014 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 01/08/2011
Efient Medcor Pharmaceuticals BV
22/04/2011 10 mg Film-coated tablet 14 EU/1/08/503/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
05/05/2011
Efient Medcor Pharmaceuticals BV
04/11/2011 10 mg Film-coated tablet 28 EU/1/08/503/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
25/11/2011
Efient Mevita HandelsGmbH
07/04/2011 5 mg Film-coated tablet 28 EU/1/08/503/002 Austria, Belgium, France, Greece, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 13/04/2011
Efient Mevita HandelsGmbH
07/04/2011 5 mg Film-coated tablet 98 EU/1/08/503/007 Austria, Belgium, France, Greece, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 13/04/2011
Efient Mevita HandelsGmbH
02/05/2011 10 mg Film-coated tablet 28 EU/1/08/503/009 Austria, Belgium, France, Greece, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 05/05/2011
Efient Mevita HandelsGmbH
02/05/2011 10 mg Film-coated tablet 98 EU/1/08/503/014 Austria, Belgium, France, Greece, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 05/05/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 68/255
Efient Orifarm AB 12/10/2011 10 mg Film-coated tablet 28 EU/1/08/503/009 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Sweden 22/11/2011
Efient Orifarm AS 27/10/2011 10 mg Film-coated tablet 28 EU/1/08/503/009 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 16/11/2011
Efient Paranova Danmark AS
28/10/2011 10 mg Film-coated tablet 28 EU/1/08/503/009 Austria, Belgium, Bulgaria, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 22/11/2011
Efient Pharmachim AB
09/10/2011 10 mg Film-coated tablet 28 EU/1/08/503/009 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 24/10/2011
Efient Swingward Ltd TA Medihealth
08/02/2011 10 mg Film-coated tablet 28 EU/1/08/503/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands
United Kingdom
10/02/2011
Efient Waymade PLC 31/01/2011 10 mg Film-coated tablet 28 EU/1/08/503/009 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
22/02/2011
Efient Waymade PLC 31/01/2011 5 mg Film-coated tablet 28 EU/1/08/503/002 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
24/02/2011
Elaprase Haemato Pharm AG
05/05/2011 2 mg/ml Concentrate for solution for infusion
1 vial EU/1/06/365/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Austria, Germany
07/06/2011
Elaprase Haemato Pharm AG
12/05/2011 2 mg/ml Concentrate for solution for infusion
1 vial EU/1/06/365/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 07/06/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 69/255
ellaOne Emra-Med 15/04/2011 30 mg Tablet 1 EU/1/09/522/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 06/06/2011
ellaOne Kohlpharma GmbH
31/03/2011 30 mg Tablet 1 EU/1/09/522/001 Austria Germany 13/04/2011
Emadine Kohlpharma GmbH
17/02/2011 0.05% Eye drops, solution 1 bottle EU/1/98/095/001 Czech Republic, Greece Germany 11/03/2011
Emend Dr Fisher Farma BV
14/12/2010 125 mg + 80 mg
Capsule, hard 1 capsule (125 mg) + 2 (80 mg)
EU/1/03/262/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
11/01/2011
Emend Dr Fisher Farma BV
23/09/2011 125 mg Capsule, hard 5 x 1 EU/1/03/262/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
03/10/2011
Emselex Beragena Arzneimittel GmbH
19/05/2011 15 mg Prolonged-release tablet
98 EU/1/04/294/026 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 25/05/2011
Emselex Emra-Med 25/07/2011 15 mg Prolonged release tablet
98 EU/1/04/294/026 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 08/08/2011
Emselex EuroPharma DK
02/08/2011 15 mg Prolonged-release tablet
28 EU/1/04/294/023 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 03/08/2011
Emselex EuroPharma DK
02/08/2011 15 mg Prolonged-release tablet
98 EU/1/04/294/026 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 03/08/2011
Emselex EuroPharma DK
02/08/2011 7.5 mg Prolonged-release tablet
28 EU/1/04/294/017 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 03/08/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 70/255
Emselex EuroPharma DK
02/08/2011 7.5 mg Prolonged-release tablet
98 EU/1/04/294/020 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 03/08/2011
Emselex Pharmachim AB
01/08/2011 15 mg Prolonged-release tablet
28 EU/1/04/294/023 Austria, Belgium, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 15/08/2011
Emselex Pharmachim AB
01/08/2011 15 mg Prolonged-release tablet
98 EU/1/04/294/026 Austria, Belgium, Czech Republic, Denmark, Estonia, France, Germany, Greece, Ireland, Italy, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 15/08/2011
Emselex Pharmachim AB
01/08/2011 7.5 mg Prolonged-release tablet
28 EU/1/04/294/017 Austria, Belgium, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 15/08/2011
Emselex Pharmachim AB
01/08/2011 7.5 mg Prolonged-release tablet
98 EU/1/04/294/020 Austria, Belgium, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 15/08/2011
Enbrel Abacus Medicine A/S
17/01/2011 25 mg Solution for injection in pre-filled syringe
4 pre-filled syringes + 8 alcohol swabs
EU/1/99/126/013 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 18/01/2011
Enbrel Abacus Medicine A/S
17/01/2011 50 mg Solution for injection in pre-filled syringe
4 pre-filled syringes + 8 alcohol swabs
EU/1/99/126/017 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 18/01/2011
Enbrel Emra-Med 08/03/2010 50 mg Solution for injection in pre-filled pen
4 pre-filled pens + 8 alcohol swabs
EU/1/99/126/020 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 26/01/2011
Enbrel Haemato Pharm AG
31/03/2011 50 mg Solution for injection in pre-filled pen
4 pre-filled pens + 8 alcohol swabs
EU/1/99/126/020 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 24/05/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 71/255
Enbrel Haemato Pharm AG
20/07/2011 50 mg Solution for injection in pre-filled pen
12 pre-filled pens + 24 alcohol swabs
EU/1/99/126/021 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 16/08/2011
Enbrel Kohlpharma GmbH
23/11/2011 50 mg Solution for injection in pre-filled pen
12 pre-filled pens + 24 alcohol swabs
EU/1/99/126/021 France, The Netherlands Germany 28/11/2011
Enbrel Orifarm AB 31/03/2011 25 mg Solution for injection in pre-filled syringe
4 pre-filled syringes + 8 alcohol swabs
EU/1/99/126/013 Austria, Belgium, Cyprus, Denmark, Estonia, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 07/04/2011
Enbrel Orifarm AB 31/03/2011 50 mg Solution for injection in pre-filled syringe
4 pre-filled syringes + 8 alcohol swabs
EU/1/99/126/017 Austria, Belgium, Cyprus, Denmark, Estonia, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 07/04/2011
Enbrel Orifarm AB 06/06/2011 50 mg Solution for injection in pre-filled pen
4 pre-filled pens + 8 alcohol swabs
EU/1/99/126/020 Austria, Belgium, Cyprus, Denmark, Estonia, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 24/06/2011
Enbrel Orifarm AB 16/11/2011 25 mg Powder and solvent for solution for injection
4 vials + 4 pre-filled syringes + 8 syringes + 20 needles + 24 alcohol swabs
EU/1/99/126/012 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 16/12/2011
Enbrel Pharma Westen GmbH
09/03/2010 50 mg Solution for injection in pre-filled pen
4 pre-filled pens + 8 alcohol swabs
EU/1/99/126/020 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 20/01/2011
Enbrel Pharma Westen GmbH
26/03/2010 50 mg Solution for injection in pre-filled pen
12 pre-filled pens + 24 alcohol swabs
EU/1/99/126/021 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 20/01/2011
Enbrel Pharmachim AB
27/09/2011 25 mg Solution for injection in pre-filled syringe
4 pre-filled syringes + 8 alcohol swabs
EU/1/99/126/013 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 10/11/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 72/255
Enbrel Pharmachim AB
27/09/2011 50 mg Solution for injection in pre-filled syringe
4 pre-filled syringes + 8 alcohol swabs
EU/1/99/126/017 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 10/11/2011
erbitux Haemato Pharm AG
01/04/2011 5 mg/ml Solution for infusion
1 vial EU/1/04/281/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 06/04/2011
erbitux Haemato Pharm AG
04/04/2011 5 mg/ml Solution for infusion
1 vial EU/1/04/281/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 06/04/2011
Erbitux Orifarm AS 11/05/2011 5 mg/ml Solution for infusion
1 vial EU/1/04/281/005 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 04/07/2011
Eucreas 2 Care 4 15/11/2011 50 mg / 850 mg
Film-coated tablet 60 EU/1/07/425/003 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 30/11/2011
Eucreas 2 Care 4 15/11/2011 50 mg / 850 mg
Film-coated tablet 180 EU/1/07/425/005 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 30/11/2011
Eucreas Abacus Medicine A/S
18/10/2011 50 mg / 850 mg
Film-coated tablet 60 EU/1/07/425/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 08/11/2011
Eucreas Abacus Medicine A/S
20/10/2011 50 mg / 850 mg
Film-coated tablet 180 EU/1/07/425/005 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 08/11/2011
Eucreas CC Pharma 18/01/2011 50 mg / 1000 mg
Film-coated tablet 180 tablet (3 x 60)
EU/1/07/425/017 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 28/01/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 73/255
Eucreas CC Pharma 18/01/2011 50 mg / 850 mg
Film-coated tablet 180 tablet (3 x 60)
EU/1/07/425/014 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 28/01/2011
Eucreas EuroPharma DK
29/03/2011 50 mg / 1000 mg
Film-coated tablet 60 EU/1/07/425/009 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 26/04/2011
Eucreas EuroPharma DK
29/03/2011 50 mg / 1000 mg
Film-coated tablet 180 EU/1/07/425/011 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 26/04/2011
Eucreas EuroPharma DK
02/08/2011 50 mg / 850 mg
Film-coated tablet 60 EU/1/07/425/003 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 03/08/2011
Eucreas EuroPharma DK
03/08/2011 50 mg / 850 mg
Film-coated tablet 180 EU/1/07/425/005 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 03/08/2011
Eucreas Orifarm AS 18/07/2011 50 mg / 1000 mg
Film-coated tablet 60 EU/1/07/425/009 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 02/08/2011
Eucreas Orifarm AS 04/11/2011 50 mg / 1000 mg
Film-coated tablet 180 EU/1/07/425/011 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 09/11/2011
Eucreas Paranova Danmark AS
28/04/2011 50 mg / 1000 mg
Film-coated tablet 60 EU/1/07/425/009 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 17/05/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 74/255
Eucreas Paranova Danmark AS
28/04/2011 50 mg / 1000 mg
Film-coated tablet 180 tablet (3 x 60)
EU/1/07/425/017 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 17/05/2011
Eucreas Pharmacodane Aps
24/01/2011 50 mg / 1000 mg
Film-coated tablet 60 EU/1/07/425/009 United Kingdom Denmark 25/05/2011
Eucreas Pharmacodane Aps
24/01/2011 50 mg / 1000 mg
Film-coated tablet 180 EU/1/07/425/011 United Kingdom Denmark 25/05/2011
Evista Mediwin Ltd 25/11/2011 60 mg Film-coated tablet 28 EU/1/98/073/002 Austria, Belgium, Cyprus, Denmark, Finland, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom
France 05/12/2011
Evista Mediwin Ltd 25/11/2011 60 mg Film-coated tablet 84 EU/1/98/073/003 Austria, Belgium, Cyprus, Denmark, Finland, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom
France 05/12/2011
EVRA BCN Farma SL 12/11/2010 - - Transdermal patch 3 transdermal patches
EU/1/02/223/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Sweden, The Netherlands, United Kingdom
Spain 14/01/2011
EVRA Elpis Ltd. 09/08/2011 - - Transdermal patch 3 transdermal patches
EU/1/02/223/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Liechtenstein, Lithuania, Luxembourg, Malta, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Latvia 25/08/2011
EVRA Medkon Hurt Sp. z o.o.
08/07/2011 - - Transdermal patch 3 transdermal patches
EU/1/02/223/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Poland 16/08/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 75/255
EVRA Storkpharm Sp.z.o.o.
25/01/2011 - - Transdermal patch 3 transdermal patches
EU/1/02/223/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Poland 27/05/2011
Exelon Chemilines Ltd 21/09/2011 4.6 mg / 24 hours
Transdermal patch 30 sachets EU/1/98/066/020 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands
Ireland, United Kingdom
10/10/2011
Exelon Delfarma SpZoo
25/10/2011 3 mg Capsule, hard 28 EU/1/98/066/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands
Poland 08/12/2011
Exelon Delfarma SpZoo
25/10/2011 3 mg Capsule, hard 56 EU/1/98/066/005 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Poland 08/12/2011
Exelon Dr Fisher Farma BV
28/06/2011 9.5 mg / 24 hours
Transdermal patch 30 sachets EU/1/98/066/024 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
25/07/2011
Exelon Emra-Med 08/11/2011 3 mg Capsule, hard 112 EU/1/98/066/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 15/11/2011
Exelon Emra-Med 08/11/2011 3 mg Capsule, hard 56 EU/1/98/066/005 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 15/11/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 76/255
Exelon EuroPharma DK
05/01/2011 4.6 mg / 24 hours
Transdermal patch 30 sachets EU/1/98/066/020 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 17/01/2011
Exelon EuroPharma DK
05/01/2011 4.6 mg / 24 hours
Transdermal patch 60 (30 x 2) sachets
EU/1/98/066/021 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 17/01/2011
Exelon EuroPharma DK
05/01/2011 4.6 mg / 24 hours
Transdermal patch 90 (30 x 3) sachets
EU/1/98/066/022 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 17/01/2011
Exelon EuroPharma DK
05/01/2011 9.5 mg / 24 hours
Transdermal patch 30 sachets EU/1/98/066/024 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 17/01/2011
Exelon EuroPharma DK
05/01/2011 9.5 mg / 24 hours
Transdermal patch 60 sachets (30 x 2 sachets)
EU/1/98/066/025 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 17/01/2011
Exelon EuroPharma DK
05/01/2011 9.5 mg / 24 hours
Transdermal patch 90 sachets (30 x 3 sachets)
EU/1/98/066/026 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 17/01/2011
Exelon PCO Manufacturing
06/06/2011 4.6 mg / 24 hours
Transdermal patch 30 sachets EU/1/98/066/020 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands
Ireland, United Kingdom
21/06/2011
Exelon PCO Manufacturing
06/06/2011 9.5 mg / 24 hours
Transdermal patch 30 sachets EU/1/98/066/024 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands
Ireland, United Kingdom
21/06/2011
Exelon S.C. Farmastore Prest S.R.L.
26/01/2011 4.6 mg / 24 hours
Transdermal patch 30 sachets EU/1/98/066/020 Austria, Belgium, Czech Republic, Denmark, France, Germany, Greece, Hungary, Italy, Latvia, Lithuania, Poland, Portugal, Slovak Republic, Spain, The Netherlands, United Kingdom
Romania 24/03/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 77/255
Exelon S.C. Farmastore Prest S.R.L.
26/01/2011 9.5 mg / 24 hours
Transdermal patch 30 sachets EU/1/98/066/024 Austria, Belgium, Czech Republic, Denmark, France, Germany, Greece, Hungary, Italy, Latvia, Lithuania, Poland, Portugal, Slovak Republic, Spain, The Netherlands, United Kingdom
Romania 24/03/2011
Exforge Autumn Healthcare Ltd
19/04/2011 10 mg/160 mg Film-coated tablet 28 EU/1/06/370/019 Ireland, United Kingdom Ireland, United Kingdom
17/05/2011
Exforge Autumn Healthcare Ltd
19/04/2011 5 mg/160 mg Film-coated tablet 28 EU/1/06/370/011 Ireland, United Kingdom Ireland, United Kingdom
17/05/2011
Exforge Autumn Healthcare Ltd
19/04/2011 5 mg/80 mg Film-coated tablet 28 EU/1/06/370/003 Ireland, United Kingdom Ireland, United Kingdom
17/05/2011
Exforge PCO Manufacturing
07/05/2009 10 mg/160 mg Film-coated tablet 28 EU/1/06/370/019 Austria, Belgium, Cyprus, Denmark, France, Germany, Greece, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
15/02/2011
Exforge PCO Manufacturing
07/05/2009 5 mg/160 mg Film-coated tablet 28 EU/1/06/370/011 Austria, Belgium, Cyprus, Denmark, France, Germany, Greece, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
15/02/2011
Exforge PCO Manufacturing
07/05/2009 5 mg/80 mg Film-coated tablet 28 EU/1/06/370/003 Austria, Belgium, Cyprus, Denmark, France, Germany, Greece, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
15/02/2011
Exforge Pharmachim AB
07/09/2011 10 mg/160 mg Film-coated tablet 28 EU/1/06/370/019 Austria, Belgium, Czech Republic, France, Germany, Greece, Ireland, Italy, Norway, Portugal, Slovak Republic, Spain, The Netherlands, United Kingdom
Sweden 27/09/2011
Exforge Pharmachim AB
07/09/2011 10 mg/160 mg Film-coated tablet 98 EU/1/06/370/023 Austria, Belgium, Czech Republic, France, Germany, Greece, Ireland, Italy, Norway, Portugal, Slovak Republic, Spain, The Netherlands, United Kingdom
Sweden 27/09/2011
Exforge Pharmachim AB
07/09/2011 5 mg/160 mg Film-coated tablet 28 EU/1/06/370/011 Austria, Belgium, Czech Republic, France, Germany, Greece, Ireland, Italy, Norway, Portugal, Slovak Republic, Spain, The Netherlands, United Kingdom
Sweden 27/09/2011
Exforge Pharmachim AB
07/09/2011 5 mg/160 mg Film-coated tablet 98 EU/1/06/370/015 Austria, Belgium, Czech Republic, France, Germany, Greece, Ireland, Italy, Norway, Portugal, Slovak Republic, Spain, The Netherlands, United Kingdom
Sweden 27/09/2011
Exforge Pharmachim AB
07/09/2011 5 mg/80 mg Film-coated tablet 28 EU/1/06/370/003 Austria, Belgium, Czech Republic, France, Germany, Greece, Ireland, Italy, Norway, Portugal, Slovak Republic, Spain, The Netherlands, United Kingdom
Sweden 27/09/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 78/255
Exforge Pharmachim AB
07/09/2011 5 mg/80 mg Film-coated tablet 98 EU/1/06/370/007 Austria, Belgium, Czech Republic, France, Germany, Greece, Ireland, Italy, Norway, Portugal, Slovak Republic, Spain, The Netherlands, United Kingdom
Sweden 27/09/2011
Exforge HCT Dr Fisher Farma BV
16/11/2010 10 mg/ 160 mg/ 12.5 mg
Film-coated tablet 28 EU/1/09/569/014 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
21/03/2011
Exforge HCT Dr Fisher Farma BV
16/11/2010 10 mg/ 320 mg/ 25 mg
Film-coated tablet 28 EU/1/09/569/050 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
21/03/2011
Exforge HCT Dr Fisher Farma BV
16/11/2010 5 mg/ 160 mg/ 12.5 mg
Film-coated tablet 28 EU/1/09/569/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
21/03/2011
Exforge HCT Eureco-Pharma B.V.
05/05/2010 10 mg/ 160 mg/ 12.5 mg
Film-coated tablet 28 EU/1/09/569/014 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
11/01/2011
Exforge HCT Eureco-Pharma B.V.
05/05/2010 10 mg/ 160 mg/ 25 mg
Film-coated tablet 28 EU/1/09/569/038 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
11/01/2011
Exforge HCT Eureco-Pharma B.V.
05/05/2010 10 mg/ 320 mg/ 25 mg
Film-coated tablet 28 EU/1/09/569/050 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
11/01/2011
Exforge HCT Eureco-Pharma B.V.
05/05/2010 5 mg/ 160 mg/ 12.5 mg
Film-coated tablet 28 EU/1/09/569/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
11/01/2011
Exforge HCT Eureco-Pharma B.V.
05/05/2010 5 mg/ 160 mg/ 25 mg
Film-coated tablet 28 EU/1/09/569/026 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
11/01/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 79/255
Exforge HCT Euro Registratie Collectief BV
27/01/2011 10 mg/ 320 mg/ 25 mg
Film-coated tablet 28 EU/1/09/569/050 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
01/02/2011
Exjade Kohlpharma GmbH
07/02/2011 250 mg Dispersible tablet 84 EU/1/06/356/004 Romania, United Kingdom Germany 21/03/2011
Exjade Kohlpharma GmbH
29/03/2011 125 mg Dispersible tablet 84 EU/1/06/356/002 France, Spain, United Kingdom Germany 01/04/2011
Extavia Orifarm AB 01/02/2011 250 µg / ml Powder and solvent for solution for injection
15 vials + 15 pre-filled syringes
EU/1/08/454/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 03/03/2011
Extavia Orifarm AS 13/12/2010 250 µg / ml Powder and solvent for solution for injection
15 vials + 15 pre-filled syringes
EU/1/08/454/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 03/01/2011
Fabrazyme Orifarm AS 11/05/2011 35 mg Powder for concentrate for solution for infusion
1 vial EU/1/01/188/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 10/06/2011
Faslodex Axicorp Pharma GmbH
13/05/2011 250 mg/5 ml Solution for injection
1 pre-filled syringe + 1 safety needle
EU/1/03/269/001 Austria, Belgium, Bulgaria, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Germany 19/05/2011
Faslodex Dr Fisher Farma BV
26/07/2011 250 mg/5 ml Solution for injection
1 pre-filled syringe + 1 safety needle
EU/1/03/269/001 Austria, Belgium, Bulgaria, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
02/08/2011
Faslodex Dr Fisher Farma BV
25/11/2011 250 mg/5 ml Solution for injection
2 pre-filled syringes + 2 safety needles
EU/1/03/269/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
13/12/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 80/255
Faslodex Euro Registratie Collectief BV
14/11/2011 250 mg/5 ml Solution for injection
2 pre-filled syringes + 2 safety needles
EU/1/03/269/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
18/11/2011
Faslodex Haemato Pharm AG
19/01/2011 250 mg/5 ml Solution for injection
2 pre-filled syringes + 2 safety needles
EU/1/03/269/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Austria, Germany
26/01/2011
Faslodex Haemato Pharm AG
10/03/2011 250 mg/5 ml Solution for injection
1 pre-filled syringe + 1 safety needle
EU/1/03/269/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 21/03/2011
Faslodex Haemato Pharm AG
16/03/2011 250 mg/5 ml Solution for injection
2 pre-filled syringes + 2 safety needles
EU/1/03/269/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 21/03/2011
Faslodex Pharma Westen GmbH
06/09/2011 250 mg/5 ml Solution for injection
2 pre-filled syringes + 2 safety needles
EU/1/03/269/002 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 08/11/2011
Faslodex Propharmed GmbH
18/03/2011 250 mg/5 ml Solution for injection
1 pre-filled syringe + 1 safety needle
EU/1/03/269/001 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Germany 19/04/2011
Fendrix Medcor Pharmaceuticals BV
01/04/2011 20 µg/0.5 ml Suspension for injection
1 pre-filled syringe + 1 needle
EU/1/04/299/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
04/04/2011
Ferriprox Abacus Medicine A/S
13/07/2011 500 mg Film-coated tablet 1 bottle EU/1/99/108/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 20/07/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 81/255
Firmagon Dr Fisher Farma BV
25/05/2011 80 mg Powder and solvent for solutionfor injection
1 vial + 1 vial + 1 syringe + 2 needles
EU/1/08/504/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
28/06/2011
Firmagon Dr Fisher Farma BV
13/07/2011 120 mg Powder and solvent for solution for injection
2 vials + 2 vials + 2 syringes+ 4 needles
EU/1/08/504/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
03/08/2011
Firmagon Euro Registratie Collectief BV
18/10/2011 80 mg Powder and solvent for solution for injection
1 vial + 1 vial + 1 syringe + 2 needles
EU/1/08/504/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
03/11/2011
Firmagon Medcor Pharmaceuticals BV
25/08/2011 120 mg Powder and solvent for solution for injection
2 vials + 2 vials + 2 syringes+ 4 needles
EU/1/08/504/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
06/09/2011
Firmagon Medcor Pharmaceuticals BV
25/08/2011 80 mg Powder and solvent for solution for injection
1 vial + 1 vial + 1 syringe + 2 needles
EU/1/08/504/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
06/09/2011
Forsteo Mevita HandelsGmbH
14/01/2011 20 µg/80 µl Solution for injection
1 pre-filled pen
EU/1/03/247/001 Austria, Belgium, France, Greece, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 09/03/2011
Forsteo Omnia Läkemedel AB
13/12/2011 20 µg/80 µl Solution for injection
1 pre-filled pen
EU/1/03/247/001 Austria, Belgium, Bulgaria, Finland, France, Germany, Greece, Ireland, Italy, Lithuania, Poland, Portugal, Romania, Spain, The Netherlands, United Kingdom
Sweden 19/12/2011
Fosavance Axicorp Pharma GmbH
16/10/2009 70 mg/ 2800 IU
Tablet 1 x 4 EU/1/05/310/002 Austria, Belgium, Denmark, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 03/02/2011
Fosavance Axicorp Pharma GmbH
16/10/2009 70 mg/ 2800 IU
Tablet 3 x 4 EU/1/05/310/004 Austria, Belgium, Denmark, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 03/02/2011
FOSAVANCE Axicorp Pharma GmbH
27/09/2011 70 mg / 5600 IU
Tablet 4 EU/1/05/310/007 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Germany 12/10/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 82/255
FOSAVANCE Axicorp Pharma GmbH
28/09/2011 70 mg / 5600 IU
Tablet 12 EU/1/05/310/008 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Germany 12/10/2011
FOSAVANCE Clear Pharmacy
05/09/2011 70 mg / 5600 IU
Tablet 4 EU/1/05/310/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
27/09/2011
FOSAVANCE Dr Fisher Farma BV
10/08/2011 70 mg / 5600 IU
Tablet 4 EU/1/05/310/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
30/08/2011
Fosavance Eureco-Pharma B.V.
15/03/2010 70 mg/ 2800 IU
Tablet 1 x 4 EU/1/05/310/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
25/03/2011
FOSAVANCE PCO Manufacturing
17/05/2010 70 mg / 5600 IU
Tablet 4 EU/1/05/310/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
13/01/2011
Fosavance Pharma Lab 25/03/2010 70 mg / 5600 IU
Tablet 12 EU/1/05/310/008 Belgium France 11/01/2011
FOSAVANCE PHARMECO ApS
24/08/2011 70 mg / 2800 IU
Tablet 1 x 4 EU/1/05/310/002 Czech Republic, Greece, Italy, Lithuania, Romania, United Kingdom
Denmark 21/09/2011
FOSAVANCE PHARMECO ApS
24/08/2011 70 mg / 2800 IU
Tablet 3 x 4 EU/1/05/310/004 Czech Republic, Greece, Italy, Lithuania, Romania, United Kingdom
Denmark 21/09/2011
Galvus Dr Fisher Farma BV
06/04/2011 50 mg Tablet 112 EU/1/07/414/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
12/05/2011
Galvus Swingward Ltd TA Medihealth
28/11/2011 50 mg Tablet 28 EU/1/07/414/003 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands
United Kingdom
06/12/2011
Ganfort Autumn Healthcare Ltd
23/05/2011 300 µg/ml + 5 mg/ml
Eye drops, solution 1 bottle EU/1/06/340/001 Ireland, United Kingdom Ireland, United Kingdom
23/06/2011
Ganfort Doncaster Pharmaceuticals Group Ltd
07/09/2011 300 µg/ml + 5 mg/ml
Eye drops, solution 1 bottle EU/1/06/340/001 Poland Ireland, Malta, United Kingdom
04/11/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 83/255
Ganfort Eureco-Pharma B.V.
28/11/2011 300 µg/ml + 5 mg/ml
Eye drops, solution 1 bottle EU/1/06/340/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, United Kingdom
The Netherlands
02/12/2011
Ganfort EuroPharma DK
30/09/2011 300 µg/ml + 5 mg/ml
Eye drops, solution 1 bottle EU/1/06/340/001 Austria, Belgium, Cyprus, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 09/11/2011
Ganfort EuroPharma DK
30/09/2011 300 µg/ml + 5 mg/ml
Eye drops, solution 3 bottles EU/1/06/340/002 Austria, Belgium, Cyprus, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 09/11/2011
Ganfort Mediwin Ltd 14/01/2011 300 µg/ml + 5 mg/ml
Eye drops, solution 1 bottle EU/1/06/340/001 Austria, Belgium, Cyprus, Denmark, Finland, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
France 18/01/2011
Ganfort Oy Cross Pharma AB
01/03/2011 300 µg/ml + 5 mg/ml
Eye drops, solution 3 bottles EU/1/06/340/002 Austria, Belgium, Cyprus, Denmark, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Finland 02/03/2011
Ganfort Paranova Läkemedel AB
14/03/2011 300 µg/ml + 5 mg/ml
Eye drops, solution 1 bottle EU/1/06/340/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Sweden 11/04/2011
Ganfort Paranova Läkemedel AB
14/03/2011 300 µg/ml + 5 mg/ml
Eye drops, solution 3 bottles EU/1/06/340/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 11/04/2011
Ganfort Paranova OY 14/03/2011 300 µg/ml + 5 mg/ml
Eye drops, solution 3 bottles EU/1/06/340/002 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Finland 10/05/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 84/255
Ganfort PCO Manufacturing
11/05/2010 300 µg/ml + 5 mg/ml
Eye drops, solution 1 bottle EU/1/06/340/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
04/02/2011
Ganfort STRATHCLYDE PHARMACEUTICALS LTD
01/09/2011 300 µg/ml + 5 mg/ml
Eye drops, solution 1 bottle EU/1/06/340/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
13/09/2011
Ganfort Swingward Ltd TA Medihealth
11/04/2007 300 µg/ml + 5 mg/ml
Eye drops, solution 1 bottle EU/1/06/340/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, The Netherlands
United Kingdom
16/11/2011
Gardasil Cross Pharma AB
31/03/2011 - - Suspension for injection
1 pre-filled syringe + 2 needles
EU/1/06/357/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 04/05/2011
Gardasil Emra-Med 30/06/2011 - - Suspension for injection
10 pre-filled syringes + 20 needles
EU/1/06/357/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 16/09/2011
Gardasil Parallell Pharma AB
11/01/2011 - - Suspension for injection
1 pre-filled syringe + 2 needles
EU/1/06/357/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, The Netherlands, United Kingdom
Sweden 14/04/2011
Gilenya Haemato Pharm AG
28/06/2011 0.5 mg Capsule, hard 28 EU/1/11/677/005 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 11/07/2011
Glivec Clear Pharmacy
25/07/2011 100 mg Film-coated tablet 60 EU/1/01/198/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
29/07/2011
Glivec Clear Pharmacy
25/07/2011 400 mg Film-coated tablet 30 EU/1/01/198/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
29/07/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 85/255
Glivec MedicoPharm AG
24/03/2009 100 mg Film-coated tablet 60 EU/1/01/198/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 09/02/2011
Glivec MedicoPharm AG
24/03/2009 400 mg Film-coated tablet 30 EU/1/01/198/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 09/02/2011
Glivec Orifarm AB 12/05/2011 400 mg Film-coated tablet 30 EU/1/01/198/010 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 19/05/2011
Glivec Paranova Läkemedel AB
12/10/2011 400 mg Film-coated tablet 30 EU/1/01/198/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 27/10/2011
GONAL-f 2 Care 4 20/06/2011 900 IU/ 1.5 ml (66 micrograms/ 1.5 ml)
Solution for injection in pre-filled pen
1 pre-filled pen + 14 needles
EU/1/95/001/035 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 26/07/2011
GONAL-f Axicorp Pharma GmbH
04/04/2011 450 IU/ 0.75 ml (33 micrograms/ 0.75 ml)
Solution for injection in pre-filled pen
1 pre-filled pen + 12 needles
EU/1/95/001/034 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Germany 06/05/2011
GONAL-f Axicorp Pharma GmbH
04/04/2011 900 IU/ 1.5 ml (66 micrograms/ 1.5 ml)
Solution for injection in pre-filled pen
1 pre-filled pen + 20 needles
EU/1/95/001/035 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Germany 06/05/2011
GONAL-f eurorx Arzneimittel GmbH
17/11/2010 300 IU/ 0.5 ml (22 micrograms/ 0.5 ml)
Solution for injection in pre-filled pen
1 pre-filled pen + 5 needles
EU/1/95/001/033 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 26/01/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 86/255
GONAL-f eurorx Arzneimittel GmbH
17/11/2010 450 IU/ 0.75 ml (33 micrograms/ 0.75 ml)
Solution for injection in pre-filled pen
1 pre-filled pen + 7 needles
EU/1/95/001/034 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 26/01/2011
GONAL-f eurorx Arzneimittel GmbH
17/11/2010 900 IU/ 1.5 ml (66 micrograms/ 1.5 ml)
Solution for injection in pre-filled pen
1 pre-filled pen + 14 needles
EU/1/95/001/035 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 26/01/2011
GONAL-f Paranova Danmark AS
15/09/2009 450 IU/ 0.75 ml (33 micrograms/ 0.75 ml)
Powder and solvent for solution for injection
1 vial + 1 pre-filled syringe + 6 disposable syringes
EU/1/95/001/031 Austria, Belgium, Finland, France, Germany, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 15/08/2011
GONAL-f Paranova Danmark AS
18/10/2011 300 IU/ 0.5 ml (22 micrograms/ 0.5 ml)
Solution for injection in pre-filled pen
1 pre-filled pen + 5 needles
EU/1/95/001/033 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 05/12/2011
GONAL-f Paranova Danmark AS
18/10/2011 450 IU/ 0.75 ml (33 micrograms/ 0.75 ml)
Solution for injection in pre-filled pen
1 pre-filled pen + 7 needles
EU/1/95/001/034 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 05/12/2011
GONAL-f Paranova Läkemedel AB
19/10/2011 300 IU/ 0.5 ml (22 micrograms/ 0.5 ml)
Solution for injection in pre-filled pen
1 pre-filled pen + 8 needles
EU/1/95/001/033 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 09/12/2011
GONAL-f Paranova Läkemedel AB
19/10/2011 450 IU/0.75 ml (33 micrograms/0.75 ml)
Solution for injection in pre-filled pen
1 pre-filled pen + 12 needles
EU/1/95/001/034 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 09/12/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 87/255
Halaven Haemato Pharm AG
20/05/2011 0.44 mg/ml Solution for injection
1 vial EU/1/11/678/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 23/05/2011
Halaven Haemato Pharm AG
30/06/2011 0.44 mg/ml Solution for injection
1 vial EU/1/11/678/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Austria, Germany
05/07/2011
Hepsera Delfarma SpZoo
11/08/2011 10 mg Tablet 30 EU/1/03/251/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Poland 17/08/2011
Hepsera Inopha GmbH 30/03/2011 10 mg Tablet 30 EU/1/03/251/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, United Kingdom
The Netherlands
05/04/2011
Hepsera Parallell Pharma AB
19/08/2011 10 mg Tablet 30 EU/1/03/251/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, The Netherlands, United Kingdom
Sweden 14/09/2011
Hepsera Propharmed GmbH
19/05/2011 10 mg Tablet 30 EU/1/03/251/001 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 27/05/2011
Hepsera Propharmed GmbH
19/05/2011 10 mg Tablet 3 x 30 EU/1/03/251/002 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 30/05/2011
Herceptin Abacus Medicine A/S
07/07/2011 150 mg Powder for concentrate for solution for infusion
1 vial EU/1/00/145/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 25/07/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 88/255
Herceptin Dr Fisher Farma BV
31/03/2011 150 mg Powder for concentrate for solution for infusion
1 vial EU/1/00/145/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
05/04/2011
Herceptin Inopha GmbH 29/04/2011 150 mg Powder for concentrate for solution for infusion
1 vial EU/1/00/145/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 19/05/2011
Herceptin Paranova Läkemedel AB
17/05/2011 150 mg Powder for concentrate for solution for infusion
1 vial EU/1/00/145/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 01/06/2011
Herceptin Pharmachim AB
30/05/2011 150 mg Powder for concentrate for solution for infusion
1 vial EU/1/00/145/001 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 14/06/2011
Herceptin Simgen GmbH 24/05/2011 150 mg Powder for concentrate for solution for infusion
1 vial EU/1/00/145/001 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 30/06/2011
Hirobriz Breezhaler
CC Pharma 02/12/2011 300 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/594/007 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 21/12/2011
Hirobriz Breezhaler
CC Pharma 02/12/2011 300 µg Inhalation powder, hard capsule
3 x (30 + 1 inhaler)
EU/1/09/594/009 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 21/12/2011
Hirobriz Breezhaler
Dr Fisher Farma BV
18/11/2011 150 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/594/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
07/12/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 89/255
Hirobriz Breezhaler
Dr Fisher Farma BV
18/11/2011 300 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/594/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
07/12/2011
Hirobriz Breezhaler
Emra-Med 18/07/2011 300 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/594/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 19/09/2011
Hirobriz Breezhaler
Emra-Med 18/07/2011 300 µg Inhalation powder, hard capsule
3 x (30 + 1 inhaler)
EU/1/09/594/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 19/09/2011
Humalog Euro Registratie Collectief BV
28/09/2011 100 U/ml Solution for injection
5 pens EU/1/96/007/031 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
05/10/2011
Humalog Medcor Pharmaceuticals BV
15/03/2011 100 U/ml Suspension for injection
5 cartridges EU/1/96/007/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, United Kingdom
The Netherlands
28/03/2011
Humalog Medcor Pharmaceuticals BV
17/03/2011 100 U/ml Suspension for injection
5 pens EU/1/96/007/033 Austria, Belgium, Bulgaria, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, United Kingdom
The Netherlands
28/03/2011
Humalog Medcor Pharmaceuticals BV
17/03/2011 100 U/ml Solution for injection
5 pens EU/1/96/007/031 Austria, Belgium, Bulgaria, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, United Kingdom
The Netherlands
28/03/2011
Humalog Mix50 Pharma Westen GmbH
02/03/2010 100 U/ml Suspension for injection
2 x 5 pens EU/1/96/007/036 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 04/02/2011
Humira Axicorp Pharma GmbH
27/06/2011 40 mg Solution for injection
6 pre-filled pens + 6 alcohol pads in a blister
EU/1/03/256/010 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 13/07/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 90/255
Humira Axicorp Pharma GmbH
27/06/2011 40 mg Solution for injection
2 pre-filled pens + 2 alcohol pads in a blister
EU/1/03/256/008 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 11/07/2011
Humira CC Pharma 11/10/2011 40 mg/0.8 ml Solution for injection
2 carton pack. Each carton contains: 1 vial + 1 syringe + 1 sterile adapter + 2 alcohol pads
EU/1/03/256/001 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 24/10/2011
Humira Orifarm AS 04/05/2011 40 mg Solution for injection
2 pre-filled pens + 2 alcohol pads in a blister
EU/1/03/256/008 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 06/06/2011
Humira Veron Pharma Vertriebs GmbH
13/12/2010 40 mg Solution for injection
2 pre-filled syringes + 2 alcohol pads
EU/1/03/256/003 Austria Germany 14/02/2011
Hycamtin EuroPharma DK
04/02/2011 0.25 mg Capsule, hard 10 EU/1/96/027/006 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 21/02/2011
Hycamtin EuroPharma DK
04/02/2011 1 mg Capsule, hard 10 EU/1/96/027/007 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 21/02/2011
Hycamtin Medartuum AB 17/10/2011 4 mg Powder for concentrate for solution for infusion
1 vial (17 ml)
EU/1/96/027/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 29/11/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 91/255
Hycamtin Omnia Läkemedel AB
10/05/2011 4 mg Powder for concentrate for solution for infusion
1 vial (17 ml)
EU/1/96/027/003 France, Greece, Italy, Lithuania, Spain, United Kingdom
Sweden 24/05/2011
Hycamtin Omnia Läkemedel AB
11/05/2011 1 mg Capsule, hard 10 EU/1/96/027/007 Bulgaria, Germany, Spain, The Netherlands, United Kingdom
Sweden 09/06/2011
Hycamtin Orifarm AB 14/12/2011 1 mg Capsule, hard 10 EU/1/96/027/007 Austria, Belgium, Bulgaria, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Spain, The Netherlands, United Kingdom
Sweden 21/12/2011
Infanrix hexa CC Pharma 06/12/2010 - - Powder and suspension for suspension for injection
50 vials + 50 pre-filled syringes
EU/1/00/152/004 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 07/01/2011
Infanrix hexa CC Pharma 21/06/2011 - - Powder and suspension for suspension for injection
20 vials + 20 pre-filled syringes
EU/1/00/152/003 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 13/07/2011
Infanrix hexa Pharma Westen GmbH
06/05/2011 - - Powder and suspension for suspension for injection
50 vials + 50 pre-filledsyringes + 100 needles
EU/1/00/152/008 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/05/2011
Inovelon 2 Care 4 27/10/2011 400 mg Film-coated tablet 100 EU/1/06/378/015 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 10/11/2011
Inovelon Emra-Med 30/05/2011 400 mg Film-coated tablet 200 EU/1/06/378/016 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 14/06/2011
Inovelon Orifarm AS 07/10/2011 400 mg Film-coated tablet 60 EU/1/06/378/014 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 25/10/2011
Inovelon Orifarm AS 07/10/2011 400 mg Film-coated tablet 100 EU/1/06/378/015 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 25/10/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 92/255
Insuman CC Pharma 03/01/2011 100 IU/ml Suspension for injection
10 cartridges
EU/1/97/030/062 Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Hungary, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 27/01/2011
Insuman Basal Emra-Med 24/01/2011 100 IU/ml OptiSet, suspension for injection
5 pens EU/1/97/030/071 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 17/02/2011
Insuman Basal Emra-Med 24/01/2011 100 IU/ml OptiSet, suspension for injection
10 pens EU/1/97/030/072 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 02/02/2011
Insuman Basal Emra-Med 30/06/2011 100 IU/ml Suspension for injection
5 cartridges EU/1/97/030/035 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 16/09/2011
Insuman Basal Emra-Med 30/06/2011 100 IU/ml Suspension for injection
10 cartridges
EU/1/97/030/058 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 16/09/2011
Insuman Comb 25 Emra-Med 12/05/2011 100 IU/ml OptiSet, suspension for injection
5 pens EU/1/97/030/079 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 16/06/2011
Insuman Comb 25 Emra-Med 12/05/2011 100 IU/ml OptiSet, suspension for injection
10 pens EU/1/97/030/080 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 16/06/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 93/255
Insuman Comb 25 Pharma Westen GmbH
22/07/2011 100 IU/ml Suspension for injection
10 pre-filled pens
EU/1/97/030/163 Austria, Belgium, Denmark, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 05/09/2011
Insuman Comb 50 Pharma Westen GmbH
22/07/2011 100 IU/ml OptiSet, suspension for injection
10 pens EU/1/97/030/084 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 05/09/2011
Insuman Rapid Emra-Med 01/03/2011 100 IU/ml Solution for injection
5 pre-filled pens
EU/1/97/030/142 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 15/04/2011
Insuman Rapid Emra-Med 01/03/2011 100 IU/ml Solution for injection
10 pre-filled pens
EU/1/97/030/145 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 15/04/2011
Insuman Rapid Emra-Med 13/04/2011 100 IU/ml OptiSet, solution for injection
10 pens EU/1/97/030/068 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 15/04/2011
Insuman Rapid Emra-Med 13/04/2011 100 IU/ml OptiSet, solution for injection
5 pens EU/1/97/030/067 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 15/04/2011
INTELENCE Orifarm AS 16/11/2011 100 mg Tablet 120 EU/1/08/468/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 24/11/2011
Intrinsa Doncaster Pharmaceuticals Group Ltd
29/11/2010 300 µ/ 24 hours
Transdermal patch 8 patches EU/1/06/352/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
10/01/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 94/255
Intrinsa G-Pharma Ltd 12/01/2011 300 µg/ 24 hours
Transdermal patch 8 patches EU/1/06/352/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
26/01/2011
Invanz Omnia Läkemedel AB
04/10/2011 1 g Powder for concentrate for solution for infusion
1 vial EU/1/02/216/001 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 12/10/2011
Invanz Omnia Läkemedel AB
17/11/2011 1 g Powder for concentrate for solution for infusion
10 vials EU/1/02/216/002 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, The Netherlands, United Kingdom
Sweden 07/12/2011
Invanz Orifarm AB 23/11/2011 1 g Powder for concentrate for solution for infusion
1 vial EU/1/02/216/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 23/11/2011
Invanz Orifarm AB 23/11/2011 1 g Powder for concentrate for solution for infusion
10 vials EU/1/02/216/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 23/11/2011
Invanz Paranova Danmark AS
24/06/2011 1 g Powder for concentrate for solution for infusion
1 vial EU/1/02/216/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 07/07/2011
Invega 2 Care 4 07/09/2011 3 mg Prolonged-release tablet
28 EU/1/07/395/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 23/09/2011
Invega 2 Care 4 07/09/2011 6 mg Prolonged-release tablet
28 EU/1/07/395/006 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 26/09/2011
Invega 2 Care 4 07/09/2011 9 mg Prolonged-release tablet
28 EU/1/07/395/011 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 26/09/2011
Invega Abacus Medicine A/S
10/10/2011 3 mg Prolonged-release tablet
28 EU/1/07/395/001 Austria, Belgium, Cyprus, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Denmark 24/10/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 95/255
Invega Abacus Medicine A/S
10/10/2011 9 mg Prolonged-release tablet
28 EU/1/07/395/011 Austria, Belgium, Cyprus, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Denmark 24/10/2011
Invega Abacus Medicine A/S
20/10/2011 6 mg Prolonged-release tablet
28 EU/1/07/395/006 Austria, Belgium, Cyprus, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Denmark 24/10/2011
Invega EuroPharma DK
15/03/2011 9 mg Prolonged-release tablet
28 EU/1/07/395/011 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Denmark 04/04/2011
Invega EuroPharma DK
18/05/2011 3 mg Prolonged-release tablet
28 EU/1/07/395/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 07/06/2011
Invega EuroPharma DK
18/05/2011 3 mg Prolonged-release tablet
28 EU/1/07/395/021 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 07/06/2011
Invega Orifarm AB 09/02/2011 3 mg Prolonged-release tablet
28 EU/1/07/395/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 23/03/2011
Invega Orifarm AS 09/02/2011 3 mg Prolonged-release tablet
28 EU/1/07/395/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 05/05/2011
Invega PCO Manufacturing
07/07/2009 6 mg Prolonged-release tablet
28 EU/1/07/395/006 Austria, Belgium, Cyprus, Denmark, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
03/02/2011
Invega PCO Manufacturing
22/03/2011 6 mg Prolonged-release tablet
28 EU/1/07/395/026 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands
Ireland, United Kingdom
10/06/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 96/255
Invirase Abacus Medicine A/S
23/06/2011 500 mg Film-coated tablet 1 bottle EU/1/96/026/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 02/08/2011
Invirase Haemato Pharm AG
30/05/2011 500 mg Film-coated tablet 1 bottle EU/1/96/026/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 22/06/2011
Invirase Orifarm AS 05/01/2011 500 mg Film-coated tablet 1 bottle EU/1/96/026/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 15/01/2011
Isentress Dr Fisher Farma BV
25/11/2011 400 mg Film-coated tablet 60 EU/1/07/436/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
15/12/2011
Ixiaro Abacus Medicine A/S
04/10/2011 6 µg Suspension for injection
1 pre-filled syringe
EU/1/08/501/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 27/10/2011
Janumet 2 Care 4 06/07/2011 50 mg / 1000 mg
Film-coated tablet 196 EU/1/08/455/013 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Sweden 12/07/2011
Janumet Dr Fisher Farma BV
22/09/2010 50 mg / 850 mg
Film-coated tablet 56 EU/1/08/455/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
25/02/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 97/255
Janumet Medartuum AB 12/10/2011 50 mg / 1000 mg
Film-coated tablet 196 (2 x 98)
EU/1/08/455/016 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 08/11/2011
Janumet Orifarm AB 25/03/2011 50 mg / 1000 mg
Film-coated tablet 196 EU/1/08/455/013 Austria, Belgium, Cyprus, Denmark, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 13/04/2011
Janumet Paranova Danmark AS
24/10/2011 50 mg / 1000 mg
Film-coated tablet 196 EU/1/08/455/013 Austria, Belgium, Bulgaria, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 22/11/2011
Janumet Paranova Danmark AS
24/10/2011 50 mg / 1000 mg
Film-coated tablet 56 EU/1/08/455/010 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 22/11/2011
Janumet PCO Manufacturing
12/08/2011 50 mg / 850 mg
Film-coated tablet 56 EU/1/08/455/003 Austria, Belgium, Bulgaria, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Romania, Spain, Sweden, The Netherlands
Ireland, United Kingdom
16/08/2011
Janumet Pharmachim AB
26/09/2011 50 mg / 1000 mg
Film-coated tablet 56 EU/1/08/455/010 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 12/10/2011
Janumet Pharmachim AB
26/09/2011 50 mg / 1000 mg
Film-coated tablet 196 EU/1/08/455/013 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 12/10/2011
Januvia B&S Healthcare Ltd
08/11/2011 100 mg Film-coated tablet 28 EU/1/07/383/014 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
28/11/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 98/255
Januvia Cross Pharma AB
17/01/2011 100 mg Film-coated tablet 28 EU/1/07/383/014 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 25/02/2011
Januvia Cross Pharma AB
20/01/2011 100 mg Film-coated tablet 98 EU/1/07/383/017 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 25/02/2011
Januvia Omnia Läkemedel AB
13/05/2011 100 mg Film-coated tablet 98 EU/1/07/383/017 Belgium, France, Greece, Italy, Spain, The Netherlands, United Kingdom
Sweden 22/06/2011
Januvia Orifarm AB 02/02/2011 100 mg Film-coated tablet 98 EU/1/07/383/017 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 17/02/2011
Januvia Paranova Läkemedel AB
18/11/2011 100 mg Film-coated tablet 98 EU/1/07/383/017 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 07/12/2011
Januvia Paranova Läkemedel AB
18/11/2011 100 mg Film-coated tablet 28 EU/1/07/383/014 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 07/12/2011
Januvia STRATHCLYDE PHARMACEUTICALS LTD
18/01/2011 100 mg Film-coated tablet 28 EU/1/07/383/014 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
17/02/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 99/255
Kaletra Abacus Medicine A/S
19/01/2011 200 mg / 50 mg
Film-coated tablet 120 EU/1/01/172/004 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Cyprus 24/01/2011
Kaletra Abacus Medicine A/S
24/01/2011 100 mg / 25mg
Film-coated tablet 60 EU/1/01/172/006 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 27/01/2011
Kaletra Abacus Medicine A/S
24/01/2011 200 mg / 50 mg
Film-coated tablet 120 EU/1/01/172/004 Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 27/01/2011
Kaletra Axicorp Pharma GmbH
27/01/2011 200 mg / 50 mg
Film-coated tablet 120 EU/1/01/172/005 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 03/02/2011
Kaletra Axicorp Pharma GmbH
04/05/2011 200 mg / 50 mg
Film-coated tablet 120 EU/1/01/172/004 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 17/05/2011
Kaletra Axicorp Pharma GmbH
28/06/2011 200 mg / 50 mg
Film-coated tablet 120 (10 x 12)
EU/1/01/172/008 Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Germany 13/07/2011
Kaletra CC Pharma 11/07/2011 200 mg / 50 mg
Film-coated tablet 120 (10 x 12)
EU/1/01/172/008 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 27/07/2011
Kaletra Emra-Med 02/05/2011 200 mg / 50 mg
Film-coated tablet 120 (10 x 12)
EU/1/01/172/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 17/05/2011
Kaletra Haemato Pharm AG
26/05/2011 200 mg / 50 mg
Film-coated tablet 120 (10 x 12) ; blister
EU/1/01/172/008 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 31/05/2011
Kaletra Kohlpharma GmbH
07/06/2011 200 mg / 50 mg
Film-coated tablet 120 (10 x 12)
EU/1/01/172/008 Norway, Sweden, The Netherlands, United Kingdom
Germany 29/06/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 100/255
Kaletra MedicoPharm AG
02/02/2011 200 mg / 50 mg
Film-coated tablet 360 (3 x 120)
EU/1/01/172/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 21/02/2011
Kaletra MedicoPharm AG
11/10/2011 200 mg / 50 mg
Film-coated tablet 120 (10 x 12)
EU/1/01/172/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 09/11/2011
Kaletra Orifarm OY 24/02/2011 200 mg / 50 mg
Film-coated tablet 120 EU/1/01/172/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Finland 13/04/2011
Kaletra Paranova OY 10/03/2011 200 mg / 50 mg
Film-coated tablet 120 EU/1/01/172/004 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Finland 14/04/2011
Kaletra Pharma Westen GmbH
01/03/2011 200 mg / 50 mg
Film-coated tablet 120 (10 x 12)
EU/1/01/172/008 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 19/04/2011
Kaletra Pharma Westen GmbH
06/06/2011 200 mg / 50 mg
Film-coated tablet 360 (3 x 120)
EU/1/01/172/007 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 15/08/2011
KARVEA Beragena Arzneimittel GmbH
21/04/2011 150 mg Tablet 98 EU/1/97/049/006 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 05/05/2011
Karvea Beragena Arzneimittel GmbH
21/04/2011 300 mg Tablet 98 EU/1/97/049/009 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 05/05/2011
Karvea Emra-Med 08/12/2011 75 mg Film-coated tablet 98 EU/1/97/049/020 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 09/12/2011
Karvea Kohlpharma GmbH
11/01/2011 75 mg Tablet 98 EU/1/97/049/003 Greece Germany 24/01/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 101/255
Karvea MPT Pharma 04/07/2011 150 mg Film-coated tablet 28 EU/1/97/049/022 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
14/07/2011
Karvea MPT Pharma 04/07/2011 300 mg Film-coated tablet 28 EU/1/97/049/027 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
20/07/2011
Karvea Orifarm AB 11/03/2011 150 mg Film-coated tablet 98 EU/1/97/049/025 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 24/03/2011
Karvea Orifarm AB 11/03/2011 300 mg Film-coated tablet 98 EU/1/97/049/030 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 24/03/2011
Karvezide Axicorp Pharma GmbH
11/07/2011 150 mg/ 12.50 mg
Tablet 14 EU/1/98/085/003 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 13/07/2011
Karvezide Axicorp Pharma GmbH
12/10/2011 300 mg/ 12.50 mg
Film-coated tablet 98 EU/1/98/085/020 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 10/11/2011
Karvezide Axicorp Pharma GmbH
04/11/2011 150 mg/ 12.50 mg
Film-coated tablet 98 EU/1/98/085/015 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 14/11/2011
Karvezide B&S Healthcare Ltd
16/08/2011 150 mg/ 12.50 mg
Film-coated tablet 28 EU/1/98/085/012 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
02/09/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 102/255
Karvezide B&S Healthcare Ltd
16/08/2011 300 mg/ 12.50 mg
Film-coated tablet 28 EU/1/98/085/017 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
02/09/2011
Karvezide Emra-Med 25/08/2011 150 mg/ 12.50 mg
Film-coated tablet 98 EU/1/98/085/015 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 31/08/2011
Karvezide Emra-Med 09/09/2011 300 mg/ 12.50 mg
Film-coated tablet 98 EU/1/98/085/020 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 07/11/2011
Karvezide Pharma Westen GmbH
23/03/2011 300 mg/ 12.50 mg
Film-coated tablet 98 EU/1/98/085/020 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 14/04/2011
Karvezide Waymade PLC 25/10/2011 150 mg/ 12.50 mg
Film-coated tablet 28 EU/1/98/085/012 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
27/10/2011
Karvezide Waymade PLC 25/10/2011 300 mg/ 12.50 mg
Film-coated tablet 28 EU/1/98/085/017 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
27/10/2011
Kentera PCO Manufacturing
01/06/2011 3.9 mg/ 24 h
Transdermal patch 8 transdermal patches
EU/1/03/270/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
12/07/2011
Keppra 2 Care 4 22/07/2010 250 mg Film-coated tablet 100 EU/1/00/146/005 Austria, Belgium, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 06/01/2011
Keppra 2 Care 4 05/11/2010 1000 mg Film-coated tablet 100 EU/1/00/146/025 Austria, Belgium, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 12/01/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 103/255
Keppra 2 Care 4 08/11/2010 500 mg Film-coated tablet 200 EU/1/00/146/013 Austria, Belgium, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 31/01/2011
Keppra 2 Care 4 08/11/2010 500 mg Film-coated tablet 100 EU/1/00/146/011 Austria, Belgium, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 12/01/2011
Keppra Abacus Medicine A/S
13/12/2010 250 mg Film-coated tablet 50 EU/1/00/146/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 06/01/2011
Keppra Abacus Medicine A/S
13/12/2010 250 mg Film-coated tablet 200 EU/1/00/146/029 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 03/01/2011
Keppra Abacus Medicine A/S
13/12/2010 750 mg Film-coated tablet 50 EU/1/00/146/016 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 04/01/2011
Keppra Abacus Medicine A/S
01/08/2011 100 mg/ml Oral solution 1 bottle + 1 oral syringe 10 ml
EU/1/00/146/027 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 30/09/2011
Keppra ADL Pharma GmbH
11/03/2011 100 mg/ml Oral solution 1 bottle + 1 oral syringe 10 ml
EU/1/00/146/027 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 07/04/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 104/255
Keppra BB Farma s.r.l.
17/05/2011 100 mg/ml Oral solution 1 bottle + 1 oral syringe 10 ml
EU/1/00/146/027 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 07/06/2011
Keppra Chemilines Ltd 18/03/2010 1000 mg Film-coated tablet 60 EU/1/00/146/024 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands
Ireland, United Kingdom
05/07/2011
Keppra Kohlpharma GmbH
25/08/2011 100 mg/ml Oral solution 1 bottle + 1 oral syringe 1 ml
EU/1/00/146/032 Italy, The Netherlands Germany 25/08/2011
Keppra Lexon (UK) Ltd
09/03/2011 250 mg Film-coated tablet 30 EU/1/00/146/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
28/03/2011
Keppra Orifarm AB 03/02/2011 750 mg Film-coated tablet 100 EU/1/00/146/019 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 02/03/2011
Keppra Paranova Danmark AS
13/07/2011 750 mg Film-coated tablet 100 EU/1/00/146/019 Austria, Belgium, Finland, France, Germany, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 20/07/2011
Keppra Paranova Läkemedel AB
12/05/2011 250 mg Film-coated tablet 50 EU/1/00/146/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 18/05/2011
Keppra Paranova Läkemedel AB
12/05/2011 250 mg Film-coated tablet 100 EU/1/00/146/005 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 17/05/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 105/255
Keppra PCO Manufacturing
17/06/2011 100 mg/ml Oral solution 1 bottle + 1 oral syringe 10 ml
EU/1/00/146/027 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
14/07/2011
Keppra STRATHCLYDE PHARMACEUTICALS LTD
19/01/2011 250 mg Film-coated tablet 100 EU/1/00/146/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
27/01/2011
Keppra Waymade PLC 04/03/2011 250 mg Film-coated tablet 30 EU/1/00/146/002 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
31/03/2011
Keppra Waymade PLC 07/03/2011 1000 mg Film-coated tablet 50 EU/1/00/146/023 Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
01/04/2011
Keppra Waymade PLC 07/03/2011 250 mg Film-coated tablet 50 EU/1/00/146/003 Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
01/04/2011
Keppra Waymade PLC 07/03/2011 500 mg Film-coated tablet 50 EU/1/00/146/009 Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
01/04/2011
Kinzalkomb MTK Pharma GmbH
07/06/2011 40 mg/ 12.5 mg
Tablet 98 EU/1/02/214/005 The Netherlands Germany 20/06/2011
Kinzalkomb MTK Pharma GmbH
07/06/2011 80 mg/ 12.5 mg
Tablet 98 EU/1/02/214/010 The Netherlands Germany 20/06/2011
Kiovig Axicorp Pharma GmbH
26/07/2011 100 mg/ml Solution for infusion
1 vial EU/1/05/329/004 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 29/07/2011
Kiovig Axicorp Pharma GmbH
23/08/2011 100 mg/ml Solution for infusion
1 vial EU/1/05/329/005 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/08/2011
Kiovig Dr Fisher Farma BV
28/09/2011 100 mg/ml Solution for infusion
1 vial EU/1/05/329/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
06/10/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 106/255
Kiovig Medcor Pharmaceuticals BV
24/02/2011 100 mg/ml Solution for infusion
1 vial EU/1/05/329/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
15/03/2011
Kiovig Medcor Pharmaceuticals BV
04/11/2011 100 mg/ml Solution for infusion
1 vial EU/1/05/329/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
15/11/2011
Kiovig Pharma Westen GmbH
07/02/2011 100 mg/ml Solution for infusion
1 vial EU/1/05/329/004 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 22/03/2011
Kiovig Pharma Westen GmbH
07/02/2011 100 mg/ml Solution for infusion
1 vial EU/1/05/329/005 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 22/03/2011
Kivexa Axicorp Pharma B.V.
01/03/2011 600mg/ 300mg
Film-coated tablet 3 x 30 EU/1/04/298/003 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Germany 18/03/2011
Kivexa Orifarm AB 11/03/2011 - - Film-coated tablet 30 EU/1/04/298/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 28/03/2011
Kivexa Orifarm OY 11/03/2011 600 mg/ 300 mg
Film-coated tablet 30 EU/1/04/298/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Finland 17/03/2011
Kivexa Paranova OY 10/03/2011 - - Film-coated tablet 30 EU/1/04/298/002 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Finland 14/04/2011
Kivexa Veron Pharma Vertriebs GmbH
19/10/2011 - - Film-coated tablet 30 EU/1/04/298/002 Austria, Belgium, France, Greece, Italy, Portugal, Spain, United Kingdom
Germany 23/11/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 107/255
Lantus Cross Pharma AB
03/02/2011 100 Units/ml Solution for injection
5 pre-filled pens
EU/1/00/134/033 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 25/02/2011
Lantus (SoloStar) Orifarm AB 01/09/2011 100 Units/ml Solution for injection
5 pre-filled pens
EU/1/00/134/033 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 27/09/2011
Lantus OptiClik PCO Manufacturing
03/09/2007 100 Units/ml Solution for injection in cartridge
5 cartridges EU/1/00/134/025 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
10/05/2011
Lantus OptiSet ABACUS MEDICINE A/S
14/12/2011 100 Units/ml Solution for injection
5 pre-filled pens
EU/1/00/134/010 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 22/12/2011
Lantus OptiSet Medartuum AB 25/03/2010 100 Units/ml Solution for injection
5 pre-filled pens
EU/1/00/134/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Spain, The Netherlands, United Kingdom
Sweden 14/01/2011
Lantus SoloStar Orifarm OY 30/05/2011 100 Units/ml Solution for injection
5 pre-filled pens
EU/1/00/134/033 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Finland 30/06/2011
Lantus Solostar Paranova Danmark AS
15/09/2009 100 Units/ml Solution for injection
5 pre-filled pens
EU/1/00/134/033 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 21/07/2011
Levemir Delphi Pharmaceuticals BV
11/11/2010 100 U/ml Solution for injection
5 cartridges EU/1/04/278/002 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Luxembourg, Portugal, Spain, United Kingdom
The Netherlands
17/03/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 108/255
Levemir Medartuum AB 25/08/2011 100 U/ml Solution for injection
5 cartridges EU/1/04/278/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 01/09/2011
Levemir Pharmachim AB
19/08/2011 100 U/ml Solution for injection
5 cartridges EU/1/04/278/002 Austria, Belgium, Bulgaria, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 22/08/2011
Levemir Pharmachim AB
19/08/2011 100 U/ml Solution for injection
5 pre-filled pens
EU/1/04/278/005 Austria, Belgium, Bulgaria, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 22/08/2011
Levemir FlexPen Medartuum AB 08/07/2011 100 U/ml Solution for injection
5 pre-filled pens
EU/1/04/278/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 20/07/2011
Levitra Amimed Direct Ltd
07/04/2011 10 mg Film-coated tablet 12 EU/1/03/248/008 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
12/04/2011
Levitra Amimed Direct Ltd
10/11/2011 10 mg Film-coated tablet 4 EU/1/03/248/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
07/12/2011
Levitra Euro Registratie Collectief BV
11/11/2011 10 mg Film-coated tablet 4 EU/1/03/248/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
24/11/2011
Levitra Euro Registratie Collectief BV
11/11/2011 5 mg Film-coated tablet 4 EU/1/03/248/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
24/11/2011
Levitra MedicoPharm AG
08/02/2011 20 mg Film-coated tablet 4 EU/1/03/248/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 18/02/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 109/255
Levitra Pharmachim AB
06/07/2011 10 mg Film-coated tablet 4 EU/1/03/248/006 Austria, Belgium, Bulgaria, Czech Republic, Denmark, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Malta, Norway, Poland, Portugal, Romania, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 21/07/2011
Levitra Pharmachim AB
06/07/2011 10 mg Film-coated tablet 8 EU/1/03/248/007 Austria, Belgium, Bulgaria, Czech Republic, Denmark, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Malta, Norway, Poland, Portugal, Romania, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 21/07/2011
Levitra Pharmachim AB
06/07/2011 20 mg Film-coated tablet 8 EU/1/03/248/011 Austria, Belgium, Bulgaria, Czech Republic, Denmark, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Malta, Norway, Poland, Portugal, Romania, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 15/07/2011
Levitra Pharmachim AB
06/07/2011 20 mg Film-coated tablet 4 EU/1/03/248/010 Austria, Belgium, Bulgaria, Czech Republic, Denmark, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Malta, Norway, Poland, Portugal, Romania, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 15/07/2011
Levitra Pharmachim AB
06/07/2011 5 mg Film-coated tablet 4 EU/1/03/248/002 Austria, Belgium, Bulgaria, Czech Republic, Denmark, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Malta, Norway, Poland, Portugal, Romania, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 15/07/2011
Lucentis Dr Fisher Farma BV
06/07/2011 10 mg/ml Solution for injection
1 vial EU/1/06/374/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
18/07/2011
Lucentis Orifarm AB 01/02/2011 10 mg/ml Solution for injection
1 vial EU/1/06/374/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 17/03/2011
Lumigan BR Pharma International Ltd
10/02/2010 0.3 mg/ml Eye drops, solution 3 bottles EU/1/02/205/002 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 26/01/2011
Lumigan Parallell Pharma AB
24/10/2011 0.3 mg/ml Eye drops, solution 1 bottle EU/1/02/205/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, The Netherlands, United Kingdom
Sweden 29/11/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 110/255
Lumigan Parallell Pharma AB
24/10/2011 0.3 mg/ml Eye drops, solution 3 bottles EU/1/02/205/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, The Netherlands, United Kingdom
Sweden 29/11/2011
Lyrica Abacus Medicine A/S
18/02/2011 150 mg Capsule, hard 56 EU/1/04/279/018 Austria, Belgium, Cyprus, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 25/02/2011
Lyrica ADL Pharma GmbH
23/08/2010 75 mg Capsule, hard 14 EU/1/04/279/011 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 11/01/2011
Lyrica ADL Pharma GmbH
23/08/2010 75 mg Capsule, hard 56 EU/1/04/279/012 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 11/01/2011
Lyrica ADL Pharma GmbH
16/09/2010 300 mg Capsule, hard 100 EU/1/04/279/043 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 11/01/2011
Lyrica ADL Pharma GmbH
15/12/2010 75 mg Capsule, hard 100 EU/1/04/279/038 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 12/01/2011
Lyrica BB Farma s.r.l.
20/06/2011 200 mg Capsule, hard 21 EU/1/04/279/020 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 08/07/2011
Lyrica BB Farma s.r.l.
20/06/2011 50 mg Capsule, hard 21 EU/1/04/279/007 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 08/07/2011
Lyrica BB Farma s.r.l.
24/06/2011 100 mg Capsule, hard 21 EU/1/04/279/014 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 08/07/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 111/255
Lyrica BB Farma s.r.l.
28/06/2011 75 mg Capsule, hard 14 EU/1/04/279/011 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 14/07/2011
Lyrica BB Farma s.r.l.
28/06/2011 75 mg Capsule, hard 56 EU/1/04/279/012 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 14/07/2011
Lyrica BR Pharma International Ltd
23/09/2011 75 mg Capsule, hard 100 x 1 EU/1/04/279/013 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Liechtenstein, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands
United Kingdom
10/10/2011
Lyrica CC Pharma 28/04/2011 150 mg Capsule, hard 100 x 1 EU/1/04/279/019 Norway Germany 16/05/2011
Lyrica CC Pharma 06/05/2011 225 mg Capsule, hard 56 EU/1/04/279/034 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 16/05/2011
Lyrica CC Pharma 06/05/2011 225 mg Capsule, hard 100 EU/1/04/279/042 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 07/06/2011
Lyrica CC Pharma 06/05/2011 25 mg Capsule, hard 100 EU/1/04/279/036 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 07/06/2011
Lyrica CC Pharma 04/10/2011 100 mg Capsule, hard 100 EU/1/04/279/039 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 06/10/2011
Lyrica CC Pharma 04/10/2011 50 mg Capsule, hard 100 EU/1/04/279/037 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 06/10/2011
Lyrica Docpharm GmbH&CoKGaA
28/06/2011 100 mg Capsule, hard 100 EU/1/04/279/039 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 23/08/2011
Lyrica Emra-Med 09/02/2011 300 mg Capsule, hard 100 EU/1/04/279/043 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 08/06/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 112/255
Lyrica Ethigen Limited
07/10/2011 100 mg Capsule, hard 21 EU/1/04/279/014 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
19/10/2011
Lyrica Ethigen Limited
07/10/2011 100 mg Capsule, hard 84 EU/1/04/279/015 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
19/10/2011
Lyrica Ethigen Limited
07/10/2011 100 mg Capsule, hard 100 EU/1/04/279/039 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
19/10/2011
Lyrica Ethigen Limited
07/10/2011 150 mg Capsule, hard 14 EU/1/04/279/017 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
19/10/2011
Lyrica Ethigen Limited
07/10/2011 150 mg Capsule, hard 56 EU/1/04/279/018 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
19/10/2011
Lyrica Ethigen Limited
07/10/2011 150 mg Capsule, hard 100 EU/1/04/279/040 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
19/10/2011
Lyrica Ethigen Limited
07/10/2011 200 mg Capsule, hard 21 EU/1/04/279/020 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
19/10/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 113/255
Lyrica Ethigen Limited
07/10/2011 200 mg Capsule, hard 84 EU/1/04/279/021 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
19/10/2011
Lyrica Ethigen Limited
07/10/2011 25 mg Capsule, hard 14 EU/1/04/279/001 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
19/10/2011
Lyrica Ethigen Limited
07/10/2011 25 mg Capsule, hard 56 EU/1/04/279/003 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
19/10/2011
Lyrica Ethigen Limited
07/10/2011 25 mg Capsule, hard 84 EU/1/04/279/004 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
19/10/2011
Lyrica Ethigen Limited
07/10/2011 25 mg Capsule, hard 100 EU/1/04/279/036 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
19/10/2011
Lyrica Ethigen Limited
07/10/2011 25 mg Capsule, hard 112 (2 x 56)
EU/1/04/279/026 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
19/10/2011
Lyrica Ethigen Limited
07/10/2011 50 mg Capsule, hard 56 EU/1/04/279/008 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
19/10/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 114/255
Lyrica Ethigen Limited
07/10/2011 50 mg Capsule, hard 21 EU/1/04/279/007 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
19/10/2011
Lyrica Ethigen Limited
07/10/2011 50 mg Capsule, hard 84 EU/1/04/279/009 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
19/10/2011
Lyrica Ethigen Limited
07/10/2011 50 mg Capsule, hard 100 EU/1/04/279/037 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
19/10/2011
Lyrica Ethigen Limited
07/10/2011 75 mg Capsule, hard 14 EU/1/04/279/011 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
19/10/2011
Lyrica Ethigen Limited
07/10/2011 75 mg Capsule, hard 56 EU/1/04/279/012 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
19/10/2011
Lyrica Ethigen Limited
07/10/2011 75 mg Capsule, hard 100 EU/1/04/279/038 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
19/10/2011
Lyrica Ethigen Limited
11/11/2011 75 mg Capsule, hard 112 (2 x 56)
EU/1/04/279/027 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
23/11/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 115/255
Lyrica EuroPharma DK
04/02/2011 300 mg Capsule, hard 56 EU/1/04/279/024 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 10/02/2011
Lyrica Ginova Ltd 28/06/2011 50 mg Capsule, hard 56 EU/1/04/279/008 Austria, Belgium, Cyprus, Denmark, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands
United Kingdom
18/08/2011
Lyrica Kosei Pharma UK Limited
23/05/2011 150 mg Capsule, hard 56 EU/1/04/279/018 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
21/06/2011
Lyrica Kosei Pharma UK Limited
23/05/2011 25 mg Capsule, hard 56 EU/1/04/279/003 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
21/06/2011
Lyrica Kosei Pharma UK Limited
23/05/2011 75 mg Capsule, hard 56 EU/1/04/279/012 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
21/06/2011
Lyrica Kosei Pharma UK Limited
01/07/2011 50 mg Capsule, hard 21 EU/1/04/279/007 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
21/07/2011
Lyrica Kosei Pharma UK Limited
05/07/2011 25 mg Capsule, hard 14 EU/1/04/279/001 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
18/07/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 116/255
Lyrica Kosei Pharma UK Limited
05/07/2011 50 mg Capsule, hard 84 EU/1/04/279/009 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
15/07/2011
Lyrica Kosei Pharma UK Limited
06/07/2011 100 mg Capsule, hard 84 EU/1/04/279/015 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
19/07/2011
Lyrica Kosei Pharma UK Limited
06/07/2011 200 mg Capsule, hard 84 EU/1/04/279/021 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
18/07/2011
Lyrica Kosei Pharma UK Limited
06/07/2011 25 mg Capsule, hard 84 EU/1/04/279/004 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
19/07/2011
Lyrica Kosei Pharma UK Limited
06/07/2011 75 mg Capsule, hard 14 EU/1/04/279/011 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
19/07/2011
Lyrica Kosei Pharma UK Limited
07/07/2011 100 mg Capsule, hard 21 EU/1/04/279/014 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
19/07/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 117/255
Lyrica Kosei Pharma UK Limited
07/07/2011 150 mg Capsule, hard 14 EU/1/04/279/017 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
19/07/2011
Lyrica Kosei Pharma UK Limited
07/07/2011 25 mg Capsule, hard 21 EU/1/04/279/002 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
19/07/2011
Lyrica Kosei Pharma UK Limited
25/11/2011 25 mg Capsule, hard 100 EU/1/04/279/036 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
22/12/2011
Lyrica Lexon (UK) Ltd
21/03/2011 50 mg Capsule, hard 56 EU/1/04/279/008 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
05/04/2011
Lyrica Lexon (UK) Ltd
06/10/2011 100 mg Capsule, hard 21 EU/1/04/279/014 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
11/11/2011
Lyrica Mediwin Ltd 02/03/2011 25 mg Capsule, hard 100 EU/1/04/279/036 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Latvia, Luxembourg, Malta, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands
United Kingdom
08/03/2011
Lyrica Orifarm AB 27/10/2011 225 mg Capsule, hard 56 EU/1/04/279/034 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 16/11/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 118/255
Lyrica Orifarm AS 27/10/2011 225 mg Capsule, hard 56 EU/1/04/279/034 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 10/11/2011
Lyrica PCO Manufacturing
28/04/2010 200 mg Capsule, hard 84 EU/1/04/279/021 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
18/01/2011
Lyrica Pharmachim AB
15/04/2011 225 mg Capsule, hard 56 EU/1/04/279/034 Austria, Belgium, Czech Republic, France, Germany, Greece, Ireland, Italy, Latvia, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 19/04/2011
Lyrica Propharmed GmbH
15/04/2011 100 mg Capsule, hard 21 EU/1/04/279/014 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 29/04/2011
Lyrica Propharmed GmbH
15/04/2011 150 mg Capsule, hard 100 EU/1/04/279/040 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Germany 29/04/2011
Lyrica Propharmed GmbH
15/04/2011 50 mg Capsule, hard 21 EU/1/04/279/007 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 29/04/2011
Lyrica Propharmed GmbH
15/04/2011 75 mg Capsule, hard 56 EU/1/04/279/012 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Germany 29/04/2011
Lyrica Propharmed GmbH
11/05/2011 200 mg Capsule, hard 21 EU/1/04/279/020 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 18/05/2011
Lyrica Propharmed GmbH
17/08/2011 300 mg Capsule, hard 56 EU/1/04/279/024 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 29/08/2011
Lyrica Propharmed GmbH
17/08/2011 75 mg Capsule, hard 100 x 1 EU/1/04/279/013 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 06/09/2011
Lyrica Waymade PLC 01/02/2011 75 mg Capsule, hard 100 x 1 EU/1/04/279/013 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
07/02/2011
Lyrica Waymade PLC 24/05/2011 100 mg Capsule, hard 21 EU/1/04/279/014 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
07/06/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 119/255
Lysodren MedicoPharm AG
18/02/2010 500 mg Tablet 100 EU/1/04/273/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 26/01/2011
MabCampath Abacus Medicine A/S
07/07/2011 30 mg/ml Concentrate for solution for infusion
3 vials EU/1/01/193/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 14/07/2011
MabCampath Medartuum AB 31/10/2011 30 mg/ml Concentrate for solution for infusion
3 vials EU/1/01/193/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 11/11/2011
MabCampath Orifarm AS 16/02/2011 30 mg/ml Concentrate for solution for infusion
3 vials EU/1/01/193/002 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 04/03/2011
MabCampath Orifarm OY 16/02/2011 30 mg/ml Concentrate for solution for infusion
3 vials EU/1/01/193/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Finland 28/02/2011
Mabthera Abacus Medicine A/S
15/11/2011 100 mg Concentrate for solution for infusion
2 vials EU/1/98/067/001 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Cyprus 17/11/2011
Mabthera Abacus Medicine A/S
15/11/2011 500 mg Concentrate for solution for infusion
1 vial EU/1/98/067/002 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Cyprus 17/11/2011
Mabthera Pharmachim AB
13/04/2011 100 mg Concentrate for solution for infusion
2 vials EU/1/98/067/001 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 18/04/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 120/255
Metalyse Lex ano UAB 09/03/2011 10000 Units Powder and solvent for solution for injection
1 vial + 1 pre-filled syringe + 1 vial adapter + 1 needle
EU/1/00/169/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Lithuania 24/03/2011
Metalyse Orifarm AB 14/09/2011 10000 Units Powder and solvent for solution for injection
1 vial + 1 pre-filled syringe + 1 vial adapter + 1 needle
EU/1/00/169/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 16/12/2011
Micardis AN Pharmacy Sp. z o.o.
21/02/2011 80 mg Tablet 28 EU/1/98/090/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Poland 28/02/2011
Micardis Axicorp Pharma GmbH
10/01/2011 80 mg Tablet 98 EU/1/98/090/008 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 18/01/2011
Micardis BR Pharma International Ltd
13/09/2011 40 mg Tablet 14 EU/1/98/090/001 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Italy, Liechtenstein, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands
Ireland, Malta, United Kingdom
13/12/2011
Micardis BR Pharma International Ltd
13/09/2011 80 mg Tablet 14 EU/1/98/090/005 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Italy, Liechtenstein, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands
Ireland, Malta, United Kingdom
13/12/2011
Micardis Orifarm AB 15/12/2010 80 mg Tablet 98 EU/1/98/090/008 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Spain, The Netherlands
Sweden 24/01/2011
Micardis Pharmachim AB
19/09/2011 20 mg Tablet 98 EU/1/98/090/012 Austria, Belgium, Czech Republic, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, The Netherlands, United Kingdom
Sweden 17/10/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 121/255
Micardis Pharmachim AB
19/09/2011 40 mg Tablet 28 EU/1/98/090/002 Austria, Belgium, Czech Republic, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, The Netherlands, United Kingdom
Sweden 11/10/2011
Micardis Pharmachim AB
19/09/2011 40 mg Tablet 98 EU/1/98/090/004 Austria, Belgium, Czech Republic, Estonia, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, The Netherlands, United Kingdom
Sweden 11/10/2011
Micardis Pharmachim AB
29/11/2011 80 mg Tablet 28 EU/1/98/090/006 Austria, Belgium, Czech Republic, France, Germany, Greece, Italy, Malta, Norway, Romania, Slovak Republic, Spain, The Netherlands, United Kingdom
Sweden 02/12/2011
Micardis Pharmachim AB
29/11/2011 80 mg Tablet 98 EU/1/98/090/008 Austria, Belgium, Czech Republic, France, Germany, Greece, Italy, Malta, Norway, Romania, Slovak Republic, Spain, The Netherlands, United Kingdom
Sweden 06/12/2011
Micardis STRATHCLYDE PHARMACEUTICALS LTD
15/12/2010 40 mg Tablet 28 EU/1/98/090/002 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
28/02/2011
Micardis STRATHCLYDE PHARMACEUTICALS LTD
15/12/2010 80 mg Tablet 28 EU/1/98/090/006 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
28/02/2011
Micardis STRATHCLYDE PHARMACEUTICALS LTD
15/03/2011 40 mg Tablet 14 EU/1/98/090/001 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
01/04/2011
Micardis STRATHCLYDE PHARMACEUTICALS LTD
15/03/2011 80 mg Tablet 14 EU/1/98/090/005 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
01/04/2011
Micardis Swingward Ltd TA Medihealth
19/08/2011 40 mg Tablet 14 EU/1/98/090/001 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands
United Kingdom
12/10/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 122/255
Micardis Swingward Ltd TA Medihealth
01/09/2011 80 mg Tablet 14 EU/1/98/090/005 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands
United Kingdom
12/10/2011
MicardisPlus AN Pharmacy Sp. z o.o.
22/02/2011 80 mg/ 12.5 mg
Tablet 28 EU/1/02/213/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Poland 28/02/2011
MicardisPlus Beragena Arzneimittel GmbH
24/02/2011 80 mg/ 12.5 mg
Tablet 98 EU/1/02/213/010 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 02/03/2011
MicardisPlus Beragena Arzneimittel GmbH
24/02/2011 80 mg/ 25 mg
Tablet 98 EU/1/02/213/023 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 02/03/2011
MicardisPlus BR Pharma International Ltd
10/05/2011 80 mg/ 25 mg
Tablet 14 EU/1/02/213/017 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Italy, Liechtenstein, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands
Ireland, Malta, United Kingdom
28/09/2011
MicardisPlus BR Pharma International Ltd
10/05/2011 80 mg/ 25 mg
Tablet 28 EU/1/02/213/018 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Italy, Liechtenstein, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands
Ireland, Malta, United Kingdom
28/09/2011
MicardisPlus Clear Pharmacy
17/12/2010 40 mg/ 12.5 mg
Tablet 28 EU/1/02/213/002 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
10/01/2011
MicardisPlus Clear Pharmacy
17/12/2010 80 mg/ 12.5 mg
Tablet 28 EU/1/02/213/007 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
10/01/2011
MicardisPlus Dr Fisher Farma BV
20/04/2011 80 mg/ 25 mg
Tablet 28 EU/1/02/213/018 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
26/04/2011
MicardisPlus EU-Pharma BV 30/03/2011 80 mg/ 12.5 mg
Tablet 28 EU/1/02/213/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
12/04/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 123/255
MicardisPlus Imed Healthcare Ltd
11/07/2011 80 mg/ 12.5 mg
Tablet 28 EU/1/02/213/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
22/07/2011
MicardisPlus Pharmachim AB
09/09/2011 80 mg/ 12.5 mg
Tablet 28 EU/1/02/213/007 Austria, Belgium, Czech Republic, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Slovak Republic, Spain, The Netherlands, United Kingdom
Sweden 26/09/2011
MicardisPlus Pharmachim AB
09/09/2011 80 mg/ 12.5 mg
Tablet 98 EU/1/02/213/010 Austria, Belgium, Czech Republic, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Slovak Republic, Spain, The Netherlands, United Kingdom
Sweden 26/09/2011
MicardisPlus PI-Pharma N.V.
15/10/2010 80 mg/ 12.5 mg
Tablet 28 EU/1/02/213/007 Austria, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Belgium 11/01/2011
MicardisPlus PI-Pharma N.V.
12/01/2011 80 mg/ 12.5 mg
Tablet 98 EU/1/02/213/010 Austria, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Belgium 20/01/2011
MicardisPlus STRATHCLYDE PHARMACEUTICALS LTD
07/02/2011 40 mg/ 12.5 mg
Tablet 14 EU/1/02/213/001 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
01/03/2011
MicardisPlus STRATHCLYDE PHARMACEUTICALS LTD
07/02/2011 80 mg/ 12.5 mg
Tablet 14 EU/1/02/213/006 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
01/03/2011
MicardisPlus STRATHCLYDE PHARMACEUTICALS LTD
02/03/2011 40 mg/ 12.5 mg
Tablet 28 EU/1/02/213/002 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
03/03/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 124/255
MicardisPlus STRATHCLYDE PHARMACEUTICALS LTD
02/03/2011 80 mg/ 12.5 mg
Tablet 28 EU/1/02/213/007 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
03/03/2011
MicardisPlus Vital Supplies UK Limited
17/06/2010 80 mg/ 25 mg
Tablet 28 EU/1/02/213/018 France, Germany, Greece, Italy, Portugal, Spain, Sweden, The Netherlands
Ireland, United Kingdom
24/01/2011
Mimpara Dr Fisher Farma BV
18/11/2010 30 mg Film-coated tablet 28 EU/1/04/292/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
20/04/2011
Mimpara Haemato Pharm AG
23/03/2011 30 mg Film-coated tablet 28 EU/1/04/292/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 11/04/2011
Mimpara Haemato Pharm AG
23/03/2011 60 mg Film-coated tablet 28 EU/1/04/292/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 11/04/2011
Mimpara Haemato Pharm AG
23/03/2011 90 mg Film-coated tablet 28 EU/1/04/292/010 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 11/04/2011
Mimpara Medartuum AB 07/10/2011 60 mg Film-coated tablet 28 EU/1/04/292/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 19/10/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 125/255
Mimpara Medartuum AB 14/11/2011 30 mg Film-coated tablet 28 EU/1/04/292/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands
Sweden 14/11/2011
Mimpara Paranova Danmark AS
12/07/2011 30 mg Film-coated tablet 28 EU/1/04/292/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 18/07/2011
Mimpara Paranova Danmark AS
12/07/2011 60 mg Film-coated tablet 28 EU/1/04/292/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 18/07/2011
Mimpara Paranova Danmark AS
12/07/2011 90 mg Film-coated tablet 28 EU/1/04/292/010 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 18/07/2011
Mimpara Paranova Läkemedel AB
18/10/2011 60 mg Film-coated tablet 28 EU/1/04/292/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 07/11/2011
Mimpara Paranova Läkemedel AB
18/10/2011 90 mg Film-coated tablet 28 EU/1/04/292/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 07/11/2011
Mimpara Pharmachim AB
10/06/2011 30 mg Film-coated tablet 28 EU/1/04/292/002 Austria, Belgium, Czech Republic, Denmark, France, Germany, Greece, Hungary, Ireland, Italy, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 21/06/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 126/255
Mimpara Pharmachim AB
10/06/2011 60 mg Film-coated tablet 28 EU/1/04/292/006 Austria, Belgium, Czech Republic, Denmark, France, Germany, Greece, Hungary, Ireland, Italy, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 21/06/2011
Mimpara Pharmachim AB
10/06/2011 90 mg Film-coated tablet 28 EU/1/04/292/010 Austria, Belgium, Czech Republic, Denmark, France, Germany, Greece, Hungary, Ireland, Italy, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 21/06/2011
Mirapexin 2 Care 4 17/12/2010 0.52 mg Prolonged-release tablet
100 EU/1/97/051/018 Austria, Belgium, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Denmark 11/02/2011
Mirapexin 2 Care 4 17/12/2010 1.05 mg Prolonged-release tablet
100 EU/1/97/051/021 Austria, Belgium, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Denmark 11/02/2011
Mirapexin 2 Care 4 17/12/2010 2.1 mg Prolonged-release tablet
100 EU/1/97/051/024 Austria, Belgium, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Denmark 11/02/2011
Mirapexin 2 Care 4 08/02/2011 0.18 mg Tablet 30 EU/1/97/051/003 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Spain, The Netherlands, United Kingdom
Sweden 04/03/2011
Mirapexin 2 Care 4 08/02/2011 0.18 mg Tablet 100 EU/1/97/051/004 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Spain, The Netherlands, United Kingdom
Sweden 04/03/2011
Mirapexin 2 Care 4 08/02/2011 0.7 mg Tablet 100 EU/1/97/051/006 Austria, Belgium, Bulgaria, Czech Republic, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Spain, The Netherlands, United Kingdom
Sweden 29/03/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 127/255
Mirapexin 2 Care 4 28/02/2011 3.15 mg Prolonged-release tablet
100 EU/1/97/051/027 Austria, Belgium, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Denmark 28/03/2011
Mirapexin Axicorp Pharma GmbH
26/04/2011 1.05 mg Prolonged-release tablet
30 EU/1/97/051/020 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 03/05/2011
Mirapexin Axicorp Pharma GmbH
26/04/2011 1.05 mg Prolonged-release tablet
100 EU/1/97/051/021 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 03/05/2011
Mirapexin Axicorp Pharma GmbH
26/04/2011 2.1 mg Prolonged-release tablet
30 EU/1/97/051/023 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 03/05/2011
Mirapexin Axicorp Pharma GmbH
26/04/2011 2.1 mg Prolonged-release tablet
100 EU/1/97/051/024 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 03/05/2011
Mirapexin B2B Medical GmbH
19/12/2010 1.05 mg Prolonged-release tablet
30 EU/1/97/051/020 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 15/03/2011
Mirapexin B2B Medical GmbH
19/12/2010 1.05 mg Prolonged-release tablet
100 EU/1/97/051/021 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 11/03/2011
Mirapexin B2B Medical GmbH
19/12/2010 2.1 mg Prolonged-release tablet
30 EU/1/97/051/023 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 15/03/2011
Mirapexin B2B Medical GmbH
19/12/2010 2.1 mg Prolonged-release tablet
100 EU/1/97/051/024 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 11/03/2011
Mirapexin B2B Medical GmbH
13/02/2011 0.52 mg Prolonged-release tablet
30 EU/1/97/051/017 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 15/03/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 128/255
Mirapexin B2B Medical GmbH
13/02/2011 0.52 mg Prolonged-release tablet
100 EU/1/97/051/018 Austria, Belgium, Cyprus, Denmark, Estonia, Finland, France, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 15/03/2011
Mirapexin B2B Medical GmbH
13/02/2011 3.15 mg Prolonged-release tablet
30 EU/1/97/051/026 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 15/03/2011
Mirapexin B2B Medical GmbH
13/02/2011 3.15 mg Prolonged-release tablet
100 EU/1/97/051/027 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 15/03/2011
Mirapexin BR Pharma International Ltd
13/01/2011 1.05 mg Prolonged-release tablet
30 EU/1/97/051/020 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Italy, Liechtenstein, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands
Ireland, Malta, United Kingdom
10/05/2011
Mirapexin BR Pharma International Ltd
13/01/2011 2.1 mg Prolonged-release tablet
30 EU/1/97/051/023 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Italy, Liechtenstein, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands
Ireland, Malta, United Kingdom
10/05/2011
Mirapexin BR Pharma International Ltd
04/02/2011 3.15 mg Prolonged-release tablet
30 EU/1/97/051/026 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Italy, Liechtenstein, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands
Ireland, Malta, United Kingdom
06/05/2011
Mirapexin Chemilines Ltd 06/01/2011 0.26 mg Prolonged-release tablet
10 EU/1/97/051/013 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands
United Kingdom
08/04/2011
Mirapexin Chemilines Ltd 06/01/2011 0.52 mg Prolonged-release tablet
10 EU/1/97/051/016 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands
United Kingdom
08/04/2011
Mirapexin Chemilines Ltd 06/01/2011 1.05 mg Prolonged-release tablet
30 EU/1/97/051/020 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands
United Kingdom
11/04/2011
Mirapexin Chemilines Ltd 06/01/2011 2.1 mg Prolonged-release tablet
30 EU/1/97/051/023 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands
United Kingdom
11/04/2011
Mirapexin Chemilines Ltd 11/04/2011 1.05 mg Prolonged-release tablet
100 EU/1/97/051/021 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands
United Kingdom
15/04/2011
Mirapexin Chemilines Ltd 11/04/2011 2.1 mg Prolonged-release tablet
100 EU/1/97/051/024 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands
United Kingdom
15/04/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 129/255
Mirapexin Chemilines Ltd 24/06/2011 3.15 mg Prolonged-release tablet
30 EU/1/97/051/026 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands
Ireland, United Kingdom
04/07/2011
Mirapexin Chemilines Ltd 09/09/2011 0.26 mg Prolonged-release tablet
30 EU/1/97/051/014 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands
Ireland, United Kingdom
10/10/2011
Mirapexin Cross Healthcare Ltd
28/01/2011 1.05 mg Prolonged-release tablet
30 EU/1/97/051/020 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
15/02/2011
Mirapexin Cross Healthcare Ltd
28/01/2011 2.1 mg Prolonged-release tablet
30 EU/1/97/051/023 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
15/02/2011
Mirapexin Cross Healthcare Ltd
28/01/2011 3.15 mg Prolonged-release tablet
30 EU/1/97/051/026 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
15/02/2011
Mirapexin Cross Healthcare Ltd
31/01/2011 0.26 mg Prolonged-release tablet
10 EU/1/97/051/013 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
15/02/2011
Mirapexin Cross Healthcare Ltd
31/01/2011 0.26 mg Prolonged-release tablet
30 EU/1/97/051/014 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
16/02/2011
Mirapexin Cross Healthcare Ltd
31/01/2011 0.52 mg Prolonged-release tablet
10 EU/1/97/051/016 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
15/02/2011
Mirapexin Cross Healthcare Ltd
31/01/2011 0.52 mg Prolonged-release tablet
30 EU/1/97/051/017 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
16/02/2011
Mirapexin Doncaster Pharmaceuticals Group Ltd
20/05/2010 2.1 mg Prolonged-release tablet
30 EU/1/97/051/023 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
03/01/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 130/255
Mirapexin Doncaster Pharmaceuticals Group Ltd
21/06/2011 0.26 mg Prolonged-release tablet
30 EU/1/97/051/014 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
07/07/2011
Mirapexin Ebb Medical AB
04/10/2011 0.18 mg Tablet 30 EU/1/97/051/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 08/11/2011
Mirapexin Ebb Medical AB
04/10/2011 0.18 mg Tablet 100 EU/1/97/051/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 08/11/2011
Mirapexin Ebb Medical AB
04/10/2011 0.7 mg Tablet 100 EU/1/97/051/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 08/11/2011
Mirapexin Emra-Med 10/02/2011 2.1 mg Prolonged-release tablet
100 EU/1/97/051/024 Austria, Belgium, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 01/03/2011
Mirapexin Emra-Med 10/02/2011 3.15 mg Prolonged-release tablet
100 EU/1/97/051/027 Austria, Belgium, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 01/03/2011
Mirapexin G-Pharma Ltd 25/02/2011 0.26 mg Prolonged-release tablet
30 EU/1/97/051/014 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
United Kingdom
14/03/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 131/255
Mirapexin Interport Ltd 08/08/2011 0.52 mg Prolonged-release tablet
10 EU/1/97/051/016 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands
United Kingdom
24/10/2011
Mirapexin Interport Ltd 08/08/2011 1.05 mg Prolonged-release tablet
30 EU/1/97/051/020 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands
United Kingdom
24/10/2011
Mirapexin Interport Ltd 08/08/2011 2.1 mg Prolonged-release tablet
30 EU/1/97/051/023 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands
United Kingdom
24/10/2011
Mirapexin Interport Ltd 08/08/2011 3.15 mg Prolonged-release tablet
30 EU/1/97/051/026 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands
United Kingdom
24/10/2011
Mirapexin Kohlpharma GmbH
09/03/2011 0.26 mg Prolonged-release tablet
10 EU/1/97/051/013 Italy Germany 26/04/2011
Mirapexin Kosei Pharma UK Limited
23/05/2011 0.26 mg Prolonged-release tablet
10 EU/1/97/051/013 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
25/07/2011
Mirapexin Kosei Pharma UK Limited
23/05/2011 0.26 mg Prolonged-release tablet
30 EU/1/97/051/014 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
25/07/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 132/255
Mirapexin Kosei Pharma UK Limited
23/05/2011 0.52 mg Prolonged-release tablet
10 EU/1/97/051/016 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
25/07/2011
Mirapexin Kosei Pharma UK Limited
23/05/2011 0.52 mg Prolonged-release tablet
30 EU/1/97/051/017 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
25/07/2011
Mirapexin Kosei Pharma UK Limited
24/05/2011 1.05 mg Prolonged-release tablet
30 EU/1/97/051/020 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
25/07/2011
Mirapexin Kosei Pharma UK Limited
24/05/2011 2.1 mg Prolonged-release tablet
30 EU/1/97/051/023 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
25/07/2011
Mirapexin Kosei Pharma UK Limited
24/05/2011 3.15 mg Prolonged-release tablet
30 EU/1/97/051/026 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
25/07/2011
Mirapexin Lexon (UK) Ltd
14/12/2011 0.26 mg Prolonged-release tablet
10 EU/1/97/051/013 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
19/12/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 133/255
Mirapexin Lexon (UK) Ltd
14/12/2011 0.52 mg Prolonged-release tablet
10 EU/1/97/051/016 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
19/12/2011
Mirapexin Lexon (UK) Ltd
14/12/2011 1.05 mg Prolonged-release tablet
30 EU/1/97/051/020 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
19/12/2011
Mirapexin Lexon (UK) Ltd
14/12/2011 2.1 mg Prolonged-release tablet
30 EU/1/97/051/023 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
19/12/2011
Mirapexin Lexon (UK) Ltd
14/12/2011 3.15 mg Prolonged-release tablet
30 EU/1/97/051/026 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
19/12/2011
Mirapexin Medartuum AB 17/02/2011 0.7 mg Tablet 100 EU/1/97/051/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 21/02/2011
Mirapexin Medartuum AB 18/02/2011 0.26 mg Prolonged-release tablet
100 EU/1/97/051/015 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 22/02/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 134/255
Mirapexin Medartuum AB 18/02/2011 1.05 mg Prolonged-release tablet
100 EU/1/97/051/021 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 02/03/2011
Mirapexin Medartuum AB 18/02/2011 2.1 mg Prolonged-release tablet
100 EU/1/97/051/024 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 02/03/2011
Mirapexin Medartuum AB 01/04/2011 0.18 mg Tablet 100 EU/1/97/051/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 06/04/2011
Mirapexin Medcor Pharmaceuticals BV
22/04/2011 1.05 mg Prolonged-release tablet
30 EU/1/97/051/020 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
03/05/2011
Mirapexin Medcor Pharmaceuticals BV
22/04/2011 2.1 mg Prolonged-release tablet
30 EU/1/97/051/023 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
03/05/2011
Mirapexin Medcor Pharmaceuticals BV
22/04/2011 3.15 mg Prolonged-release tablet
30 EU/1/97/051/026 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
03/05/2011
Mirapexin Medcor Pharmaceuticals BV
04/11/2011 0.26 mg Prolonged-release tablet
10 EU/1/97/051/013 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
10/11/2011
Mirapexin Mediwin Ltd 08/06/2011 0.52 mg Prolonged-release tablet
10 EU/1/97/051/016 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands
United Kingdom
20/06/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 135/255
Mirapexin Mediwin Ltd 30/06/2011 1.05 mg Prolonged-release tablet
30 EU/1/97/051/020 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands
United Kingdom
14/07/2011
Mirapexin Mediwin Ltd 05/07/2011 2.1 mg Prolonged-release tablet
30 EU/1/97/051/023 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands
United Kingdom
14/07/2011
Mirapexin Mediwin Ltd 30/08/2011 3.15 mg Prolonged-release tablet
30 EU/1/97/051/026 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands
United Kingdom
05/09/2011
Mirapexin MPT Pharma 24/01/2011 0.088 mg Tablet 30 EU/1/97/051/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
10/02/2011
Mirapexin Orifarm AB 14/10/2011 0.52 mg Prolonged-release tablet
100 EU/1/97/051/018 Austria, Belgium, Bulgaria, Cyprus, Denmark, Estonia, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 28/10/2011
Mirapexin Orifarm AB 14/10/2011 1.05 mg Prolonged-release tablet
100 EU/1/97/051/021 Austria, Belgium, Bulgaria, Cyprus, Denmark, Estonia, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 28/10/2011
Mirapexin Orifarm AB 14/10/2011 2.1 mg Prolonged-release tablet
100 EU/1/97/051/024 Austria, Belgium, Bulgaria, Cyprus, Denmark, Estonia, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 28/10/2011
Mirapexin Swingward Ltd TA Medihealth
23/02/2011 0.52 mg Prolonged-release tablet
30 EU/1/97/051/017 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands
United Kingdom
02/03/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 136/255
Mirapexin Swingward Ltd TA Medihealth
27/05/2011 0.26 mg Prolonged-release tablet
30 EU/1/97/051/014 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands
United Kingdom
30/05/2011
Mirapexin Swingward Ltd TA Medihealth
12/12/2011 0.088 mg Tablet 30 EU/1/97/051/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands
United Kingdom
21/12/2011
Mircera CC Pharma 17/01/2011 50 µg/0.3 ml Solution for injection
3 x 1 pre-filled syringe
EU/1/07/400/023 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Latvia, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 27/01/2011
Mircera CC Pharma 21/03/2011 75 µg/0.3 ml Solution for injection
3 x 1 pre-filled syringe
EU/1/07/400/024 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Latvia, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 14/04/2011
Mircera Dr Fisher Farma BV
28/10/2011 100 µg/0.3 ml Solution for injection
1 pre-filled syringe
EU/1/07/400/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, United Kingdom
The Netherlands
15/11/2011
Mircera Dr Fisher Farma BV
28/10/2011 50 µg/0.3 ml Solution for injection
1 pre-filled syringe
EU/1/07/400/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
15/11/2011
Mircera Dr Fisher Farma BV
28/10/2011 75 µg/0.3 ml Solution for injection
1 pre-filled syringe
EU/1/07/400/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
15/11/2011
Mircera Emra-Med 06/07/2011 100 µg/0.3 ml Solution for injection
1 pre-filled syringe
EU/1/07/400/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 22/07/2011
Mircera Emra-Med 06/07/2011 120 µg/0.3 ml Solution for injection
1 pre-filled syringe
EU/1/07/400/020 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 22/07/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 137/255
Mircera Emra-Med 06/07/2011 150 µg/0.3 ml Solution for injection
1 pre-filled syringe
EU/1/07/400/011 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 22/07/2011
Mircera Emra-Med 06/07/2011 200 µg/0.3 ml Solution for injection
1 pre-filled syringe
EU/1/07/400/012 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 22/07/2011
Mircera Emra-Med 06/07/2011 250 µg/0.3 ml Solution for injection
1 pre-filled syringe
EU/1/07/400/013 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 22/07/2011
Mircera Emra-Med 06/07/2011 360 µg/0.6 ml Solution for injection
1 pre-filled syringe
EU/1/07/400/021 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 22/07/2011
Mircera Emra-Med 06/07/2011 50 µg/0.3 ml Solution for injection
1 pre-filled syringe
EU/1/07/400/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 22/07/2011
Mircera Emra-Med 06/07/2011 75 µg/0.3 ml Solution for injection
1 pre-filled syringe
EU/1/07/400/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 22/07/2011
Mircera Kohlpharma GmbH
21/11/2011 50 µg/0.3 ml Solution for injection
3 x 1 pre-filled syringe
EU/1/07/400/023 Greece, Spain Germany 24/11/2011
Mircera Kohlpharma GmbH
21/11/2011 75 µg/0.3 ml Solution for injection
3 x 1 pre-filled syringe
EU/1/07/400/024 Greece, Spain Germany 23/11/2011
Mircera Medcor Pharmaceuticals BV
30/06/2011 100 µg/0.3 ml Solution for injection
1 pre-filled syringe
EU/1/07/400/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
04/08/2011
Mircera Medcor Pharmaceuticals BV
30/06/2011 200 µg/0.3 ml Solution for injection
1 pre-filled syringe
EU/1/07/400/012 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
04/08/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 138/255
Mircera Medcor Pharmaceuticals BV
30/06/2011 50 µg/0.3 ml Solution for injection
1 pre-filled syringe
EU/1/07/400/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
04/08/2011
Mircera Orifarm AB 04/03/2011 100 µg/0.3 ml Solution for injection
1 pre-filled syringe
EU/1/07/400/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 21/03/2011
Mircera Orifarm AB 04/03/2011 50 µg/0.3 ml Solution for injection
1 pre-filled syringe
EU/1/07/400/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Slovak Republic, Spain, The Netherlands, United Kingdom
Sweden 21/03/2011
Mircera Orifarm AB 04/03/2011 75 µg/0.3 ml Solution for injection
1 pre-filled syringe
EU/1/07/400/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 21/03/2011
Mircera Orifarm AS 04/03/2011 100 µg/0.3 ml Solution for injection
1 pre-filled syringe
EU/1/07/400/010 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 23/03/2011
Mircera Orifarm AS 04/03/2011 75 µg/0.3 ml Solution for injection
1 pre-filled syringe
EU/1/07/400/009 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 31/03/2011
Mircera Orifarm AS 22/08/2011 200 µg/0.3 ml Solution for injection
1 pre-filled syringe
EU/1/07/400/012 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 23/08/2011
Mircera Pharma Westen GmbH
15/11/2011 100 µg/0.3 ml Solution for injection
1 pre-filled syringe
EU/1/07/400/010 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/11/2011
Mircera Pharma Westen GmbH
15/11/2011 120 µg/0.3 ml Solution for injection
1 pre-filled syringe
EU/1/07/400/020 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/11/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 139/255
Mircera Pharma Westen GmbH
15/11/2011 150 µg/0.3 ml Solution for injection
1 pre-filled syringe
EU/1/07/400/011 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/11/2011
Mircera Pharma Westen GmbH
15/11/2011 200 µg/0.3 ml Solution for injection
1 pre-filled syringe
EU/1/07/400/012 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 24/11/2011
Mircera Pharma Westen GmbH
15/11/2011 250 µg/0.3 ml Solution for injection
1 pre-filled syringe
EU/1/07/400/013 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/11/2011
Mircera Pharma Westen GmbH
15/11/2011 360 µg/0.6 ml Solution for injection
1 pre-filled syringe
EU/1/07/400/021 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 24/11/2011
Mircera Pharma Westen GmbH
15/11/2011 50 µg/0.3 ml Solution for injection
1 pre-filled syringe
EU/1/07/400/008 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/11/2011
Mircera Pharma Westen GmbH
15/11/2011 75 µg/0.3 ml Solution for injection
1 pre-filled syringe
EU/1/07/400/009 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/11/2011
Mozobil Orifarm AB 10/05/2011 20 mg/ml Solution for injection
1 vial EU/1/09/537/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 12/05/2011
MULTAQ Doncaster Pharmaceuticals Group Ltd
09/02/2011 400 mg Film-coated tablet 60 EU/1/09/591/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
03/03/2011
MULTAQ G-Pharma Ltd 09/03/2011 400 mg Film-coated tablet 60 EU/1/09/591/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
29/03/2011
MULTAQ Orifarm AB 17/10/2011 400 mg Film-coated tablet 20 EU/1/09/591/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 08/11/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 140/255
MULTAQ Swingward Ltd TA Medihealth
22/06/2011 400 mg Film-coated tablet 60 EU/1/09/591/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands
United Kingdom
08/07/2011
MULTAQ Waymade PLC 11/01/2011 400 mg Film-coated tablet 60 EU/1/09/591/003 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
17/01/2011
Neoclarityn Autumn Healthcare Ltd
23/05/2011 5 mg Film-coated tablet 30 EU/1/00/161/011 Ireland, United Kingdom Ireland, United Kingdom
14/06/2011
Neoclarityn Dr Fisher Farma BV
26/09/2011 5 mg Film-coated tablet 30 EU/1/00/161/011 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
14/11/2011
Neoclarityn Imed Healthcare Ltd
06/07/2011 5 mg Film-coated tablet 30 EU/1/00/161/011 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
28/07/2011
Neoclarityn PCO Manufacturing
16/06/2011 0.5 mg/ml Oral solution 1 bottle EU/1/00/161/062 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
14/07/2011
NeoRecormon Abacus Medicine A/S
21/06/2011 10000 IU Solution for injection
6 pre-filled syringes
EU/1/97/031/036 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 29/06/2011
NeoRecormon Abacus Medicine A/S
21/06/2011 10000 IU Solution for injection
6 pre-filled syringes
EU/1/97/031/036 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands
Sweden 05/07/2011
NeoRecormon Abacus Medicine A/S
21/06/2011 4000 IU Solution for injection
6 pre-filled syringes
EU/1/97/031/042 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 29/06/2011
NeoRecormon Abacus Medicine A/S
21/06/2011 4000 IU Solution for injection
6 pre-filled syringes
EU/1/97/031/042 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 05/07/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 141/255
NeoRecormon Abacus Medicine A/S
21/06/2011 6000 IU Solution for injection
6 pre-filled syringes
EU/1/97/031/044 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 29/06/2011
NeoRecormon Abacus Medicine A/S
21/09/2011 6000 IU Solution for injection
6 pre-filled syringes
EU/1/97/031/044 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 19/10/2011
NeoRecormon Haemato Pharm AG
05/05/2011 10000 IU Solution for injection
6 pre-filled syringes
EU/1/97/031/036 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 19/05/2011
NeoRecormon Haemato Pharm AG
05/05/2011 2000 IU Solution for injection
6 pre-filled syringes
EU/1/97/031/030 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 19/05/2011
NeoRecormon Haemato Pharm AG
05/05/2011 30000 IU Solution for injection
4 pre-filled syringes
EU/1/97/031/046 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 19/05/2011
NeoRecormon Haemato Pharm AG
05/05/2011 5000 IU Solution for injection
6 pre-filled syringes
EU/1/97/031/034 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 19/05/2011
NeoRecormon Haemato Pharm AG
05/05/2011 6000 IU Solution for injection
6 pre-filled syringes
EU/1/97/031/044 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 19/05/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 142/255
Neulasta ABACUS MEDICINE A/S
21/09/2011 6 mg Solution for injection
1 pre-filled syringe
EU/1/02/227/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 22/09/2011
Neulasta Beragena Arzneimittel GmbH
01/06/2011 6 mg Solution for injection
1 pre-filled syringe with needle guard
EU/1/02/227/004 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 29/06/2011
Neulasta CC Pharma 07/06/2011 6 mg Solution for injection
1 pre-filled syringe with needle guard
EU/1/02/227/004 Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Poland, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Germany 17/06/2011
Neulasta Dr Fisher Farma BV
04/05/2011 6 mg Solution for injection
1 pre-filled syringe with needle guard
EU/1/02/227/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, United Kingdom
The Netherlands
10/05/2011
Neulasta Emra-Med 22/03/2011 6 mg Solution for injection
1 pre-filled syringe with needle guard
EU/1/02/227/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Austria, Germany
18/04/2011
Neulasta Haemato Pharm AG
06/01/2011 6 mg Solution for injection
1 pre-filled syringe with needle guard
EU/1/02/227/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Austria, Germany
31/01/2011
Neulasta Haemato Pharm AG
11/03/2011 6 mg Solution for injection
1 pre-filled syringe
EU/1/02/227/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 18/05/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 143/255
Neulasta Haemato Pharm AG
17/05/2011 6 mg Solution for injection
1 pre-filled syringe
EU/1/02/227/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 18/05/2011
Neulasta Inopha GmbH 03/02/2011 6 mg Solution for injection
1 pre-filled syringe
EU/1/02/227/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, United Kingdom
The Netherlands
16/02/2011
Neulasta Inopha GmbH 26/09/2011 6 mg Solution for injection
1 pre-filled syringe
EU/1/02/227/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 11/10/2011
Neulasta MedicoPharm AG
11/04/2011 6 mg Solution for injection
1 pre-filled syringe with needle guard
EU/1/02/227/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Austria, Germany
20/04/2011
Neulasta mibe GmbH Arzneimittel
01/06/2011 6 mg Solution for injection
1 pre-filled syringe
EU/1/02/227/001 Greece Germany 28/06/2011
Neulasta NewNeopharm BV
27/10/2010 6 mg Solution for injection
1 pre-filled syringe (non blister)
EU/1/02/227/002 Austria, Belgium, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 24/03/2011
Neulasta NewNeopharm BV
04/07/2011 6 mg Solution for injection
1 pre-filled syringe
EU/1/02/227/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 05/07/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 144/255
Neulasta Omnia Läkemedel AB
10/10/2011 6 mg Solution for injection
1 pre-filled syringe with needle guard
EU/1/02/227/004 Austria, Belgium, Bulgaria, Estonia, France, Germany, Greece, Ireland, Italy, Latvia, Lithuania, Poland, Portugal, Romania, Spain, The Netherlands, United Kingdom
Sweden 20/12/2011
Neulasta Orifarm AB 04/10/2011 6 mg Solution for injection
1 pre-filled syringe with needle guard
EU/1/02/227/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 04/11/2011
Neulasta Oy Cross Pharma AB
07/03/2011 6 mg Solution for injection
1 pre-filled syringe
EU/1/02/227/001 Austria, Belgium, Cyprus, Denmark, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Finland 15/03/2011
Neulasta Paranova Läkemedel AB
28/04/2005 6 mg Solution for injection
1 pre-filled syringe with needle guard
EU/1/02/227/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 20/06/2011
Neulasta Paranova OY 31/08/2011 6 mg Solution for injection
1 pre-filled syringe with needle guard
EU/1/02/227/004 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Finland 07/09/2011
Neulasta Paranova OY 26/10/2011 6 mg Solution for injection
1 pre-filled syringe
EU/1/02/227/001 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Finland 14/11/2011
Neulasta Parx AB 11/07/2011 6 mg Solution for injection
1 pre-filled syringe
EU/1/02/227/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, United Kingdom
Sweden 04/11/2011
Neulasta Pharmachim AB
04/10/2011 6 mg Solution for injection
1 pre-filled syringe with needle guard
EU/1/02/227/004 Austria, Belgium, Bulgaria, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 18/10/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 145/255
Neulasta Propharmed GmbH
24/03/2011 6 mg Solution for injection
1 pre-filled syringe
EU/1/02/227/001 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Germany 12/04/2011
Neulasta Tabsn Caps Pack ApS
05/07/2011 6 mg Solution for injection
1 pre-filled syringe with needle guard
EU/1/02/227/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 06/07/2011
Neulasta Veron Pharma Vertriebs GmbH
31/01/2011 6 mg Solution for injection
1 pre-filled syringe with needle guard
EU/1/02/227/004 Austria Germany 03/03/2011
Neulasta Veron Pharma Vertriebs GmbH
16/04/2011 6 mg Solution for injection
1 pre-filled syringe
EU/1/02/227/001 Austria, Belgium, France, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom
Germany 17/05/2011
Neupro Amimed Direct Ltd
13/07/2010 2 mg/24h Transdermal patch 7 patches EU/1/05/331/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
12/05/2011
Neupro Amimed Direct Ltd
13/07/2010 4 mg/24h Transdermal patch 7 patches EU/1/05/331/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
12/05/2011
Neupro Amimed Direct Ltd
13/07/2010 6 mg/24h Transdermal patch 7 patches EU/1/05/331/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
12/05/2011
Neupro Amimed Direct Ltd
13/07/2010 6 mg/24h Transdermal patch 28 patches EU/1/05/331/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
12/05/2011
Neupro Amimed Direct Ltd
13/07/2010 8 mg/24h Transdermal patch 28 patches EU/1/05/331/011 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
12/05/2011
Neupro Amimed Direct Ltd
16/07/2010 8 mg/24h Transdermal patch 7 patches EU/1/05/331/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
12/05/2011
Neupro Doncaster Pharmaceuticals Group Ltd
25/02/2011 2 mg/24h Transdermal patch 28 patches EU/1/05/331/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
04/04/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 146/255
Neupro Doncaster Pharmaceuticals Group Ltd
02/03/2011 4 mg/24h Transdermal patch 28 patches EU/1/05/331/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
04/04/2011
Neupro Doncaster Pharmaceuticals Group Ltd
02/03/2011 6 mg/24h Transdermal patch 28 patches EU/1/05/331/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
04/04/2011
Neupro Doncaster Pharmaceuticals Group Ltd
03/03/2011 8 mg/24h Transdermal patch 28 patches EU/1/05/331/011 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
04/04/2011
Neupro EuroPharma DK
02/02/2011 4 mg/24h Transdermal patch 7 patches EU/1/05/331/004 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 16/02/2011
Neupro EuroPharma DK
02/02/2011 4 mg/24h Transdermal patch 28 patches EU/1/05/331/005 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 16/02/2011
Neupro EuroPharma DK
15/02/2011 8 mg/24h Transdermal patch 7 patches EU/1/05/331/010 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Denmark 16/02/2011
Neupro EuroPharma DK
15/02/2011 8 mg/24h Transdermal patch 28 patches EU/1/05/331/011 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Denmark 16/02/2011
Neupro EuroPharma DK
12/10/2011 2 mg/24h Transdermal patch 7 patches EU/1/05/331/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 11/11/2011
Neupro EuroPharma DK
12/10/2011 2 mg/24h Transdermal patch 28 patches EU/1/05/331/002 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 11/11/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 147/255
Neupro EuroPharma DK
12/10/2011 6 mg/24h Transdermal patch 7 patches EU/1/05/331/007 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 11/11/2011
Neupro EuroPharma DK
12/10/2011 6 mg/24h Transdermal patch 28 patches EU/1/05/331/008 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 11/11/2011
Neupro Medcor Pharmaceuticals BV
20/06/2011 6 mg/24h Transdermal patch 28 patches EU/1/05/331/008 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
21/06/2011
Neupro Medcor Pharmaceuticals BV
20/06/2011 8 mg/24h Transdermal patch 28 patches EU/1/05/331/011 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
21/06/2011
Neupro MTK Pharma GmbH
10/03/2011 4 mg/24h Transdermal patch 84 patches EU/1/05/331/024 Austria, Czech Republic, Italy, Spain, The Netherlands, United Kingdom
Germany 12/04/2011
Neupro MTK Pharma GmbH
10/03/2011 6 mg/24h Transdermal patch 84 patches EU/1/05/331/030 Austria, Czech Republic, Italy, Spain, The Netherlands, United Kingdom
Germany 12/04/2011
Neupro MTK Pharma GmbH
10/03/2011 8 mg/24h Transdermal patch 84 patches EU/1/05/331/036 Austria, Czech Republic, Italy, Spain, The Netherlands, United Kingdom
Germany 12/04/2011
Neupro MTK Pharma GmbH
07/11/2011 2 mg/24h Transdermal patch 84 patches EU/1/05/331/018 Austria, Czech Republic, France, Italy, Spain, The Netherlands, United Kingdom
Germany 14/11/2011
Neupro PCO Manufacturing
20/06/2011 8 mg/24h Transdermal patch 28 patches EU/1/05/331/011 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands
Ireland, United Kingdom
22/06/2011
Neupro Pharma Westen GmbH
04/10/2011 2 mg/24h Transdermal patch 56 patches EU/1/05/331/016 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 20/12/2011
Neupro Pharma Westen GmbH
04/10/2011 6 mg/24h Transdermal patch 56 patches EU/1/05/331/028 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 20/12/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 148/255
Neupro Pharma Westen GmbH
04/10/2011 8 mg/24h Transdermal patch 56 patches EU/1/05/331/034 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 20/12/2011
Neupro Waymade PLC 04/10/2011 6 mg/24h Transdermal patch 28 patches EU/1/05/331/008 Austria, Belgium, Denmark, Finland, France, Germany, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
11/10/2011
NeuroBloc CC Pharma 24/02/2011 5000 U/ml Solution for injection
1 vial EU/1/00/166/002 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 07/03/2011
NeuroBloc CC Pharma 06/07/2011 5000 U/ml Solution for injection
1 vial EU/1/00/166/001 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 22/07/2011
NeuroBloc CC Pharma 29/08/2011 5000 U/ml Solution for injection
1 vial EU/1/00/166/003 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 23/09/2011
Nevanac Euro Registratie Collectief BV
30/05/2011 1 mg/ml Eye drops, suspension
1 bottle EU/1/07/433/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
28/06/2011
Nexavar Axicorp Pharma GmbH
20/06/2011 200 mg Film-coated tablet 112 EU/1/06/342/001 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 04/07/2011
Nexavar Haemato Pharm AG
11/03/2011 200 mg Film-coated tablet 112 EU/1/06/342/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, United Kingdom
Denmark 29/03/2011
Nexavar Omnia Läkemedel AB
07/06/2011 200 mg Film-coated tablet 112 EU/1/06/342/001 Bulgaria, France, Greece, Italy, Lithuania, Poland, Romania, Spain, United Kingdom
Sweden 17/06/2011
Nexavar Orifarm AB 12/05/2011 200 mg Film-coated tablet 112 EU/1/06/342/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 25/05/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 149/255
Nexavar Pharma Westen GmbH
30/09/2010 200 mg Film-coated tablet 112 EU/1/06/342/001 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 15/06/2011
Norvir CC Pharma 03/01/2011 100 mg Film-coated tablet 30 EU/1/96/016/005 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 27/01/2011
Norvir CC Pharma 28/04/2011 100 mg Film-coated tablet 90 (3 x 30) EU/1/96/016/007 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 11/05/2011
Norvir Pharma Westen GmbH
27/04/2011 100 mg Film-coated tablet 90 (3 x 30) EU/1/96/016/007 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 16/05/2011
NovoMix 30 FlexPen
EU-Pharma BV 24/05/2011 100 U/ml Suspension for injection
5 pre-filled pens
EU/1/00/142/009 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
10/08/2011
NovoMix 50 FlexPen
Euro Registratie Collectief BV
15/12/2010 100 U/ml Suspension for injection
5 pre-filled pens
EU/1/00/142/015 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
11/02/2011
NovoNorm BB Farma s.r.l.
17/11/2011 0.5 mg Tablet 120 EU/1/98/076/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 09/12/2011
NovoNorm CC Pharma 17/10/2011 0.5 mg Tablet 120 EU/1/98/076/006 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 15/11/2011
NovoNorm CC Pharma 17/10/2011 1 mg Tablet 120 EU/1/98/076/013 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 15/11/2011
NovoNorm CC Pharma 17/10/2011 2 mg Tablet 120 EU/1/98/076/020 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 15/11/2011
NovoNorm Euro Registratie Collectief BV
12/07/2011 0.5 mg Tablet 90 EU/1/98/076/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
13/07/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 150/255
NovoNorm Euro Registratie Collectief BV
12/07/2011 1 mg Tablet 90 EU/1/98/076/012 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
13/07/2011
NovoRapid Axicorp Pharma GmbH
07/09/2011 100 U/ml Solution for injection
5 x (1 x 10 ml) vials
EU/1/99/119/015 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 07/10/2011
NovoRapid CC Pharma 19/04/2011 100 U/ml Solution for injection
10 cartridges
EU/1/99/119/006 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 29/04/2011
NovoRapid Emra-Med 25/01/2010 100 U/ml Solution for injection
5 x (1 x 10 ml) vials
EU/1/99/119/015 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 12/01/2011
NovoRapid EU-Pharma BV 30/05/2011 100 U/ml Solution for injection
5 pre-filled pens
EU/1/99/119/009 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
28/06/2011
NovoRapid PCO Manufacturing
15/11/2011 100 U/ml Solution for injection
1 vial EU/1/99/119/001 United Kingdom Ireland 08/12/2011
Noxafil Euro Registratie Collectief BV
13/12/2010 40 mg/ml Oral suspension 1 bottle EU/1/05/320/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
06/01/2011
Noxafil Orifarm AB 19/05/2011 40 mg/ml Oral suspension 1 bottle EU/1/05/320/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 23/05/2011
Noxafil Orifarm AS 11/05/2011 40 mg/ml Oral suspension 1 bottle EU/1/05/320/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 25/05/2011
Noxafil Propharmed GmbH
31/03/2011 40 mg/ml Oral suspension 1 bottle EU/1/05/320/001 Austria, Belgium, Bulgaria, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Germany 20/04/2011
NutropinAq Dr Fisher Farma BV
15/12/2010 10 mg/2 ml Solution for injection
1 cartridge EU/1/00/164/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
27/07/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 151/255
Olanzapine Mylan Doncaster Pharmaceuticals Group Ltd
06/10/2011 2.5 mg Film-coated tablet 28 EU/1/08/475/001 Ireland, Malta, United Kingdom Ireland, Malta, United Kingdom
18/10/2011
Olanzapine Mylan Doncaster Pharmaceuticals Group Ltd
07/10/2011 10 mg Film-coated tablet 28 EU/1/08/475/019 Ireland, Malta, United Kingdom Ireland, Malta, United Kingdom
18/10/2011
Olanzapine Mylan Doncaster Pharmaceuticals Group Ltd
07/10/2011 5 mg Film-coated tablet 28 EU/1/08/475/007 Ireland, Malta, United Kingdom Ireland, Malta, United Kingdom
18/10/2011
Omnitrope Concept Pharma Vertriebs GmbH
07/06/2011 3.3 mg/ml Solution for injection in cartridge
1 cartridge EU/1/06/332/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 01/07/2011
Omnitrope Concept Pharma Vertriebs GmbH
07/06/2011 6.7 mg/ml Solution for injection in cartridge
1 cartridge EU/1/06/332/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 01/07/2011
Omnitrope Medartuum AB 13/01/2011 6.7 mg/ml Solution for injection in cartridge
1 cartridge EU/1/06/332/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 17/02/2011
Omnitrope MTK Pharma GmbH
17/02/2011 3.3 mg/ml Solution for injection in cartridge
10 cartridges
EU/1/06/332/006 France, Italy Germany 25/02/2011
Omnitrope MTK Pharma GmbH
17/02/2011 6.7 mg/ml Solution for injection in cartridge
10 cartridges
EU/1/06/332/009 Austria, France, Italy Germany 25/02/2011
Omnitrope Pharmachim AB
20/06/2011 3.3 mg/ml Solution for injection in cartridge
1 cartridge EU/1/06/332/004 Austria, Belgium, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 12/07/2011
Omnitrope Pharmachim AB
20/06/2011 6.7 mg/ml Solution for injection in cartridge
1 cartridge EU/1/06/332/007 Austria, Belgium, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 12/07/2011
Onbrez Breezhaler 2 Care 4 18/05/2011 150 µg Inhalation powder, hard capsule
3 x (30 + 1 inhaler)
EU/1/09/593/004 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 24/05/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 152/255
Onbrez Breezhaler 2 Care 4 18/05/2011 300 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/593/007 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 24/05/2011
Onbrez Breezhaler 2 Care 4 18/05/2011 300 µg Inhalation powder, hard capsule
3 x (30 + 1 inhaler)
EU/1/09/593/009 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 24/05/2011
Onbrez Breezhaler Amimed Direct Ltd
14/06/2011 150 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/593/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
29/06/2011
Onbrez Breezhaler Amimed Direct Ltd
14/06/2011 300 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/593/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
29/06/2011
Onbrez Breezhaler Axicorp Pharma GmbH
21/02/2011 150 µg Inhalation powder, hard capsule
3 x (30 + 1 inhaler)
EU/1/09/593/004 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 14/03/2011
Onbrez Breezhaler Axicorp Pharma GmbH
15/03/2011 300 µg Inhalation powder, hard capsule
3 x (30 + 1 inhaler)
EU/1/09/593/009 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 29/03/2011
Onbrez Breezhaler B&S Healthcare Ltd
18/07/2011 150 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/593/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
12/09/2011
Onbrez Breezhaler B&S Healthcare Ltd
18/07/2011 300 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/593/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
12/09/2011
Onbrez Breezhaler B2B Medical GmbH
10/08/2011 300 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/593/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 23/08/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 153/255
Onbrez Breezhaler B2B Medical GmbH
10/08/2011 300 µg Inhalation powder, hard capsule
3 x (30 + 1 inhaler)
EU/1/09/593/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 23/08/2011
Onbrez Breezhaler Beragena Arzneimittel GmbH
14/04/2011 300 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/593/007 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 05/05/2011
Onbrez Breezhaler Beragena Arzneimittel GmbH
14/04/2011 300 µg Inhalation powder, hard capsule
3 x (30 + 1 inhaler)
EU/1/09/593/009 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 05/05/2011
Onbrez Breezhaler BR Pharma International Ltd
22/02/2011 300 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/593/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 28/02/2011
Onbrez Breezhaler BR Pharma International Ltd
10/05/2011 150 µg Inhalation powder, hard capsule
3 x (30 + 1 inhaler)
EU/1/09/593/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 02/08/2011
Onbrez Breezhaler CC Pharma 14/12/2010 150 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/593/002 Austria, Belgium, Denmark, Finland, France, Greece, Hungary, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 12/01/2011
Onbrez Breezhaler CC Pharma 14/12/2010 150 µg Inhalation powder, hard capsule
3 x (30 + 1 inhaler)
EU/1/09/593/004 Austria, Belgium, Denmark, Finland, France, Greece, Hungary, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 12/01/2011
Onbrez Breezhaler CC Pharma 28/02/2011 300 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/593/007 Austria, Belgium, Denmark, Finland, France, Greece, Hungary, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 29/03/2011
Onbrez Breezhaler CC Pharma 12/04/2011 300 µg Inhalation powder, hard capsule
3 x (30 + 1 inhaler)
EU/1/09/593/009 Austria, Belgium, Denmark, Finland, France, Greece, Hungary, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 18/04/2011
Onbrez Breezhaler Dr Fisher Farma BV
28/03/2011 300 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/593/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
30/05/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 154/255
Onbrez Breezhaler Dr Fisher Farma BV
18/07/2011 150 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/593/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
20/07/2011
Onbrez Breezhaler Dr Fisher Farma BV
23/08/2011 150 µg Inhalation powder, hard capsule
10 + 1 inhaler
EU/1/09/593/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
24/08/2011
Onbrez Breezhaler Dr Fisher Farma BV
23/08/2011 300 µg Inhalation powder, hard capsule
10 + 1 inhaler
EU/1/09/593/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
24/08/2011
Onbrez Breezhaler Emra-Med 21/09/2011 300 µg Inhalation powder, hard capsule
3 x (30 + 1 inhaler)
EU/1/09/593/009 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, TheNetherlands, United Kingdom
Germany 20/10/2011
Onbrez Breezhaler Emra-Med 25/11/2011 150 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/593/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 30/11/2011
Onbrez Breezhaler Euro Registratie Collectief BV
14/12/2010 300 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/593/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
04/01/2011
Onbrez Breezhaler EuroPharma DK
07/07/2011 150 µg Inhalation powder, hard capsule
3 x (30 + 1 inhaler)
EU/1/09/593/004 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 30/08/2011
Onbrez Breezhaler EuroPharma DK
07/07/2011 150 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/593/002 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 30/08/2011
Onbrez Breezhaler EuroPharma DK
07/07/2011 300 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/593/007 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 30/08/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 155/255
Onbrez Breezhaler EuroPharma DK
07/07/2011 300 µg Inhalation powder, hard capsule
3 x (30 + 1 inhaler)
EU/1/09/593/009 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 30/08/2011
Onbrez Breezhaler Interport Ltd 04/11/2011 150 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/593/002 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands
United Kingdom
14/11/2011
Onbrez Breezhaler Interport Ltd 04/11/2011 300 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/593/007 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands
United Kingdom
09/11/2011
Onbrez Breezhaler Kohlpharma GmbH
12/01/2011 300 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/593/007 Italy, Spain Germany 25/01/2011
Onbrez Breezhaler Kohlpharma GmbH
25/01/2011 300 µg Inhalation powder, hard capsule
3 x (30 + 1 inhaler)
EU/1/09/593/009 Austria, France, Ireland, Italy, Spain Germany 23/03/2011
Onbrez Breezhaler Kohlpharma GmbH
29/03/2011 150 µg Inhalation powder, hard capsule
3 x (30 + 1 inhaler)
EU/1/09/593/004 Italy, Norway, United Kingdom Germany 04/05/2011
Onbrez Breezhaler Kohlpharma GmbH
20/04/2011 150 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/593/002 Italy Germany 04/05/2011
Onbrez Breezhaler Medcor Pharmaceuticals BV
28/02/2011 150 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/593/002 Austria, Belgium, Bulgaria, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
18/03/2011
Onbrez Breezhaler Medcor Pharmaceuticals BV
28/02/2011 300 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/593/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
18/03/2011
Onbrez Breezhaler MedicoPharm AG
24/02/2011 150 µg Inhalation powder, hard capsule
3 x (30 + 1 inhaler)
EU/1/09/593/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 08/03/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 156/255
Onbrez Breezhaler MedicoPharm AG
24/02/2011 150 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/593/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 08/03/2011
Onbrez Breezhaler MedicoPharm AG
24/02/2011 300 µg Inhalation powder, hard capsule
3 x (30 + 1 inhaler)
EU/1/09/593/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 08/03/2011
Onbrez Breezhaler MedicoPharm AG
24/02/2011 300 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/593/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 11/03/2011
Onbrez Breezhaler Mediwin Ltd 10/02/2011 150 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/593/002 Austria, Belgium, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands
United Kingdom
23/02/2011
Onbrez Breezhaler Mediwin Ltd 24/03/2011 300 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/593/007 Austria, Belgium, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands
United Kingdom
01/04/2011
Onbrez Breezhaler MPT Pharma 04/01/2011 150 µg Inhalation powder, hard capsule
3 x (30 + 1 inhaler)
EU/1/09/593/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
10/01/2011
Onbrez Breezhaler MPT Pharma 04/01/2011 150 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/593/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
07/01/2011
Onbrez Breezhaler MPT Pharma 04/01/2011 300 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/593/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
03/02/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 157/255
Onbrez Breezhaler MPT Pharma 04/01/2011 300 µg Inhalation powder, hard capsule
3 x (30 + 1 inhaler)
EU/1/09/593/009 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
03/02/2011
Onbrez Breezhaler Orifarm AS 28/01/2011 150 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/593/002 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 15/03/2011
Onbrez Breezhaler Orifarm AS 28/01/2011 150 µg Inhalation powder, hard capsule
3 x (30 + 1 inhaler)
EU/1/09/593/004 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 15/03/2011
Onbrez Breezhaler Paranova Danmark AS
12/09/2011 150 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/593/002 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Ireland, Italy, Norway, Portugal, Romania, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 07/10/2011
Onbrez Breezhaler Paranova Danmark AS
13/09/2011 150 µg Inhalation powder, hard capsule
3 x (30 + 1 inhaler)
EU/1/09/593/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 07/10/2011
Onbrez Breezhaler Paranova Danmark AS
13/09/2011 300 µg Inhalation powder, hard capsule
3 x (30 + 1 inhaler)
EU/1/09/593/009 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 07/10/2011
Onbrez Breezhaler Paranova Danmark AS
13/09/2011 300 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/593/007 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Ireland, Italy, Norway, Portugal, Romania, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 07/10/2011
Onglyza Lexon (UK) Ltd
12/12/2011 5 mg Film-coated tablet 28 EU/1/09/545/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
20/12/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 158/255
Onglyza Orifarm AS 27/10/2011 5 mg Film-coated tablet 28 EU/1/09/545/006 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 16/11/2011
Onglyza Paranova Danmark AS
26/09/2011 5 mg Film-coated tablet 28 EU/1/09/545/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 12/10/2011
Onglyza Paranova Danmark AS
26/09/2011 5 mg Film-coated tablet 98 EU/1/09/545/008 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 12/10/2011
Onglyza PCO Manufacturing
22/03/2011 5 mg Film-coated tablet 28 EU/1/09/545/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands
Ireland, United Kingdom
06/06/2011
Onglyza PCO Manufacturing
24/03/2011 5 mg Film-coated tablet 28 EU/1/09/545/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
22/07/2011
Onglyza Swingward Ltd TA Medihealth
15/03/2011 5 mg Film-coated tablet 28 EU/1/09/545/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands
United Kingdom
28/04/2011
Onglyza Waymade PLC 14/07/2011 5 mg Film-coated tablet 28 EU/1/09/545/006 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
01/08/2011
Opatanol B&S Healthcare Ltd
16/11/2011 1 mg/ml Eye drops, solution 1 bottle EU/1/02/217/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
07/12/2011
Opatanol Clear Pharmacy
20/12/2010 1 mg/ml Eye drops, solution 1 bottle EU/1/02/217/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
11/01/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 159/255
Opatanol Dr Fisher Farma BV
13/07/2011 1 mg/ml Eye drops, solution 1 bottle EU/1/02/217/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
03/08/2011
Opatanol Lexon (UK) Ltd
13/12/2011 1 mg/ml Eye drops, solution 1 bottle EU/1/02/217/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
20/12/2011
Opatanol Paranova Läkemedel AB
02/08/2011 1 mg/ml Eye drops, solution 1 bottle EU/1/02/217/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 23/08/2011
Opatanol Paranova Läkemedel AB
02/08/2011 1 mg/ml Eye drops, solution 3 bottles EU/1/02/217/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 23/08/2011
Opatanol Profind Wholesale Ltd.
12/10/2011 1 mg/ml Eye drops, solution 1 bottle EU/1/02/217/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
13/12/2011
Optruma Mediwin Ltd 28/11/2011 60 mg Film-coated tablet 28 EU/1/98/074/002 Austria, Belgium, Cyprus, Denmark, Finland, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom
France 07/12/2011
Optruma Mediwin Ltd 28/11/2011 60 mg Film-coated tablet 84 EU/1/98/074/003 Austria, Belgium, Cyprus, Denmark, Finland, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Poland, Spain, Sweden, The Netherlands, United Kingdom
France 07/12/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 160/255
Orencia Medartuum AB 24/05/2011 250 mg Powder for concentrate for solution for infusion
1 vial + 1 syringe
EU/1/07/389/001 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 31/05/2011
Orencia Orifarm AB 31/01/2011 250 mg Powder for concentrate for solution for infusion
1 vial + 1 syringe
EU/1/07/389/001 Austria, Belgium, Bulgaria, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 17/03/2011
Orencia Pharmachim AB
26/10/2011 250 mg Powder for concentrate for solution for infusion
1 vial + 1 syringe
EU/1/07/389/001 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 22/11/2011
Orencia Pharmachim AB
26/10/2011 250 mg Powder for concentrate for solution for infusion
3 vials + 3 syringes
EU/1/07/389/003 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 22/11/2011
Orfadin Abacus Medicine A/S
30/06/2011 10 mg Capsule, hard 60 EU/1/04/303/003 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 11/07/2011
Orfadin Abacus Medicine A/S
30/06/2011 5 mg Capsule, hard 60 EU/1/04/303/002 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 11/07/2011
Orfadin Abacus Medicine A/S
09/08/2011 2 mg Capsule, hard 60 EU/1/04/303/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 12/08/2011
Orgalutran Orifarm AB 30/06/2011 0.25 mg/ 0.5 ml
Solution for injection
5 pre-filled syringes
EU/1/00/130/002 Austria, Belgium, Cyprus, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 12/07/2011
Orgalutran Orifarm AS 30/06/2011 0.25 mg/ 0.5 ml
Solution for injection
1 pre-filled syringe
EU/1/00/130/001 Austria, Belgium, Cyprus, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 04/07/2011
Orgalutran Orifarm AS 30/06/2011 0.25 mg/ 0.5 ml
Solution for injection
5 pre-filled syringes
EU/1/00/130/002 Austria, Belgium, Cyprus, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 04/07/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 161/255
Orgalutran Pharmachim AB
08/07/2011 0.25 mg/ 0.5 ml
Solution for injection
1 pre-filled syringe
EU/1/00/130/001 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 19/07/2011
Oslif Breezhaler BR Pharma International Ltd
14/03/2011 300 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/586/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 14/04/2011
Oslif Breezhaler BR Pharma International Ltd
14/03/2011 300 µg Inhalation powder, hard capsule
3 x (30 + 1 inhaler)
EU/1/09/586/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 02/08/2011
Oslif Breezhaler Pharma Westen GmbH
16/02/2011 150 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/586/002 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 04/03/2011
Oslif Breezhaler Pharma Westen GmbH
16/02/2011 150 µg Inhalation powder, hard capsule
3 x (30 + 1 inhaler)
EU/1/09/586/004 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 04/03/2011
Oslif Breezhaler Pharma Westen GmbH
16/02/2011 300 µg Inhalation powder, hard capsule
30 (3 x 10) + 1 inhaler
EU/1/09/586/007 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 07/03/2011
Oslif Breezhaler Pharma Westen GmbH
16/02/2011 300 µg Inhalation powder, hard capsule
3 x (30 + 1 inhaler)
EU/1/09/586/009 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 07/03/2011
Ovitrelle Orifarm AB 27/10/2011 250 micrograms/ 0.5 ml
Solution for injection
1 pre-filled syringe
EU/1/00/165/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 10/11/2011
Ovitrelle Orifarm AS 27/10/2011 250 micrograms/ 0.5 ml
Solution for injection
1 pre-filled syringe
EU/1/00/165/007 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 10/11/2011
Pegasys Axicorp Pharma GmbH
12/07/2011 135 µg Solution for injection
4 pre-filled syringes + 4 injection needles
EU/1/02/221/006 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 22/08/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 162/255
Pegasys Medartuum AB 07/04/2011 135 µg Solution for injection
4 pre-filled syringes + 4 injection needles
EU/1/02/221/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 15/04/2011
Pegasys Omnia Läkemedel AB
28/09/2011 135 µg Solution for injection
4 pre-filled syringes + 4 injection needles
EU/1/02/221/006 Austria, Belgium, Bulgaria, France, Germany, Greece, Italy, Latvia, Lithuania, Portugal, Romania, Spain, The Netherlands, United Kingdom
Sweden 20/10/2011
Pegasys Omnia Läkemedel AB
28/09/2011 180 µg Solution for injection
4 pre-filled syringes + 4 injection needles
EU/1/02/221/008 Austria, Belgium, Bulgaria, France, Germany, Greece, Italy, Latvia, Lithuania, Portugal, Romania, Spain, The Netherlands, United Kingdom
Sweden 20/10/2011
Pegasys Orifarm AB 20/10/2011 180 µg Solution for injection
4 pre-filled syringes + 4 injection needles
EU/1/02/221/008 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 07/12/2011
Pegasys Orifarm AS 04/01/2011 180 µg Solution for injection
4 pre-filled syringes + 4 injection needles
EU/1/02/221/008 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 07/01/2011
Pegasys Veron Pharma Vertriebs GmbH
16/11/2011 180 µg Solution for injection
1 pre-filled syringe + 1 injection needle
EU/1/02/221/007 Austria, Greece Germany 28/11/2011
Pegasys Veron Pharma Vertriebs GmbH
16/11/2011 180 µg Solution for injection
4 pre-filled syringes + 4 injection needles
EU/1/02/221/008 Austria, Greece Germany 28/11/2011
PegIntron Emra-Med 06/06/2007 100 micrograms
Powder and solvent for solution for injection in pre-filled pen
4 pens + 4 injection needles + 8 cleansing swabs
EU/1/00/131/040 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 11/10/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 163/255
PegIntron Orifarm AS 07/01/2011 120 micrograms
Powder and solvent for solution for injection in pre-filled pen
4 pens + 4 injection needles + 8 cleansing swabs
EU/1/00/131/044 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 12/01/2011
PegIntron Propharmed GmbH
19/04/2011 100 micrograms
Powder and solvent for solution for injection in pre-filled pen
4 pens + 4 injection needles + 8 cleansing swabs
EU/1/00/131/040 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 29/04/2011
PegIntron Propharmed GmbH
19/04/2011 120 micrograms
Powder and solvent for solution for injection in pre-filled pen
4 pens + 4 injection needles + 8 cleansing swabs
EU/1/00/131/044 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 29/04/2011
PegIntron Propharmed GmbH
19/04/2011 120 micrograms
Powder and solvent for solution for injection in pre-filled pen
12 pens + 12 injection needles + 24 cleansing swabs
EU/1/00/131/046 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 29/04/2011
PegIntron Propharmed GmbH
19/04/2011 150 micrograms
Powder and solvent for solution for injection in pre-filled pen
4 pens + 4 injection needles + 8 cleansing swabs
EU/1/00/131/048 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 29/04/2011
PegIntron Propharmed GmbH
20/04/2011 100 micrograms
Powder and solvent for solution for injection in pre-filled pen
12 pens + 12 injection needles + 24 cleansing swabs
EU/1/00/131/042 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 29/04/2011
Plavix 2 Care 4 27/06/2011 300 mg Film-coated tablet 30 x 1 EU/1/98/069/009 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 12/08/2011
Plavix Acta Pharma 29/07/2011 75 mg Film-coated tablet 28 EU/1/98/069/001a Austria, Belgium, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Bulgaria 26/08/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 164/255
Plavix AN Pharmacy Sp. z o.o.
17/12/2010 75 mg Film-coated tablet 28 EU/1/98/069/001a Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Poland 17/03/2011
Plavix BB Farma s.r.l.
22/03/2011 75 mg Film-coated tablet 28 EU/1/98/069/001a Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
France 14/04/2011
Plavix Combiphar Europe BV
05/02/2009 75 mg Film-coated tablet 30 EU/1/98/069/005a Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
05/07/2011
Plavix Delfarma SpZoo
02/03/2011 75 mg Film-coated tablet 28 EU/1/98/069/001a Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Poland 16/03/2011
Plavix Lexon (UK) Ltd
31/03/2011 75 mg Film-coated tablet 30 EU/1/98/069/005a Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
12/05/2011
Plavix Mediwin Ltd 07/01/2011 75 mg Film-coated tablet 30 EU/1/98/069/005a Austria, Belgium, Cyprus, Denmark, Finland, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
France 15/02/2011
Plavix PHARMECO ApS
06/04/2011 75 mg Film-coated tablet 28 EU/1/98/069/001a Czech Republic, Italy, Lithuania, Romania, Spain
Denmark 18/04/2011
Plavix PI-Pharma N.V.
11/10/2010 75 mg Film-coated tablet 28 EU/1/98/069/001a Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Belgium 13/12/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 165/255
Plavix PI-Pharma N.V.
11/08/2011 75 mg Film-coated tablet 84 EU/1/98/069/003a Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Liechtenstein, Lithuania, Luxembourg, Malta, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Belgium 13/12/2011
Plavix SAIMA Productos Y Servicios S.L.U.
07/06/2011 75 mg Film-coated tablet 28 EU/1/98/069/001a Germany Spain 23/08/2011
Pradaxa Axicorp Pharma GmbH
06/05/2011 110 mg Capsule, hard 30 x 1 EU/1/08/442/006 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Germany 21/06/2011
Pradaxa Axicorp Pharma GmbH
06/05/2011 75 mg Capsule, hard 30 x 1 EU/1/08/442/002 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Germany 21/06/2011
Pradaxa Emra-Med 26/09/2011 110 mg Capsule, hard 60 x 1 EU/1/08/442/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 03/10/2011
Pradaxa Euro Registratie Collectief BV
30/05/2011 75 mg Capsule, hard 30 x 1 EU/1/08/442/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
27/06/2011
Pradaxa Euro Registratie Collectief BV
16/09/2011 75 mg Capsule, hard 60 x 1 EU/1/08/442/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
20/09/2011
Pradaxa Euro Registratie Collectief BV
19/09/2011 110 mg Capsule, hard 60 x 1 EU/1/08/442/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
20/09/2011
Pradaxa Euro Registratie Collectief BV
20/09/2011 110 mg Capsule, hard 30 x 1 EU/1/08/442/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
21/09/2011
Pradaxa Europharma Sverige AB
25/10/2011 110 mg Capsule, hard 60 x 1 EU/1/08/442/007 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 12/12/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 166/255
Pradaxa Europharma Sverige AB
25/10/2011 75 mg Capsule, hard 60 x 1 EU/1/08/442/003 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 12/12/2011
Pradaxa Medartuum AB 26/10/2011 110 mg Capsule, hard 60 x 1 EU/1/08/442/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 28/10/2011
Pradaxa Orifarm AB 20/10/2011 110 mg Capsule, hard 60 x 1 EU/1/08/442/007 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Spain, The Netherlands, United Kingdom
Sweden 25/11/2011
Pradaxa Orifarm AB 20/10/2011 75 mg Capsule, hard 60 x 1 EU/1/08/442/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 25/11/2011
Pradaxa Orifarm AS 07/10/2011 110 mg Capsule, hard 60 x 1 EU/1/08/442/007 Austria, Belgium, Cyprus, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 18/11/2011
Pradaxa Orifarm AS 07/10/2011 75 mg Capsule, hard 60 x 1 EU/1/08/442/003 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 18/11/2011
Pradaxa PCO Manufacturing
15/06/2011 110 mg Capsule, hard 60 x 1 EU/1/08/442/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands
Ireland, United Kingdom
09/08/2011
Pradaxa PCO Manufacturing
15/06/2011 75 mg Capsule, hard 60 x 1 EU/1/08/442/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands
Ireland, United Kingdom
09/08/2011
Pradaxa Pharma Westen GmbH
11/03/2011 110 mg Capsule, hard 30 x 1 EU/1/08/442/006 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 29/03/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 167/255
Pradaxa Pharma Westen GmbH
25/08/2011 110 mg Capsule, hard 60 x 1 EU/1/08/442/007 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 12/09/2011
Pradaxa Veron Pharma Vertriebs GmbH
31/03/2011 110 mg Capsule, hard 10 x 1 EU/1/08/442/005 Austria, Belgium, France, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom
Germany 17/05/2011
Pradaxa Veron Pharma Vertriebs GmbH
31/03/2011 110 mg Capsule, hard 30 x 1 EU/1/08/442/006 Austria, Belgium, France, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom
Germany 17/05/2011
Pradaxa Veron Pharma Vertriebs GmbH
31/03/2011 75 mg Capsule, hard 10 x 1 EU/1/08/442/001 Austria, Belgium, France, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom
Germany 17/05/2011
Pradaxa Veron Pharma Vertriebs GmbH
31/03/2011 75 mg Capsule, hard 30 x 1 EU/1/08/442/002 Austria, Belgium, France, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom
Germany 17/05/2011
Pradaxa Veron Pharma Vertriebs GmbH
27/09/2011 110 mg Capsule, hard 60 x 1 EU/1/08/442/007 Austria, Belgium, France, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom
Germany 11/10/2011
Prandin Paranova Läkemedel AB
08/04/2011 1 mg Tablet 90 EU/1/00/162/010 Spain, United Kingdom Sweden 20/04/2011
Prandin Paranova Läkemedel AB
08/04/2011 1 mg Tablet 120 EU/1/00/162/011 Spain, United Kingdom Sweden 20/04/2011
Prandin Paranova Läkemedel AB
11/04/2011 2 mg Tablet 90 EU/1/00/162/016 Spain, United Kingdom Sweden 20/04/2011
Prandin Paranova Läkemedel AB
11/04/2011 2 mg Tablet 120 EU/1/00/162/017 Spain, United Kingdom Sweden 20/04/2011
Prevenar 13 Axicorp Pharma GmbH
07/12/2010 0.5ml Suspension for injection
1 pre-filled syringe with separate needle
EU/1/09/590/002 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 11/01/2011
Prevenar 13 CC Pharma 20/12/2010 - - Suspension for injection
1 pre-filled syringe
EU/1/09/590/001 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 14/01/2011
Prezista Medcor Pharmaceuticals BV
10/05/2011 600 mg Film-coated tablet 60 EU/1/06/380/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
16/05/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 168/255
Prezista Orifarm AS 16/12/2010 600 mg Film-coated tablet 60 EU/1/06/380/002 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 10/01/2011
Prezista Orifarm OY 07/03/2011 400 mg Film-coated tablet 60 EU/1/06/380/003 Austria, Belgium, Cyprus, Denmark, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Finland 28/03/2011
Pritor BCN Farma SL 01/02/2011 40 mg Tablet 28 EU/1/98/089/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Sweden, The Netherlands, United Kingdom
Spain 15/02/2011
Pritor BCN Farma SL 23/03/2011 80 mg Tablet 28 EU/1/98/089/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Sweden, The Netherlands, United Kingdom
Spain 01/04/2011
Pritor Emra-Med 28/07/2011 40 mg Tablet 98 EU/1/98/089/004 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Germany 06/09/2011
Pritor Emra-Med 28/07/2011 80 mg Tablet 98 EU/1/98/089/009 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Germany 06/09/2011
Pritor Euromedicines, S.L.
13/12/2010 80 mg Tablet 28 EU/1/98/089/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Sweden, The Netherlands, United Kingdom
Spain 28/02/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 169/255
PritorPlus B&S Healthcare Ltd
12/05/2011 80 mg/ 12.5 mg
Tablet 28 EU/1/02/215/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
11/07/2011
PritorPlus B&S Healthcare Ltd
12/05/2011 80 mg/ 25mg
Tablet 28 EU/1/02/215/016 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
11/07/2011
PritorPlus Emra-Med 26/07/2011 80 mg/ 12.5 mg
Tablet 98 EU/1/02/215/010 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Germany 09/09/2011
PritorPlus Emra-Med 28/07/2011 80 mg/ 25mg
Tablet 98 EU/1/02/215/021 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Germany 09/09/2011
PritorPlus Emra-Med 30/09/2011 40 mg/ 12.5 mg
Tablet 98 EU/1/02/215/005 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Germany 11/10/2011
PritorPlus Euromedicines, S.L.
13/12/2010 80 mg/ 12.5 mg
Tablet 28 EU/1/02/215/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Sweden, The Netherlands, United Kingdom
Spain 28/02/2011
PritorPlus G-Pharma Ltd 02/02/2011 80 mg/ 12.5 mg
Tablet 28 EU/1/02/215/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
17/02/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 170/255
PritorPlus G-Pharma Ltd 02/02/2011 80 mg/ 25mg
Tablet 28 EU/1/02/215/016 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
17/02/2011
PritorPlus Orifarm AB 08/03/2011 80 mg/ 12.5 mg
Tablet 98 EU/1/02/215/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 17/03/2011
Privigen Axicorp Pharma B.V.
26/07/2011 100 mg/ml Solution for infusion
1 vial EU/1/08/446/002 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 01/08/2011
Privigen Emra-Med 27/10/2011 100 mg/ml Solution for infusion
1 vial EU/1/08/446/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 17/11/2011
Privigen Haemato Pharm AG
03/08/2011 100 mg/ml Solution for infusion
1 vial EU/1/08/446/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 15/08/2011
Privigen Haemato Pharm AG
03/08/2011 100 mg/ml Solution for infusion
1 vial EU/1/08/446/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 15/08/2011
Privigen Haemato Pharm AG
03/08/2011 100 mg/ml Solution for infusion
1 vial EU/1/08/446/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 15/08/2011
Procoralan Autumn Healthcare Ltd
05/07/2011 5 mg Film-coated tablet 56 EU/1/05/316/003 Ireland, United Kingdom Ireland, United Kingdom
11/07/2011
Procoralan Autumn Healthcare Ltd
05/07/2011 7.5 mg Film-coated tablet 56 EU/1/05/316/010 Ireland, United Kingdom Ireland, United Kingdom
11/07/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 171/255
Procoralan Lexon (UK) Ltd
12/12/2011 5 mg Film-coated tablet 56 EU/1/05/316/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
21/12/2011
Procoralan PCO Manufacturing
11/05/2010 5 mg Film-coated tablet 56 EU/1/05/316/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
10/02/2011
Procoralan Profind Wholesale Ltd.
17/08/2011 5 mg Film-coated tablet 56 EU/1/05/316/003 United Kingdom Ireland 25/08/2011
Procoralan Profind Wholesale Ltd.
17/08/2011 7.5 mg Film-coated tablet 56 EU/1/05/316/010 United Kingdom Ireland 25/08/2011
Prolia Axicorp Pharma GmbH
07/12/2010 60 mg/ml Solution for injection
1 pre-filled syringe with automatic needle guard (blistered)
EU/1/10/618/003 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 14/02/2011
Prolia CC Pharma 02/12/2010 60 mg/ml Solution for injection
1 pre-filled syringe with automatic needle guard (blistered)
EU/1/10/618/003 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 18/01/2011
Prolia Eureco-Pharma B.V.
05/08/2011 60 mg/ml Solution for injection
1 pre-filled syringe with automatic needle guard (blistered)
EU/1/10/618/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Spain, Sweden, United Kingdom
The Netherlands
30/08/2011
Prolia Euro Registratie Collectief BV
14/11/2011 60 mg/ml Solution for injection
1 pre-filled syringe with automatic needle guard (blistered)
EU/1/10/618/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
22/11/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 172/255
Prolia Medcor Pharmaceuticals BV 0
20/06/2011 60 mg/ml Solution for injection
1 pre-filled syringe with automatic needle guard (blistered)
EU/1/10/618/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
21/06/2011
Prolia Pharma Westen GmbH
04/11/2011 60 mg/ml Solution for injection
1 pre-filled syringe with automatic needle guard (blistered)
EU/1/10/618/003 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 15/11/2011
Prometax B&S Healthcare Ltd
17/05/2011 1.5 mg Capsule, hard 28 EU/1/98/092/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
31/05/2011
Prometax B&S Healthcare Ltd
17/05/2011 3 mg Capsule, hard 56 EU/1/98/092/005 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
31/05/2011
Prometax B&S Healthcare Ltd
17/05/2011 4.5 mg Capsule, hard 56 EU/1/98/092/008 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
31/05/2011
Prometax B&S Healthcare Ltd
17/05/2011 4.6 mg / 24 hours
Transdermal patch 30 sachets EU/1/98/092/020 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
31/05/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 173/255
Prometax B&S Healthcare Ltd
17/05/2011 6 mg Capsule, hard 56 EU/1/98/092/011 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
31/05/2011
Prometax B&S Healthcare Ltd
17/05/2011 9.5 mg / 24 hours
Transdermal patch 30 sachets EU/1/98/092/024 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
31/05/2011
Prometax Emra-Med 24/05/2011 3 mg Capsule, hard 56 EU/1/98/092/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 30/05/2011
Prometax Emra-Med 24/05/2011 4.5 mg Capsule, hard 56 EU/1/98/092/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 30/05/2011
Protelos 2 Care 4 17/05/2010 2 g Granules for oral suspension
28 sachets EU/1/04/288/003 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 07/01/2011
Protelos 2 Care 4 02/07/2010 2 g Granules for oral suspension
84 sachets EU/1/04/288/005 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 05/01/2011
Protelos Euro Registratie Collectief BV
23/06/2011 2 g Granules for oral suspension
28 sachets EU/1/04/288/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
04/07/2011
Protopic Abacus Medicine A/S
18/08/2011 0.03% Ointment 1 tube EU/1/02/201/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 12/09/2011
Protopic Abacus Medicine A/S
18/08/2011 0.03% Ointment 1 tube EU/1/02/201/002 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 12/09/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 174/255
Protopic Abacus Medicine A/S
18/08/2011 0.1% Ointment 1 tube EU/1/02/201/003 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 12/09/2011
Protopic Abacus Medicine A/S
19/08/2011 0.1% Ointment 1 tube EU/1/02/201/004 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 12/09/2011
Protopic Autumn Healthcare Ltd
23/05/2011 0.03% Ointment 1 tube EU/1/02/201/001 Ireland, United Kingdom Ireland, United Kingdom
27/06/2011
Protopic Autumn Healthcare Ltd
07/06/2011 0.1% Ointment 1 tube EU/1/02/201/003 Ireland, United Kingdom Ireland, United Kingdom
27/06/2011
Protopic Autumn Healthcare Ltd
07/06/2011 0.1% Ointment 1 tube EU/1/02/201/004 Ireland, United Kingdom Ireland, United Kingdom
27/06/2011
Protopic Doncaster Pharmaceuticals Group Ltd
16/09/2011 0.1% Ointment 1 tube EU/1/02/201/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
23/09/2011
Protopic Doncaster Pharmaceuticals Group Ltd
19/09/2011 0.03% Ointment 1 tube EU/1/02/201/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
23/09/2011
Protopic Medartuum AB 06/10/2010 0.1% Ointment 1 tube EU/1/02/201/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 11/02/2011
Protopic Medartuum AB 05/09/2011 0.1% Ointment 1 tube EU/1/02/201/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 04/10/2011
Protopic Paranova Läkemedel AB
12/10/2011 0.1% Ointment 1 tube EU/1/02/201/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 27/10/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 175/255
Protopic Paranova Läkemedel AB
12/10/2011 0.1% Ointment 1 tube EU/1/02/201/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 27/10/2011
Puregon 2 Care 4 27/06/2011 300 IU/ 0.36 ml
Solution for injection
1 cartridge + 2 packs with 3 pen needles
EU/1/96/008/038 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 05/07/2011
Puregon 2 Care 4 27/06/2011 600 IU/ 0.72 ml
Solution for injection
1 cartridge + 2 packs with 3 pen needles
EU/1/96/008/039 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 27/07/2011
Puregon Abacus Medicine A/S
30/09/2011 300 IU/ 0.36 ml
Solution for injection
1 cartridge + 2 packs with 3 pen needles
EU/1/96/008/038 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 18/10/2011
Puregon Axicorp Pharma GmbH
28/06/2011 900 IU/ 1.08 ml
Solution for injection
1 cartridge + 3 packs with 3 pen needles
EU/1/96/008/041 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 11/07/2011
Puregon Axicorp Pharma GmbH
12/07/2011 300 IU/ 0.36 ml
Solution for injection
1 cartridge + 2 packs with 3 pen needles
EU/1/96/008/038 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 27/07/2011
Puregon Axicorp Pharma GmbH
26/07/2011 600 IU/ 0.72 ml
Solution for injection
1 cartridge + 2 packs with 3 pen needles
EU/1/96/008/039 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 01/08/2011
Puregon EuroPharma DK
19/05/2011 300 IU/ 0.36 ml
Solution for injection
1 cartridge + 2 packs with 3 pen needles
EU/1/96/008/038 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 31/05/2011
Puregon EuroPharma DK
19/05/2011 600 IU/ 0.72 ml
Solution for injection
1 cartridge + 2 packs with 3 pen needles
EU/1/96/008/039 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 31/05/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 176/255
Puregon Haemato Pharm AG
08/12/2010 600 IU/ 0.72 ml
Solution for injection
1 cartridge + 2 packs with 3 pen needles
EU/1/96/008/039 Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Austria, Germany
19/01/2011
Puregon Haemato Pharm AG
09/12/2010 300 IU/ 0.36 ml
Solution for injection
1 cartridge + 2 packs with 3 pen needles
EU/1/96/008/038 Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Austria, Germany
19/01/2011
Puregon Haemato Pharm AG
10/12/2010 900 IU/ 1.08 ml
Solution for injection
1 cartridge + 3 packs with 3 pen needles
EU/1/96/008/041 Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Austria, Germany
19/01/2011
Puregon Haemato Pharm AG
08/03/2011 300 IU/ 0.36 ml
Solution for injection
1 cartridge + 2 packs with 3 pen needles
EU/1/96/008/038 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 17/03/2011
Puregon Haemato Pharm AG
08/03/2011 600 IU/ 0.72 ml
Solution for injection
1 cartridge + 2 packs with 3 pen needles
EU/1/96/008/039 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 17/03/2011
Puregon Haemato Pharm AG
08/03/2011 900 IU/ 1.08 ml
Solution for injection
1 cartridge + 3 packs with 3 pen needles
EU/1/96/008/041 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 17/03/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 177/255
Puregon Pharmachim AB
11/03/2011 300 IU/ 0.36 ml
Solution for injection
1 cartridge + 2 packs with 3 pen needles
EU/1/96/008/038 Austria, Belgium, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Lithuania, Malta, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 15/04/2011
Puregon Pharmachim AB
11/03/2011 600 IU/ 0.72 ml
Solution for injection
1 cartridge + 2 packs with 3 pen needles
EU/1/96/008/039 Austria, Belgium, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Lithuania, Malta, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 15/04/2011
Puregon Pharmachim AB
11/03/2011 900 IU/ 1.08 ml
Solution for injection
1 cartridge + 3 packs with 3 pen needles
EU/1/96/008/041 Austria, Belgium, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Lithuania, Malta, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 15/04/2011
Rapamune Kohlpharma GmbH
02/02/2011 0.5 mg Coated tablet 3 x 10 EU/1/01/171/013 Austria Germany 28/03/2011
Rapamune Kohlpharma GmbH
02/02/2011 0.5 mg Coated tablet 10 x 10 EU/1/01/171/014 Austria Germany 28/03/2011
Rapilysin Orifarm AS 28/07/2011 10 U Powder and solvent for solution for injection
2 vials + 2 pre-filled syringes + 2 reconstitution devices/needles
EU/1/96/018/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 05/08/2011
Rasilez Amimed Direct Ltd
10/06/2011 150 mg Film-coated tablet 30 EU/1/07/405/023 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
15/06/2011
Rasilez Amimed Direct Ltd
14/06/2011 300 mg Film-coated tablet 30 EU/1/07/405/033 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
15/06/2011
Rasilez Axicorp Pharma GmbH
22/02/2011 150 mg Film-coated tablet 98 EU/1/07/405/028 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 28/02/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 178/255
Rasilez B&S Healthcare Ltd
16/08/2011 300 mg Film-coated tablet 28 EU/1/07/405/032 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
17/08/2011
Rasilez B&S Healthcare Ltd
07/10/2011 150 mg Film-coated tablet 28 EU/1/07/405/022 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
18/10/2011
Rasilez Beragena Arzneimittel GmbH
18/10/2011 150 mg Film-coated tablet 28 EU/1/07/405/022 Austria, Belgium, France, Greece, Iceland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 03/11/2011
Rasilez Beragena Arzneimittel GmbH
18/10/2011 150 mg Film-coated tablet 98 EU/1/07/405/028 Austria, Belgium, France, Greece, Iceland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 08/11/2011
Rasilez Beragena Arzneimittel GmbH
18/10/2011 300 mg Film-coated tablet 98 EU/1/07/405/038 Austria, Belgium, France, Greece, Iceland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 08/11/2011
Rasilez Beragena Arzneimittel GmbH
18/10/2011 300 mg Film-coated tablet 28 EU/1/07/405/032 Austria, Belgium, France, Greece, Iceland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 08/11/2011
Rasilez CC Pharma 22/07/2011 300 mg Film-coated tablet 28 EU/1/07/405/032 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 05/09/2011
Rasilez cc Pharma 22/07/2011 300 mg Film-coated tablet 56 EU/1/07/405/035 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 05/09/2011
Rasilez CC Pharma 22/07/2011 300 mg Film-coated tablet 98 EU/1/07/405/038 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 05/09/2011
Rasilez Chemilines Ltd 07/01/2011 150 mg Film-coated tablet 28 EU/1/07/405/022 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands
Ireland, United Kingdom
12/04/2011
Rasilez Chemilines Ltd 07/01/2011 300 mg Film-coated tablet 28 EU/1/07/405/032 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands
Ireland, United Kingdom
12/04/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 179/255
Rasilez Dr Fisher Farma BV
25/05/2011 150 mg Film-coated tablet 28 EU/1/07/405/022 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
05/07/2011
Rasilez Dr Fisher Farma BV
27/07/2011 150 mg Film-coated tablet 14 EU/1/07/405/021 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
02/08/2011
Rasilez Dr Fisher Farma BV
27/07/2011 300 mg Film-coated tablet 14 EU/1/07/405/031 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
02/08/2011
Rasilez Dr Fisher Farma BV
25/08/2011 300 mg Film-coated tablet 28 EU/1/07/405/032 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
31/08/2011
Rasilez Emra-Med 07/12/2010 300 mg Film-coated tablet 28 EU/1/07/405/032 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 20/01/2011
Rasilez Emra-Med 03/01/2011 150 mg Film-coated tablet 56 EU/1/07/405/025 Austria, Portugal Germany 24/01/2011
Rasilez Emra-Med 03/01/2011 150 mg Film-coated tablet 98 EU/1/07/405/028 Austria, Portugal Germany 24/01/2011
Rasilez Emra-Med 03/01/2011 300 mg Film-coated tablet 98 EU/1/07/405/038 Austria, Greece Germany 24/01/2011
Rasilez Eureco-Pharma B.V.
11/02/2011 300 mg Film-coated tablet 30 EU/1/07/405/033 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
25/02/2011
Rasilez Eureco-Pharma B.V.
05/08/2011 150 mg Film-coated tablet 28 EU/1/07/405/022 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
09/08/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 180/255
Rasilez Euro Registratie Collectief BV
04/07/2011 150 mg Film-coated tablet 30 EU/1/07/405/023 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
03/08/2011
Rasilez EuroPharma DK
14/08/2009 150 mg Film-coated tablet 28 EU/1/07/405/003 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 11/01/2011
Rasilez EuroPharma DK
14/08/2009 150 mg Film-coated tablet 84 (3 x 28) EU/1/07/405/007 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 11/01/2011
Rasilez G-Pharma Ltd 11/01/2011 150 mg Film-coated tablet 28 EU/1/07/405/022 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
14/01/2011
Rasilez G-Pharma Ltd 11/01/2011 300 mg Film-coated tablet 28 EU/1/07/405/032 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
14/01/2011
Rasilez Kosei Pharma UK Limited
13/07/2011 150 mg Film-coated tablet 28 EU/1/07/405/022 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
01/08/2011
Rasilez Kosei Pharma UK Limited
13/07/2011 300 mg Film-coated tablet 28 EU/1/07/405/032 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
01/08/2011
Rasilez Lexon (UK) Ltd
16/02/2011 150 mg Film-coated tablet 28 EU/1/07/405/022 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
15/03/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 181/255
Rasilez Lexon (UK) Ltd
16/02/2011 300 mg Film-coated tablet 28 EU/1/07/405/032 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
15/03/2011
Rasilez Mediwin Ltd 04/02/2011 300 mg Film-coated tablet 28 EU/1/07/405/032 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands
United Kingdom
23/03/2011
Rasilez Mediwin Ltd 11/04/2011 150 mg Film-coated tablet 28 EU/1/07/405/022 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands
United Kingdom
02/05/2011
Rasilez MPT Pharma 12/01/2011 150 mg Film-coated tablet 28 EU/1/07/405/022 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
18/01/2011
Rasilez MPT Pharma 12/01/2011 300 mg Film-coated tablet 28 EU/1/07/405/032 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
18/01/2011
Rasilez MPT Pharma 03/05/2011 150 mg Film-coated tablet 30 EU/1/07/405/023 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
25/05/2011
Rasilez PCO Manufacturing
07/02/2011 300 mg Film-coated tablet 28 EU/1/07/405/032 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands
Ireland, United Kingdom
17/02/2011
Rasilez PCO Manufacturing
17/02/2011 150 mg Film-coated tablet 28 EU/1/07/405/022 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands
Ireland, United Kingdom
08/03/2011
Rasilez Swingward Ltd TA Medihealth
16/09/2010 300 mg Film-coated tablet 28 EU/1/07/405/032 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands
United Kingdom
26/10/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 182/255
Rasilez Swingward Ltd TA Medihealth
20/10/2011 150 mg Film-coated tablet 28 EU/1/07/405/022 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands
United Kingdom
21/11/2011
Rasilez HCT Axicorp Pharma GmbH
07/04/2011 150 mg / 12.5 mg
Film-coated tablet 98 EU/1/08/491/018 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 11/05/2011
Rasilez HCT Axicorp Pharma GmbH
12/05/2011 300 mg / 12.5 mg
Film-coated tablet 98 EU/1/08/491/058 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 20/05/2011
Rasilez HCT Axicorp Pharma GmbH
28/07/2011 300 mg / 25 mg
Film-coated tablet 98 EU/1/08/491/078 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 15/08/2011
Rasilez HCT Beragena Arzneimittel GmbH
10/10/2011 300 mg / 25 mg
Film-coated tablet 98 EU/1/08/491/078 Austria, Belgium, France, Greece, Iceland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 25/10/2011
Rasilez HCT Beragena Arzneimittel GmbH
18/10/2011 150 mg / 12.5 mg
Film-coated tablet 98 EU/1/08/491/018 Austria, Belgium, France, Greece, Iceland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 03/11/2011
Rasilez HCT Beragena Arzneimittel GmbH
18/10/2011 300 mg / 12.5 mg
Film-coated tablet 98 EU/1/08/491/058 Austria, Belgium, France, Greece, Iceland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 25/10/2011
Rasilez HCT Euro Registratie Collectief BV
07/07/2011 150 mg / 12.5 mg
Film-coated tablet 30 EU/1/08/491/013 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
05/09/2011
Rebetol Haemato Pharm AG
09/03/2011 200 mg Capsule, hard 168 EU/1/99/107/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 08/04/2011
Rebetol Haemato Pharm AG
09/03/2011 200 mg Capsule, hard 84 EU/1/99/107/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 08/04/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 183/255
Rebif CC Pharma 10/10/2011 22 µg Solution for injection
12 pre-filled pens
EU/1/98/063/013 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 13/10/2011
Rebif CC Pharma 10/10/2011 44 µg Solution for injection
12 pre-filled pens
EU/1/98/063/016 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 13/10/2011
Rebif CC Pharma 21/11/2011 22 µg/0.5 ml Solution for injection
12 cartridges
EU/1/98/063/018 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 08/12/2011
Rebif CC Pharma 21/11/2011 44 µg/0.5 ml Solution for injection
12 cartridges
EU/1/98/063/019 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 08/12/2011
Rebif Haemato Pharm AG
21/06/2011 22 µg Solution for injection
12 pre-filled pens
EU/1/98/063/013 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Austria, Germany
20/07/2011
Rebif Haemato Pharm AG
21/06/2011 44 µg Solution for injection
12 pre-filled pens
EU/1/98/063/016 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Austria, Germany
20/07/2011
Rebif Kohlpharma GmbH
20/12/2010 8.8 µg (2.4 m IU) + 22 µg (6 m IU)
Solution for injection
Initiation pack: 6 pre-filled syringes of 8.8 µg + 6 pre-filled syringes of 22 µg
EU/1/98/063/007 Austria Germany 26/01/2011
Rebif Orifarm OY 03/03/2011 22 µg Solution for injection
12 pre-filled syringes
EU/1/98/063/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Finland 09/03/2011
Rebif Pharma Westen GmbH
26/09/2011 22 µg Solution for injection
12 pre-filled pens
EU/1/98/063/013 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 17/11/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 184/255
Rebif Pharma Westen GmbH
26/09/2011 44 µg Solution for injection
12 pre-filled pens
EU/1/98/063/016 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 17/11/2011
Relistor Emra-Med 26/08/2010 12 mg/0.6 ml Solution for injection
7 vials + 7 sterile syringes + 14 alcohol swabs
EU/1/08/463/003 Austria, Belgium, France, Luxembourg Germany 14/06/2011
Relistor Euro Registratie Collectief BV
23/12/2010 12 mg/0.6 ml Solution for injection
7 vials + 7 sterile syringes + 14 alcohol swabs
EU/1/08/463/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
25/01/2011
Remicade Axicorp Pharma GmbH
09/06/2011 100 mg Powder for concentrate for solution for infusion
5 vials EU/1/99/116/005 Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 29/06/2011
Remicade Eureco-Pharma B.V.
24/09/2010 100 mg Powder for concentrate for solution for infusion
1 vial EU/1/99/116/001 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
08/02/2011
Remicade Haemato Pharm AG
28/06/2011 100 mg Powder for concentrate for solution for infusion
1 vial EU/1/99/116/001 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Austria, Germany
08/07/2011
Remicade MedicoPharm AG
21/01/2011 100 mg Powder for concentrate for solution for infusion
5 vials EU/1/99/116/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 24/03/2011
Remicade Paranova Läkemedel AB
13/09/2011 100 mg Powder for concentrate for solution for infusion
1 vial EU/1/99/116/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 29/09/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 185/255
Remicade Paranova Läkemedel AB
13/09/2011 100 mg Powder for concentrate for solution for infusion
3 vials EU/1/99/116/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 30/09/2011
Remicade Veron Pharma Vertriebs GmbH
13/12/2010 100 mg Powder for concentrate for solution for infusion
2 vials EU/1/99/116/002 Austria, Belgium, France, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom
Germany 03/02/2011
Renagel Aaston Healthcare GmbH
01/03/2011 800 mg Film-coated tablet 1 bottle of 180 without outer carton
EU/1/99/123/012 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 04/03/2011
Renagel Propharmed GmbH
29/03/2011 800 mg Film-coated tablet 1 bottle of 180 without outer carton
EU/1/99/123/012 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 11/04/2011
Renvela Beragena Arzneimittel GmbH
05/05/2011 2.4 g Powder for oral suspension
60 sachets EU/1/09/521/006 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 25/05/2011
Renvela Beragena Arzneimittel GmbH
05/05/2011 800 mg Film-coated tablet 180 (without outer carton)
EU/1/09/521/003 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 19/05/2011
Renvela CC Pharma 14/12/2010 800 mg Film-coated tablet 180 (without outer carton)
EU/1/09/521/003 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Germany 12/01/2011
Renvela CC Pharma 07/01/2011 2.4 g Powder for oral suspension
60 sachets EU/1/09/521/006 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 12/01/2011
Renvela Cross Pharma AB
22/02/2011 800 mg Film-coated tablet 180 (without outer carton)
EU/1/09/521/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 05/04/2011
Renvela Emra-Med 18/02/2011 800 mg Film-coated tablet 180 (without outer carton)
EU/1/09/521/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 14/03/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 186/255
Renvela Medcor Pharmaceuticals BV
14/11/2011 2.4 g Powder for oral suspension
60 sachets EU/1/09/521/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
30/11/2011
Renvela Medcor Pharmaceuticals BV
14/11/2011 800 mg Film-coated tablet 180 (without outer carton)
EU/1/09/521/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
30/11/2011
Renvela MedicoPharm AG
28/01/2011 800 mg Film-coated tablet 180 (without outer carton)
EU/1/09/521/003 Austria, Belgium, Cyprus, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 18/02/2011
Renvela Oy Cross Pharma AB
14/04/2011 800 mg Film-coated tablet 180 (without outer carton)
EU/1/09/521/003 Austria, Belgium, Cyprus, Denmark, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Finland 20/04/2011
Renvela PCO Manufacturing
16/06/2011 800 mg Film-coated tablet 180 (without outer carton)
EU/1/09/521/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
14/07/2011
Renvela Pharmachim AB
09/09/2011 800 mg Film-coated tablet 180 (without outer carton)
EU/1/09/521/003 Austria, Belgium, Czech Republic, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 26/10/2011
Replagal Abacus Medicine A/S
05/07/2011 1 mg/ml Concentrate for solution for infusion
1 vial EU/1/01/189/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 11/07/2011
Replagal NewNeopharm BV
15/09/2011 1 mg/ml Concentrate for solution for infusion
1 vial EU/1/01/189/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 20/09/2011
Revatio Abacus Medicine A/S
06/12/2011 20 mg Film-coated tablet 90 EU/1/05/318/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 14/12/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 187/255
Revatio Medartuum AB 25/08/2011 20 mg Film-coated tablet 90 EU/1/05/318/001 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Slovak Republic, Spain, The Netherlands, United Kingdom
Sweden 30/08/2011
Revatio Pharmachim AB
08/07/2011 20 mg Film-coated tablet 90 EU/1/05/318/001 Austria, Belgium, Denmark, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Slovak Republic, Spain, The Netherlands, United Kingdom
Sweden 19/07/2011
Revlimid CC Pharma 08/11/2011 10 mg Capsule, hard 21 EU/1/07/391/002 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 15/11/2011
Revlimid CC Pharma 08/11/2011 15 mg Capsule, hard 21 EU/1/07/391/003 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 08/11/2011
revlimid CC Pharma 08/11/2011 25 mg Capsule, hard 21 EU/1/07/391/004 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 15/11/2011
Revlimid Dr Fisher Farma BV
07/06/2011 25 mg Capsule, hard 21 EU/1/07/391/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
15/06/2011
Revlimid Dr Fisher Farma BV
04/11/2011 10 mg Capsule, hard 21 EU/1/07/391/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
16/11/2011
Revlimid Dr Fisher Farma BV
16/11/2011 15 mg Capsule, hard 21 EU/1/07/391/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
07/12/2011
Revlimid Medartuum AB 07/11/2011 25 mg Capsule, hard 21 EU/1/07/391/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 28/11/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 188/255
Revlimid Pharma Westen GmbH
11/01/2011 25 mg Capsule, hard 21 EU/1/07/391/004 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 14/02/2011
Revlimid Pharma Westen GmbH
15/11/2011 10 mg Capsule, hard 21 EU/1/07/391/002 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 09/12/2011
Revlimid Pharma Westen GmbH
15/11/2011 15 mg Capsule, hard 21 EU/1/07/391/003 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 09/12/2011
REVOLADE CC Pharma 17/01/2011 25 mg Film-coated tablet 14 EU/1/10/612/001 Austria, Norway Germany 11/03/2011
REVOLADE CC Pharma 17/01/2011 50 mg Film-coated tablet 14 EU/1/10/612/004 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 19/01/2011
REVOLADE CC Pharma 27/01/2011 25 mg Film-coated tablet 28 EU/1/10/612/002 Austria Germany 03/03/2011
REVOLADE CC Pharma 27/01/2011 50 mg Film-coated tablet 28 EU/1/10/612/005 Austria Germany 03/03/2011
REVOLADE Haemato Pharm AG
16/02/2011 25 mg Film-coated tablet 28 EU/1/10/612/002 Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Austria, Germany
24/03/2011
REVOLADE Haemato Pharm AG
16/02/2011 50 mg Film-coated tablet 28 EU/1/10/612/005 Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Austria, Germany
24/03/2011
Reyataz Aaston Healthcare GmbH
21/03/2011 300 mg Capsule, hard 3 x 30 EU/1/03/267/010 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 04/04/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 189/255
Reyataz Axicorp Pharma B.V.
09/02/2011 300 mg Capsule, hard 3 x 30 EU/1/03/267/010 Austria, Belgium, Bulgaria, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Germany 28/02/2011
Reyataz BB Farma s.r.l.
17/11/2011 150 mg Capsule, hard 60 EU/1/03/267/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 12/12/2011
Reyataz BB Farma s.r.l.
17/11/2011 200 mg Capsule, hard 60 EU/1/03/267/005 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 12/12/2011
Reyataz Dr Fisher Farma BV
20/04/2011 150 mg Capsule, hard 60 EU/1/03/267/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
26/04/2011
Reyataz EU-Pharma BV 29/11/2011 300 mg Capsule, hard 30 EU/1/03/267/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
06/12/2011
Reyataz Medartuum AB 08/08/2011 300 mg Capsule, hard 30 EU/1/03/267/008 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 22/08/2011
Reyataz MedicoPharm AG
25/02/2009 300 mg Capsule, hard 30 EU/1/03/267/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 08/07/2011
Reyataz Pharmachim AB
04/08/2011 300 mg Capsule, hard 30 EU/1/03/267/008 Austria, Belgium, Bulgaria, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 08/08/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 190/255
Rilutek MedicoPharm AG
03/02/2011 50 mg Film-coated tablet 56 EU/1/96/010/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 21/02/2011
Rilutek Paranova Läkemedel AB
22/02/2011 50 mg Film-coated tablet 56 EU/1/96/010/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 29/03/2011
RoActemra CC Pharma 20/01/2011 20 mg/ml Concentrate for solution for infusion
4 vials EU/1/08/492/006 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 27/01/2011
RoActemra CC Pharma 20/01/2011 20 mg/ml Concentrate for solution for infusion
4 vials EU/1/08/492/004 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Latvia, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 27/01/2011
RoActemra Emra-Med 27/10/2011 20 mg/ml Concentrate for solution for infusion
1 vial EU/1/08/492/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 23/11/2011
RoActemra Emra-Med 27/10/2011 20 mg/ml Concentrate for solution for infusion
4 vials EU/1/08/492/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 23/11/2011
RoActemra Emra-Med 27/10/2011 20 mg/ml Concentrate for solution for infusion
1 vial EU/1/08/492/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 23/11/2011
RoActemra Emra-Med 27/10/2011 20 mg/ml Concentrate for solution for infusion
1 vial EU/1/08/492/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 23/11/2011
RoActemra Pharma Westen GmbH
11/10/2011 20 mg/ml Concentrate for solution for infusion
1 vial EU/1/08/492/001 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 20/10/2011
RoActemra Pharma Westen GmbH
24/10/2011 20 mg/ml Concentrate for solution for infusion
1 vial EU/1/08/492/003 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/10/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 191/255
Sifrol Axicorp Pharma GmbH
12/10/2011 1.05 mg Prolonged-release tablet
30 EU/1/97/050/020 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 28/10/2011
Sifrol Axicorp Pharma GmbH
12/10/2011 2.1 mg Prolonged-release tablet
30 EU/1/97/050/023 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 28/10/2011
Sifrol Axicorp Pharma GmbH
12/10/2011 3.15 mg Prolonged-release tablet
30 EU/1/97/050/026 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 28/10/2011
Sifrol BR Pharma International Ltd
03/01/2011 1.57 mg Prolonged-release tablet
30 EU/1/97/050/029 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 17/01/2011
Sifrol BR Pharma International Ltd
14/02/2011 2.62 mg Prolonged-release tablet
30 EU/1/97/050/032 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 02/03/2011
Sifrol BR Pharma International Ltd
07/06/2011 3.15 mg Prolonged-release tablet
30 EU/1/97/050/026 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 21/06/2011
Sifrol MTK Pharma GmbH
11/01/2011 1.57 mg Prolonged-release tablet
30 EU/1/97/050/029 Norway, The Netherlands Germany 25/01/2011
Sifrol MTK Pharma GmbH
07/02/2011 1.57 mg Prolonged-release tablet
100 EU/1/97/050/030 Norway, The Netherlands Germany 18/02/2011
Sifrol Pharma Westen GmbH
28/02/2011 1.57 mg Prolonged-release tablet
100 EU/1/97/050/030 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 08/03/2011
Sifrol Pharma Westen GmbH
28/02/2011 2.62 mg Prolonged-release tablet
100 EU/1/97/050/033 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 08/03/2011
Sifrol Pharma Westen GmbH
08/03/2011 2.62 mg Prolonged-release tablet
30 EU/1/97/050/032 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 29/03/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 192/255
Sifrol Pharma Westen GmbH
17/03/2011 1.57 mg Prolonged-release tablet
30 EU/1/97/050/029 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 14/04/2011
Simponi Haemato Pharm AG
27/07/2011 50 mg Solution for injection in pre-filled pen
3 (3 x 1) pre-filled pens
EU/1/09/546/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 07/09/2011
Simponi Orifarm AB 05/10/2011 50 mg Solution for injection in pre-filled pen
1 pre-filled pen
EU/1/09/546/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 04/11/2011
Simponi Orifarm AS 05/05/2011 50 mg Solution for injection in pre-filled pen
1 pre-filled pen
EU/1/09/546/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 11/05/2011
Somavert CC Pharma 16/12/2010 15 mg Powder and solvent for solution for injection
30 vials + 30 vials
EU/1/02/240/002 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 04/02/2011
Somavert Orifarm AS 22/07/2011 10 mg Powder and solvent for solution for injection
30 vials + 30 vials
EU/1/02/240/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 02/08/2011
Somavert Orifarm AS 22/07/2011 15 mg Powder and solvent for solution for injection
30 vials + 30 vials
EU/1/02/240/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 02/08/2011
Somavert Orifarm AS 22/07/2011 20 mg Powder and solvent for solution for injection
30 vials + 30 vials
EU/1/02/240/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 02/08/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 193/255
SonoVue Orifarm AB 27/07/2011 8 µl/ml Powder and solvent for dispersion for injection
1 vial + 1 pre-filled syringe + 1 'MiniSpike' rec. device
EU/1/01/177/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 17/08/2011
Sprycel CC Pharma 24/05/2011 50 mg Film-coated tablet 60 x 1 (unit dose)
EU/1/06/363/008 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 01/06/2011
Sprycel CC Pharma 24/05/2011 70 mg Film-coated tablet 60 x 1 (unit dose)
EU/1/06/363/009 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 30/05/2011
Sprycel CC Pharma 19/07/2011 20 mg Film-coated tablet 60 x 1 (unit dose)
EU/1/06/363/007 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 16/08/2011
Sprycel Haemato Pharm AG
01/06/2011 50 mg Film-coated tablet 60 EU/1/06/363/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 30/06/2011
Sprycel Omnia Läkemedel AB
09/06/2011 50 mg Film-coated tablet 60 EU/1/06/363/002 Bulgaria, Germany, Greece, The Netherlands, United Kingdom
Sweden 14/06/2011
Sprycel Omnia Läkemedel AB
11/11/2011 100 mg Film-coated tablet 30 EU/1/06/363/010 Portugal, Spain, The Netherlands, United Kingdom
Sweden 16/11/2011
Stalevo BR Pharma International Ltd
10/11/2011 150 mg / 37.5 mg / 200 mg
Film-coated tablet 100 EU/1/03/260/011 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 07/12/2011
Stalevo Euro Registratie Collectief BV
19/07/2011 50 mg / 12.5 mg / 200 mg
Film-coated tablet 100 EU/1/03/260/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
26/07/2011
Stalevo Euro Registratie Collectief BV
25/07/2011 100 mg / 25 mg / 200 mg
Film-coated tablet 100 EU/1/03/260/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
26/07/2011
Stalevo Euro Registratie Collectief BV
13/09/2011 125 mg / 31.25 mg / 200 mg
Film-coated tablet 100 EU/1/03/260/031 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
15/09/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 194/255
Stalevo Euro Registratie Collectief BV
13/09/2011 150 mg / 37.5 mg / 200 mg
Film-coated tablet 100 EU/1/03/260/011 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
15/09/2011
Stalevo Euro Registratie Collectief BV
20/09/2011 200 mg / 50 mg / 200 mg
Film-coated tablet 100 EU/1/03/260/021 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
22/09/2011
Stalevo EuroPharma DK
14/02/2011 125 mg / 31.25 mg / 200 mg
Film-coated tablet 100 EU/1/03/260/031 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Norway, Portugal, Spain, The Netherlands, United Kingdom
Denmark 01/03/2011
Stalevo EuroPharma DK
14/02/2011 75 mg / 18.75 mg / 200 mg
Film-coated tablet 100 EU/1/03/260/026 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Denmark 01/03/2011
Stalevo Haemato Pharm AG
26/04/2011 100 mg / 25 mg / 200 mg
Film-coated tablet 100 EU/1/03/260/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 19/05/2011
Stalevo Haemato Pharm AG
26/04/2011 150 mg / 37.5 mg / 200 mg
Film-coated tablet 30 EU/1/03/260/010 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 19/05/2011
Stalevo Haemato Pharm AG
26/04/2011 50 mg / 12.5 mg / 200 mg
Film-coated tablet 30 EU/1/03/260/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 19/05/2011
Stalevo Haemato Pharm AG
26/04/2011 50 mg / 12.5 mg / 200 mg
Film-coated tablet 100 EU/1/03/260/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 19/05/2011
Stalevo Haemato Pharm AG
27/04/2011 100 mg / 25 mg / 200 mg
Film-coated tablet 30 EU/1/03/260/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 19/05/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 195/255
Stalevo Haemato Pharm AG
27/04/2011 150 mg / 37.5 mg / 200 mg
Film-coated tablet 100 EU/1/03/260/011 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 19/05/2011
Stalevo Imed Healthcare Ltd
14/07/2011 100 mg / 25 mg / 200 mg
Film-coated tablet 100 EU/1/03/260/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
20/07/2011
Stalevo Kohlpharma GmbH
22/09/2011 125 mg / 31.25 mg / 200 mg
Film-coated tablet 30 EU/1/03/260/030 France, Italy, The Netherlands, United Kingdom
Germany 27/10/2011
Stalevo Lexon (UK) Ltd
12/12/2011 100 mg / 25 mg / 200 mg
Film-coated tablet 100 EU/1/03/260/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
20/12/2011
Stalevo Lexon (UK) Ltd
12/12/2011 150 mg / 37.5 mg / 200 mg
Film-coated tablet 100 EU/1/03/260/011 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
20/12/2011
Stalevo Lexon (UK) Ltd
12/12/2011 50 mg / 12.5 mg / 200 mg
Film-coated tablet 100 EU/1/03/260/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
20/12/2011
Stalevo Orifarm AS 23/09/2011 125 mg / 31.25 mg / 200 mg
Film-coated tablet 100 EU/1/03/260/031 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 17/10/2011
Stelara Orifarm AB 21/07/2011 45 mg Solution for injection in pre-filled syringe
1 pre-filled syringe
EU/1/08/494/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 09/08/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 196/255
Stocrin 2 Care 4 11/01/2011 600 mg Film-coated tablet 30 EU/1/99/111/008 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 14/01/2011
Stocrin Medcor Pharmaceuticals BV
04/03/2011 200 mg Film-coated tablet 90 EU/1/99/111/011 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
23/03/2011
Stocrin Medcor Pharmaceuticals BV
26/04/2011 600 mg Film-coated tablet 30 EU/1/99/111/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
03/05/2011
Stocrin Propharmed GmbH
07/04/2011 600 mg Film-coated tablet 30 EU/1/99/111/008 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 20/04/2011
Suboxone EuroPharma DK
08/07/2011 2 mg/0.5 mg Sublingual tablet 7 EU/1/06/359/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 12/07/2011
Suboxone EuroPharma DK
08/07/2011 2 mg/0.5 mg Sublingual tablet 28 EU/1/06/359/002 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 12/07/2011
Suboxone Omnia Läkemedel AB
18/10/2011 8 mg/2 mg Sublingual tablet 7 EU/1/06/359/003 The Netherlands, United Kingdom Sweden 14/11/2011
Suboxone Omnia Läkemedel AB
18/10/2011 8 mg/2 mg Sublingual tablet 28 EU/1/06/359/004 The Netherlands, United Kingdom Sweden 14/11/2011
Sustiva Orifarm AS 23/03/2011 600 mg Film-coated tablet 30 EU/1/99/110/009 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 05/04/2011
Sustiva Propharmed GmbH
09/08/2011 600 mg Film-coated tablet 30 EU/1/99/110/009 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 11/08/2011
Sutent Omnia Läkemedel AB
23/08/2011 50 mg Capsule, hard 30 EU/1/06/347/003 Austria, Belgium, Bulgaria, France, Germany, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom
Sweden 26/09/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 197/255
Sutent Omnia Läkemedel AB
14/11/2011 25 mg Capsule, hard 28 EU/1/06/347/005 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Poland, Portugal, Spain, The Netherlands, United Kingdom
Sweden 08/12/2011
Sutent Omnia Läkemedel AB
14/11/2011 50 mg Capsule, hard 28 EU/1/06/347/006 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Poland, Portugal, Spain, The Netherlands, United Kingdom
Sweden 08/12/2011
Sutent Orifarm AB 21/03/2011 25 mg Capsule, hard 28 EU/1/06/347/005 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 11/05/2011
Sutent Orifarm AB 21/03/2011 50 mg Capsule, hard 28 EU/1/06/347/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 11/05/2011
Sutent Orifarm AB 04/11/2011 12.5 mg Capsule, hard 28 EU/1/06/347/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 15/11/2011
Sutent UAB East Europe Pharmacy Group
12/04/2011 50 mg Capsule, hard 30 EU/1/06/347/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Lithuania 23/05/2011
Sutent UAB East Europe Pharmacy Group
05/07/2011 50 mg Capsule, hard 28 EU/1/06/347/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Lithuania 12/07/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 198/255
Synagis Lex ano UAB 08/03/2011 100 mg Powder and solvent for solution for injection
1 vial + 1 ampoule
EU/1/99/117/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Lithuania 18/03/2011
Synagis Orifarm OY 14/03/2011 100 mg Powder and solvent for solution for injection
1 vial + 1 ampoule
EU/1/99/117/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Finland 14/04/2011
TachoSil Orifarm AB 14/02/2011 - - Medicated sponge 1 sponge of 9.5 x 4.8 cm
EU/1/04/277/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 08/03/2011
TachoSil Orifarm AB 14/02/2011 - - Medicated sponge 2 sponges of 4.8 x 4.8 cm
EU/1/04/277/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 24/03/2011
TachoSil Orifarm AB 14/02/2011 - - Medicated sponge 1 sponge of 3.0 x 2.5 cm
EU/1/04/277/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 08/03/2011
TachoSil Orifarm AB 14/02/2011 - - Medicated sponge 5 sponges of 3.0 x 2.5 cm
EU/1/04/277/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 08/03/2011
Tarceva CC Pharma 24/05/2011 25 mg Film-coated tablet 30 EU/1/05/311/001 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 28/06/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 199/255
Tarceva Medcor Pharmaceuticals BV
03/11/2011 150 mg Film-coated tablet 30 EU/1/05/311/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Finland, France, Germany,Greece, Hungary, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
The Netherlands
10/11/2011
Tarceva Orifarm AB 09/03/2011 100 mg Film-coated tablet 30 EU/1/05/311/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 18/03/2011
Tarceva Paranova Läkemedel AB
15/09/2011 100 mg Film-coated tablet 30 EU/1/05/311/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 05/10/2011
Tarceva Paranova Läkemedel AB
15/09/2011 150 mg Film-coated tablet 30 EU/1/05/311/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 05/10/2011
Targretin Axicorp Pharma GmbH
15/11/2011 75 mg Capsule, soft 100 EU/1/01/178/001 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Germany 21/11/2011
Targretin MedicoPharm AG
10/02/2011 75 mg Capsule, soft 100 EU/1/01/178/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 18/03/2011
Targretin Propharmed GmbH
21/02/2011 75 mg Capsule, soft 100 EU/1/01/178/001 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Germany 18/04/2011
Tasigna CC Pharma 24/05/2011 150 mg Capsule, hard 112 EU/1/07/422/006 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Germany 30/05/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 200/255
Tasigna Emra-Med 07/09/2011 150 mg Capsule, hard 112 (4x28); (multipack)
EU/1/07/422/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 04/10/2011
Tasigna Haemato Pharm AG
03/08/2011 200 mg Capsule, hard 28 EU/1/07/422/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 31/08/2011
Tasigna Omnia Läkemedel AB
21/11/2011 200 mg Capsule, hard 112 (4x28); (multipack)
EU/1/07/422/003 Austria, Belgium, Finland, France, Germany, Greece, Ireland, Italy, Poland, Portugal, Spain, The Netherlands, United Kingdom
Sweden 08/12/2011
Tasigna Orifarm AS 18/11/2011 200 mg Capsule, hard 112 (4x28); (multipack)
EU/1/07/422/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 29/11/2011
Tasmar Emra-Med 09/09/2011 100 mg Film-coated tablet 30 EU/1/97/044/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 20/09/2011
Taxotere Axicorp Pharma GmbH
09/06/2011 80 mg/4 ml Concentrate for solution for infusion
1 vial EU/1/95/002/004 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 12/07/2011
Taxotere Pharma Westen GmbH
20/07/2011 160 mg/8 ml Concentrate for solution for infusion
1 vial EU/1/95/002/005 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 26/07/2011
Telzir Paranova OY 09/03/2011 700 mg Film-coated tablet 60 EU/1/04/282/001 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Finland 04/04/2011
Telzir Propharmed GmbH
21/02/2011 700 mg Film-coated tablet 60 EU/1/04/282/001 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 02/03/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 201/255
Temodal BB Farma s.r.l.
12/07/2011 20 mg Capsule, hard 20 EU/1/98/096/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 19/07/2011
Temodal BB Farma s.r.l.
12/07/2011 5 mg Capsule, hard 20 EU/1/98/096/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 19/07/2011
Temodal BR Pharma International Ltd
26/03/2009 100 mg Capsule, hard 5 EU/1/98/096/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 10/02/2011
Temodal Medartuum AB 17/05/2011 100 mg Capsule, hard 20 EU/1/98/096/016 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 30/05/2011
Temodal Orifarm AB 21/06/2011 140 mg Capsule, hard 5 EU/1/98/096/017 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 26/08/2011
Temodal Orifarm AB 21/06/2011 180 mg Capsule, hard 5 EU/1/98/096/019 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 26/08/2011
Thyrogen Orifarm OY 11/03/2011 0.9 mg Powder for solution for injection
2 vials EU/1/99/122/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Finland 11/05/2011
Toviaz 2 Care 4 10/12/2010 4 mg Prolonged-release tablet
84 EU/1/07/386/011 Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Poland, Portugal, Spain, The Netherlands, United Kingdom
Sweden 07/03/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 202/255
Toviaz 2 Care 4 10/12/2010 4 mg Prolonged-release tablet
28 EU/1/07/386/003 Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Poland, Portugal, Spain, The Netherlands, United Kingdom
Sweden 04/03/2011
Toviaz 2 Care 4 10/12/2010 8 mg Prolonged-release tablet
28 EU/1/07/386/008 Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Poland, Portugal, Spain, The Netherlands, United Kingdom
Sweden 04/03/2011
Toviaz 2 Care 4 10/12/2010 8 mg Prolonged-release tablet
84 EU/1/07/386/012 Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Poland, Portugal, Spain, The Netherlands, United Kingdom
Sweden 07/03/2011
Toviaz 2 Care 4 24/11/2011 4 mg Prolonged-release tablet
98 EU/1/07/386/005 Austria, Belgium, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Spain, The Netherlands, United Kingdom
Sweden 01/12/2011
Toviaz 2 Care 4 24/11/2011 8 mg Prolonged-release tablet
98 EU/1/07/386/010 Austria, Belgium, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Spain, The Netherlands, United Kingdom
Sweden 01/12/2011
Toviaz Amimed Direct Ltd
20/06/2011 4 mg Prolonged-release tablet
28 EU/1/07/386/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
01/07/2011
Toviaz Cross Pharma AB
19/01/2011 4 mg Prolonged-release tablet
28 EU/1/07/386/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 02/02/2011
Toviaz Cross Pharma AB
19/01/2011 4 mg Prolonged-release tablet
84 EU/1/07/386/011 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 02/02/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 203/255
Toviaz Cross Pharma AB
19/01/2011 8 mg Prolonged-release tablet
84 EU/1/07/386/012 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 02/02/2011
Toviaz Doncaster Pharmaceuticals Group Ltd
11/03/2011 4 mg Prolonged-release tablet
28 EU/1/07/386/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
11/04/2011
Toviaz Doncaster Pharmaceuticals Group Ltd
11/03/2011 8 mg Prolonged-release tablet
28 EU/1/07/386/008 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
11/04/2011
Toviaz Emra-Med 09/09/2011 4 mg Prolonged-release tablet
100 (10 x 10)
EU/1/07/386/017 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 24/10/2011
Toviaz Medartuum AB 21/02/2011 8 mg Prolonged-release tablet
84 EU/1/07/386/012 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 02/03/2011
Toviaz Medartuum AB 08/11/2011 4 mg Prolonged-release tablet
84 EU/1/07/386/011 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 16/11/2011
Toviaz Omnia Läkemedel AB
07/06/2011 4 mg Prolonged-release tablet
84 EU/1/07/386/011 Czech Republic, France, Greece, Italy, Spain, United Kingdom
Sweden 17/06/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 204/255
Toviaz Omnia Läkemedel AB
07/06/2011 8 mg Prolonged-release tablet
84 EU/1/07/386/012 Czech Republic, France, Greece, Italy, Poland, Spain, United Kingdom
Sweden 14/06/2011
Toviaz Paranova Danmark AS
26/05/2011 4 mg Prolonged-release tablet
28 EU/1/07/386/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 07/06/2011
Toviaz Paranova Danmark AS
26/05/2011 4 mg Prolonged-release tablet
84 EU/1/07/386/011 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 08/06/2011
Toviaz Paranova Danmark AS
26/05/2011 8 mg Prolonged-release tablet
28 EU/1/07/386/008 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 07/06/2011
Toviaz Paranova Danmark AS
26/05/2011 8 mg Prolonged-release tablet
84 EU/1/07/386/012 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 08/06/2011
Toviaz Paranova Läkemedel AB
12/10/2011 4 mg Prolonged-release tablet
28 EU/1/07/386/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 27/10/2011
Toviaz Paranova Läkemedel AB
12/10/2011 4 mg Prolonged-release tablet
84 EU/1/07/386/011 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 27/10/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 205/255
Toviaz Paranova Läkemedel AB
12/10/2011 8 mg Prolonged-release tablet
84 EU/1/07/386/012 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 27/10/2011
Toviaz Paranova Läkemedel AB
12/10/2011 8 mg Prolonged-release tablet
28 EU/1/07/386/008 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 27/10/2011
Toviaz PCO Manufacturing
15/06/2011 4 mg Prolonged-release tablet
28 EU/1/07/386/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
02/08/2011
Toviaz PCO Manufacturing
15/06/2011 8 mg Prolonged-release tablet
28 EU/1/07/386/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
02/08/2011
Toviaz Pharma Westen GmbH
06/12/2010 4 mg Prolonged-release tablet
100 (10 x 10)
EU/1/07/386/017 Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Germany 03/03/2011
Toviaz Pharmachim AB
15/09/2011 4 mg Prolonged-release tablet
28 EU/1/07/386/003 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 13/10/2011
Toviaz Pharmachim AB
15/09/2011 4 mg Prolonged-release tablet
84 EU/1/07/386/011 Austria, Belgium, Bulgaria, Czech Republic, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 12/10/2011
Toviaz Profind Wholesale Ltd.
17/08/2011 4 mg Prolonged-release tablet
28 EU/1/07/386/003 United Kingdom Ireland 05/09/2011
Toviaz Profind Wholesale Ltd.
17/08/2011 8 mg Prolonged-release tablet
28 EU/1/07/386/008 United Kingdom Ireland 05/09/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 206/255
Toviaz Waymade PLC 07/04/2011 4 mg Prolonged-release tablet
28 EU/1/07/386/003 Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
17/05/2011
Tracleer Haemato Pharm AG
09/03/2011 125 mg Film-coated tablet 56 EU/1/02/220/004 Austria, Belgium, Cyprus, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 26/04/2011
Tracleer Haemato Pharm AG
09/03/2011 125 mg Film-coated tablet 56 EU/1/02/220/004 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Austria, Germany
30/03/2011
Tracleer Haemato Pharm AG
09/03/2011 62.5 mg Film-coated tablet 56 EU/1/02/220/002 Austria, Belgium, Cyprus, Czech Republic, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Denmark 26/04/2011
Tracleer Haemato Pharm AG
09/03/2011 62.5 mg Film-coated tablet 56 EU/1/02/220/002 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Austria, Germany
30/03/2011
Tracleer NewNeopharm BV
06/09/2011 125 mg Film-coated tablet 56 EU/1/02/220/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 15/09/2011
Tracleer NewNeopharm BV
06/09/2011 62.5 mg Film-coated tablet 56 EU/1/02/220/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 15/09/2011
Tracleer Orifarm AB 12/10/2011 125 mg Film-coated tablet 56 EU/1/02/220/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 17/10/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 207/255
Tracleer Orifarm AB 12/10/2011 62.5 mg Film-coated tablet 56 EU/1/02/220/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 20/10/2011
Tractocile NewNeopharm BV
07/09/2011 7.5 mg/ml Concentrate for solution for infusion
1 vial EU/1/99/124/002 Austria, Belgium, Cyprus, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 20/09/2011
Tredaptive Emra-Med 07/01/2011 1000 mg / 20 mg
Modified-release tablet
28 EU/1/08/459/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 11/01/2011
Trizivir Aaston Healthcare GmbH
29/04/2011 - - Film-coated tablet 60 EU/1/00/156/004 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 17/05/2011
Trizivir Docpharm GmbH&CoKGaA
26/01/2011 - - Film-coated tablet 60 EU/1/00/156/002 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 02/02/2011
Trizivir Docpharm GmbH&CoKGaA
05/09/2011 - - Film-coated tablet 60 EU/1/00/156/004 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 20/09/2011
Trizivir Emra-Med 07/12/2010 - - Film-coated tablet 60 EU/1/00/156/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 01/03/2011
Trizivir Haemato Pharm AG
27/10/2011 - - Film-coated tablet 60 EU/1/00/156/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 08/11/2011
Trizivir Kohlpharma GmbH
20/12/2010 - - Film-coated tablet 60 EU/1/00/156/004 Austria, Belgium, France, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 09/02/2011
Trizivir Medcor Pharmaceuticals BV
30/05/2011 - - Film-coated tablet 60 EU/1/00/156/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Spain, Sweden, United Kingdom
The Netherlands
27/06/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 208/255
Trizivir Mevita HandelsGmbH
10/12/2010 - - Film-coated tablet 60 EU/1/00/156/004 Austria, France, Italy, The Netherlands, United Kingdom
Germany 28/10/2011
Trizivir Propharmed GmbH
07/04/2011 - - Film-coated tablet 60 EU/1/00/156/002 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 13/04/2011
Trobalt BR Pharma International Ltd
16/08/2011 100 mg Film-coated tablet 84 EU/1/11/681/005 Ireland, United Kingdom Germany 22/08/2011
Trobalt BR Pharma International Ltd
17/08/2011 200 mg Film-coated tablet 84 EU/1/11/681/007 Ireland, United Kingdom Germany 22/08/2011
Trobalt BR Pharma International Ltd
17/08/2011 300 mg Film-coated tablet 84 EU/1/11/681/009 Ireland, United Kingdom Germany 22/08/2011
Trobalt BR Pharma International Ltd
18/08/2011 200 mg Film-coated tablet 168 (2 x 84) (multipack)
EU/1/11/681/008 Ireland, United Kingdom Germany 22/08/2011
Trobalt BR Pharma International Ltd
18/08/2011 300 mg Film-coated tablet 168 (2 x 84) (multipack)
EU/1/11/681/010 Ireland, United Kingdom Germany 22/08/2011
Trobalt Orifarm AS 04/10/2011 100 mg Film-coated tablet 84 EU/1/11/681/005 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 24/11/2011
Trobalt Orifarm AS 04/10/2011 300 mg Film-coated tablet 84 EU/1/11/681/009 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 06/12/2011
Trobalt Orifarm AS 04/10/2011 50 mg Film-coated tablet 84 EU/1/11/681/002 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 24/11/2011
Truvada eurorx Arzneimittel GmbH
17/11/2010 200 mg/ 245 mg
Film-coated tablet 30 EU/1/04/305/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 05/01/2011
Truvada Haemato Pharm AG
01/06/2011 200 mg/ 245 mg
Film-coated tablet 30 EU/1/04/305/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 16/06/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 209/255
Truvada Lex ano UAB 09/03/2011 200 mg/ 245 mg
Film-coated tablet 30 EU/1/04/305/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Lithuania 16/03/2011
Truvada MedicoPharm AG
28/01/2011 200 mg/ 245 mg
Film-coated tablet 3 x 30 EU/1/04/305/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 09/02/2011
Truvada Orifarm OY 16/02/2011 200 mg/ 245 mg
Film-coated tablet 30 EU/1/04/305/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Finland 23/03/2011
Truvada Paranova OY 09/03/2011 200 mg/ 245 mg
Film-coated tablet 30 EU/1/04/305/001 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Finland 04/04/2011
Truvada Pharmachim AB
18/11/2011 200 mg/ 245 mg
Film-coated tablet 30 EU/1/04/305/001 Austria, Belgium, France, Germany, Greece, Ireland, Italy, Malta, Norway, Spain, The Netherlands, United Kingdom
Sweden 07/12/2011
Twinrix Adult BB Farma s.r.l.
16/11/2011 - - Suspension for injection
1 syringe with separate needle
EU/1/96/020/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 30/11/2011
Twinrix Adult BB Farma s.r.l.
16/11/2011 - - Suspension for injection
10 syringes with separate needle
EU/1/96/020/008 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 30/11/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 210/255
TWYNSTA Emra-Med 20/06/2011 40 mg/5 mg Tablet 28 EU/1/10/648/002 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Germany 30/06/2011
TWYNSTA Emra-Med 29/06/2011 40 mg/10 mg Tablet 28 EU/1/10/648/009 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Germany 30/06/2011
TWYNSTA Emra-Med 29/06/2011 80 mg/10 mg Tablet 28 EU/1/10/648/023 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Germany 29/06/2011
TWYNSTA Emra-Med 29/06/2011 80 mg/5 mg Tablet 28 EU/1/10/648/016 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Germany 30/06/2011
TWYNSTA Emra-Med 15/09/2011 80 mg/5 mg Tablet 56 EU/1/10/648/018 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Germany 07/10/2011
Twynsta Kohlpharma GmbH
23/11/2011 80 mg/10 mg Tablet 98 EU/1/10/648/027 Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 01/12/2011
Twynsta Kohlpharma GmbH
23/11/2011 80 mg/5 mg Tablet 98 EU/1/10/648/020 Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 01/12/2011
Tygacil Abacus Medicine A/S
15/07/2011 50 mg Powder for solution for infusion
10 vials EU/1/06/336/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 01/08/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 211/255
Tygacil Orifarm AB 10/05/2011 50 mg Powder for solution for infusion
10 vials EU/1/06/336/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 13/05/2011
Tysabri Axicorp Pharma B.V.
09/06/2011 300 mg Concentrate for solution for infusion
1 vial EU/1/06/346/001 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 21/06/2011
Tysabri Haemato Pharm AG
08/12/2011 300 mg Concentrate for solution for infusion
1 vial EU/1/06/346/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 22/12/2011
Tysabri Orifarm AB 18/03/2011 300 mg Concentrate for solution for infusion
1 vial EU/1/06/346/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 31/03/2011
Tysabri Orifarm OY 11/03/2011 300 mg Concentrate for solution for infusion
1 vial EU/1/06/346/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Finland 24/03/2011
Tyverb Abacus Medicine A/S
05/07/2011 250 mg Film-coated tablet 70 EU/1/07/440/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 11/07/2011
Tyverb Abacus Medicine A/S
07/07/2011 250 mg Film-coated tablet 70 EU/1/07/440/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 10/08/2011
Tyverb CC Pharma 30/08/2011 250 mg Film-coated tablet 70 EU/1/07/440/004 Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 23/09/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 212/255
Tyverb Emra-Med 07/10/2011 250 mg Film-coated tablet 70 EU/1/07/440/004 Ireland, The Netherlands, United Kingdom Germany 20/10/2011
Tyverb Haemato Pharm AG
11/04/2011 250 mg Film-coated tablet 70 EU/1/07/440/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 05/05/2011
Tyverb Orifarm AB 13/05/2011 250 mg Film-coated tablet 70 EU/1/07/440/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 23/05/2011
Tyverb Orifarm AB 21/09/2011 250 mg Film-coated tablet 70 (Bottle) EU/1/07/440/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 26/09/2011
Tyverb Orifarm AS 27/07/2011 250 mg Film-coated tablet 70 EU/1/07/440/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 05/08/2011
Tyverb Pharma Westen GmbH
19/10/2011 250 mg Film-coated tablet 70 EU/1/07/440/004 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 08/11/2011
Urorec Beragena Arzneimittel GmbH
01/09/2011 4 mg Capsule, hard 100 EU/1/09/608/007 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 16/09/2011
Urorec Beragena Arzneimittel GmbH
01/09/2011 4 mg Capsule, hard 50 EU/1/09/608/005 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 16/09/2011
Urorec Beragena Arzneimittel GmbH
14/09/2011 8 mg Capsule, hard 50 EU/1/09/608/012 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 16/09/2011
Urorec Beragena Arzneimittel GmbH
14/09/2011 8 mg Capsule, hard 100 EU/1/09/608/014 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 16/09/2011
Urorec BERAGENA Arzneimittel GmbH
07/12/2011 4 mg Capsule, hard 30 EU/1/09/608/004 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 13/12/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 213/255
Urorec BERAGENA Arzneimittel GmbH
07/12/2011 8 mg Capsule, hard 30 EU/1/09/608/011 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 13/12/2011
Urorec CC Pharma 12/09/2011 8 mg Capsule, hard 50 EU/1/09/608/012 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 14/09/2011
Urorec CC Pharma 12/09/2011 8 mg Capsule, hard 100 EU/1/09/608/014 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 14/09/2011
Urorec Emra-Med 11/07/2011 8 mg Capsule, hard 100 EU/1/09/608/014 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 18/07/2011
Urorec Emra-Med 11/07/2011 8 mg Capsule, hard 50 EU/1/09/608/012 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 18/07/2011
Urorec Emra-Med 15/09/2011 4 mg Capsule, hard 100 EU/1/09/608/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 26/09/2011
Urorec Kohlpharma GmbH
12/09/2011 8 mg Capsule, hard 20 EU/1/09/608/010 France, Italy Germany 19/09/2011
Urorec Kohlpharma GmbH
12/09/2011 8 mg Capsule, hard 50 EU/1/09/608/012 France, Italy Germany 19/09/2011
Urorec Kohlpharma GmbH
12/09/2011 8 mg Capsule, hard 100 EU/1/09/608/014 France, Italy Germany 19/09/2011
Urorec Kohlpharma GmbH
06/10/2011 4 mg Capsule, hard 100 EU/1/09/608/007 Italy Germany 13/10/2011
Urorec Kohlpharma GmbH
10/11/2011 4 mg Capsule, hard 30 EU/1/09/608/004 Italy, Portugal Germany 15/11/2011
Urorec Pharma Westen Ges.m.b.H.
07/12/2011 8 mg Capsule, hard 100 EU/1/09/608/014 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 12/12/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 214/255
Valdoxan Amimed Direct Ltd
05/07/2011 25 mg Film-coated tablet 28 EU/1/08/499/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
12/07/2011
Valdoxan axicorp Pharma GmbH
06/12/2011 25 mg Film-coated tablet 98 EU/1/08/499/007 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 07/12/2011
Valdoxan Emra-Med 05/05/2011 25 mg Film-coated tablet 28 EU/1/08/499/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 17/05/2011
Valdoxan Emra-Med 05/05/2011 25 mg Film-coated tablet 98 EU/1/08/499/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 17/05/2011
Valdoxan Medcor Pharmaceuticals BV
24/02/2011 25 mg Film-coated tablet 28 EU/1/08/499/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
02/05/2011
Valdoxan STRATHCLYDE PHARMACEUTICALS LTD
06/12/2011 25 mg Film-coated tablet 28 EU/1/08/499/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
08/12/2011
Vectibix Orifarm AB 19/05/2011 20 mg/ml Concentrate for solution for infusion
1 vial EU/1/07/423/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 25/05/2011
Vectibix Orifarm AB 19/05/2011 20 mg/ml Concentrate for solution for infusion
1 vial EU/1/07/423/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 25/05/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 215/255
Vectibix Orifarm AS 11/05/2011 20 mg/ml Concentrate for solution for infusion
1 vial EU/1/07/423/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 24/06/2011
Vectibix Orifarm AS 11/05/2011 20 mg/ml Concentrate for solution for infusion
1 vial EU/1/07/423/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 24/06/2011
VELCADE Abacus Medicine A/S
07/07/2011 3.5 mg Powder for solution for injection
1 vial EU/1/04/274/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 22/07/2011
VELCADE Inopha GmbH 26/05/2011 3.5 mg Powder for solution for injection
1 vial EU/1/04/274/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 16/06/2011
VELCADE Orifarm OY 24/02/2011 3.5 mg Powder for solution for injection
1 vial EU/1/04/274/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Finland 25/05/2011
VELCADE Propharmed GmbH
24/03/2011 3.5 mg Powder for solution for injection
1 vial EU/1/04/274/001 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Germany 12/04/2011
Ventavis CC Pharma 26/04/2011 10 µg/ml Nebuliser solution 30 ampoules
EU/1/03/255/004 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 06/05/2011
Ventavis CC Pharma 26/04/2011 10 µg/ml Nebuliser solution 168 ampoules
EU/1/03/255/005 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 06/05/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 216/255
Vfend 2 Care 4 06/12/2010 200 mg Tablet 56 EU/1/02/212/020 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Romania, Spain, The Netherlands, United Kingdom
Sweden 08/03/2011
Vfend 2 Care 4 06/12/2010 200 mg Tablet 28 EU/1/02/212/017 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Romania, Spain, The Netherlands, United Kingdom
Sweden 08/03/2011
Vfend 2 Care 4 06/12/2010 50 mg Tablet 28 EU/1/02/212/005 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Romania, Spain, The Netherlands, United Kingdom
Sweden 08/03/2011
Vfend 2 Care 4 17/12/2010 50 mg Tablet 28 EU/1/02/212/005 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Romania, Spain, The Netherlands, United Kingdom
Denmark 03/03/2011
Vfend Abacus Medicine A/S
07/07/2011 200 mg Powder for solution for infusion
1 vial EU/1/02/212/025 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 13/07/2011
Vfend Beragena Arzneimittel GmbH
23/11/2011 200 mg Tablet 28 EU/1/02/212/017 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 22/12/2011
Vfend BR Pharma International Ltd
18/01/2011 200 mg Tablet 14 EU/1/02/212/015 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Italy, Liechtenstein, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands
Ireland, Malta, United Kingdom
16/02/2011
Vfend EuroPharma DK
11/02/2011 40 mg/ml Powder for oral suspension
1 bottle EU/1/02/212/026 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 02/03/2011
Vfend Haemato Pharm AG
23/06/2011 200 mg Powder for solution for infusion
1 vial EU/1/02/212/025 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Denmark 13/07/2011
Vfend Medartuum AB 05/07/2011 200 mg Tablet 28 EU/1/02/212/017 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, The Netherlands, United Kingdom
Sweden 12/08/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 217/255
Vfend Medartuum AB 05/07/2011 200 mg Tablet 56 EU/1/02/212/020 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, The Netherlands, United Kingdom
Sweden 22/07/2011
Vfend MedicoPharm AG
24/11/2009 200 mg Tablet 30 EU/1/02/212/018 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 08/02/2011
Vfend Orifarm AS 30/09/2010 200 mg Tablet 28 EU/1/02/212/017 Austria, Belgium, Cyprus, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Denmark 10/01/2011
Vfend Orifarm AS 06/12/2011 200 mg Tablet 56 EU/1/02/212/020 Austria, Belgium, Cyprus, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Denmark 19/12/2011
Vfend Paranova Läkemedel AB
27/09/2011 200 mg Tablet 28 EU/1/02/212/017 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 04/10/2011
Vfend PCO Manufacturing
11/07/2011 200 mg Tablet 28 EU/1/02/212/017 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
08/08/2011
Vfend Pharma Westen GmbH
14/03/2011 200 mg Tablet 100 EU/1/02/212/021 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Germany 18/03/2011
Viagra BCN Farma SL 24/01/2011 100 mg Film-coated tablet 4 EU/1/98/077/010 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Sweden, The Netherlands, United Kingdom
Spain 01/02/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 218/255
Viagra BCN Farma SL 24/01/2011 100 mg Film-coated tablet 8 EU/1/98/077/011 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Sweden, The Netherlands, United Kingdom
Spain 01/02/2011
Viagra BCN Farma SL 24/01/2011 50 mg Film-coated tablet 4 EU/1/98/077/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Sweden, The Netherlands, United Kingdom
Spain 01/02/2011
Viagra BCN Farma SL 24/01/2011 50 mg Film-coated tablet 8 EU/1/98/077/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Sweden, The Netherlands, United Kingdom
Spain 01/02/2011
Viagra CC Pharma 16/11/2011 25 mg Film-coated tablet 4 EU/1/98/077/002 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 09/12/2011
Viagra Emra-Med 11/03/2011 50 mg Film-coated tablet 4 EU/1/98/077/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 29/03/2011
Viagra Medartuum AB 31/03/2010 50 mg Film-coated tablet 12 EU/1/98/077/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 30/05/2011
Viagra Omnia Läkemedel AB
13/05/2011 50 mg Film-coated tablet 12 EU/1/98/077/008 France, Germany, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom
Sweden 02/08/2011
Viagra Orifarm AS 29/11/2011 100 mg Film-coated tablet 8 EU/1/98/077/011 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 19/12/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 219/255
Viagra PCO Manufacturing
19/01/2009 100 mg Film-coated tablet 4 EU/1/98/077/010 Austria, Belgium, Cyprus, Denmark, France, Germany, Greece, Iceland, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
07/02/2011
Victoza Abacus Medicine A/S
08/04/2011 6 mg/ml Solution for injection in pre-filled pen
3 pre-filled pens
EU/1/09/529/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 19/04/2011
Victoza Abacus Medicine A/S
11/05/2011 6 mg/ml Solution for injection in pre-filled pen
1 pre-filled pen
EU/1/09/529/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 07/06/2011
Victoza Abacus Medicine A/S
19/05/2011 6 mg/ml Solution for injection in pre-filled pen
2 pre-filled pens
EU/1/09/529/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 07/06/2011
Victoza CC Pharma 31/01/2011 6 mg/ml Solution for injection in pre-filled pen
5 pre-filled pens
EU/1/09/529/004 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 04/02/2011
Victoza Cross Pharma AB
05/04/2011 6 mg/ml Solution for injection in pre-filled pen
3 pre-filled pens
EU/1/09/529/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 30/05/2011
Victoza Dr Fisher Farma BV
04/05/2011 6 mg/ml Solution for injection in pre-filled pen
2 pre-filled pens
EU/1/09/529/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
10/05/2011
Victoza Medartuum AB 05/12/2011 6 mg/ml Solution for injection in pre-filled pen
3 pre-filled pens
EU/1/09/529/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 08/12/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 220/255
Victoza Medcor Pharmaceuticals BV
09/06/2011 6 mg/ml Solution for injection in pre-filled pen
2 pre-filled pens
EU/1/09/529/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
15/06/2011
Victoza Orifarm AS 07/09/2011 6 mg/ml Solution for injection in pre-filled pen
3 pre-filled pens
EU/1/09/529/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 15/09/2011
Victoza Paranova Danmark AS
01/06/2011 6 mg/ml Solution for injection in pre-filled pen
2 pre-filled pens
EU/1/09/529/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 30/06/2011
Victoza Paranova Danmark AS
01/06/2011 6 mg/ml Solution for injection in pre-filled pen
3 pre-filled pens
EU/1/09/529/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 30/06/2011
Victoza Paranova Läkemedel AB
03/01/2011 6 mg/ml Solution for injection in pre-filled pen
3 pre-filled pens
EU/1/09/529/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 07/02/2011
Victoza Paranova OY 25/05/2011 6 mg/ml Solution for injection in pre-filled pen
3 pre-filled pens
EU/1/09/529/003 Austria, Belgium, Denmark, France, Germany, Greece, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Finland 04/07/2011
Victoza PCO Manufacturing
21/03/2011 6 mg/ml Solution for injection in pre-filled pen
2 pre-filled pens
EU/1/09/529/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
07/06/2011
Victoza Pharmachim AB
01/11/2011 6 mg/ml Solution for injection in pre-filled pen
3 pre-filled pens
EU/1/09/529/003 Austria, Belgium, Bulgaria, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 11/11/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 221/255
Victoza Pharmachim AB
01/11/2011 6 mg/ml Solution for injection in pre-filled pen
2 pre-filled pens
EU/1/09/529/002 Austria, Belgium, Bulgaria, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands
Sweden 14/11/2011
Victrelis HAEMATO PHARM AG
15/12/2011 200 mg Capsule, hard 336 (4 packs of 84) hard
EU/1/11/704/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 22/12/2011
Vidaza Abacus Medicine A/S
07/07/2011 25 mg/ml Powder for suspension for injection
1 vial EU/1/08/488/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 22/07/2011
Vidaza Orifarm AB 10/12/2010 25 mg/ml Powder for suspension for injection
1 vial EU/1/08/488/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 03/01/2011
Vimpat Axicorp Pharma GmbH
03/02/2011 100 mg Film-coated tablet 56 EU/1/08/470/005 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/02/2011
Vimpat Axicorp Pharma GmbH
24/02/2011 100 mg Film-coated tablet 168 EU/1/08/470/006 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 29/03/2011
Vimpat Axicorp Pharma GmbH
06/09/2011 50 mg Film-coated tablet 56 EU/1/08/470/002 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 30/09/2011
Vimpat B2B Medical GmbH
10/06/2011 100 mg Film-coated tablet 56 EU/1/08/470/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 13/07/2011
Vimpat B2B Medical GmbH
10/06/2011 100 mg Film-coated tablet 168 EU/1/08/470/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 13/07/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 222/255
Vimpat B2B Medical GmbH
10/06/2011 50 mg Film-coated tablet 56 EU/1/08/470/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 13/07/2011
Vimpat B2B Medical GmbH
26/09/2011 50 mg Film-coated tablet 168 EU/1/08/470/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 10/10/2011
Vimpat Beragena Arzneimittel GmbH
02/12/2011 50 mg Film-coated tablet 168 EU/1/08/470/003 Austria, Belgium, France, Greece, Ireland, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 19/12/2011
Vimpat BR Pharma International Ltd
06/06/2011 150 mg Film-coated tablet 168 EU/1/08/470/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 07/06/2011
Vimpat BR Pharma International Ltd
07/06/2011 150 mg Film-coated tablet 56 EU/1/08/470/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 08/06/2011
Vimpat Doncaster Pharmaceuticals Group Ltd
24/01/2011 150 mg Film-coated tablet 14 EU/1/08/470/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
02/02/2011
Vimpat Doncaster Pharmaceuticals Group Ltd
17/02/2011 100 mg Film-coated tablet 14 EU/1/08/470/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
21/02/2011
Vimpat Doncaster Pharmaceuticals Group Ltd
17/02/2011 50 mg Film-coated tablet 14 EU/1/08/470/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
21/02/2011
Vimpat Dr Fisher Farma BV
03/02/2011 50 mg Film-coated tablet 56 EU/1/08/470/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
19/04/2011
Vimpat Dr Fisher Farma BV
26/10/2011 50 mg Film-coated tablet 14 EU/1/08/470/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
28/11/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 223/255
Vimpat Emra-Med 14/10/2011 50 mg Film-coated tablet 168 EU/1/08/470/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 21/12/2011
Vimpat Emra-Med 14/11/2011 150 mg Film-coated tablet 168 EU/1/08/470/009 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 21/12/2011
Vimpat Emra-Med 14/11/2011 150 mg Film-coated tablet 56 EU/1/08/470/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 21/12/2011
Vimpat Emra-Med 14/11/2011 200 mg Film-coated tablet 56 EU/1/08/470/011 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 21/12/2011
Vimpat Emra-Med 14/11/2011 200 mg Film-coated tablet 168 EU/1/08/470/012 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 21/12/2011
Vimpat G-Pharma Ltd 14/02/2011 100 mg Film-coated tablet 14 EU/1/08/470/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
02/03/2011
Vimpat G-Pharma Ltd 14/02/2011 100 mg Film-coated tablet 56 EU/1/08/470/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
02/03/2011
Vimpat G-Pharma Ltd 14/02/2011 150 mg Film-coated tablet 14 EU/1/08/470/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
02/03/2011
Vimpat G-Pharma Ltd 14/02/2011 150 mg Film-coated tablet 56 EU/1/08/470/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
02/03/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 224/255
Vimpat G-Pharma Ltd 14/02/2011 200 mg Film-coated tablet 56 EU/1/08/470/011 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
02/03/2011
Vimpat G-Pharma Ltd 14/02/2011 50 mg Film-coated tablet 14 EU/1/08/470/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
02/03/2011
Vimpat Kohlpharma GmbH
10/11/2011 50 mg Film-coated tablet 168 EU/1/08/470/003 Belgium, France, Greece, Italy, The Netherlands
Germany 15/11/2011
Vimpat Mevita HandelsGmbH
17/02/2011 100 mg Film-coated tablet 56 EU/1/08/470/005 Austria, Belgium, France, Greece, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 15/08/2011
Vimpat Mevita HandelsGmbH
17/02/2011 50 mg Film-coated tablet 14 EU/1/08/470/001 Austria, Belgium, France, Greece, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 15/08/2011
Vimpat Mevita HandelsGmbH
17/02/2011 50 mg Film-coated tablet 56 EU/1/08/470/002 Austria, Belgium, France, Greece, Italy, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 15/08/2011
Vimpat O.P.D. Laboratories Ltd
24/06/2011 100 mg Film-coated tablet 14 EU/1/08/470/004 Belgium, Denmark, France, Germany, Greece, Italy, Portugal, Spain, Sweden, The Netherlands
United Kingdom
18/08/2011
Vimpat O.P.D. Laboratories Ltd
24/06/2011 200 mg Film-coated tablet 56 EU/1/08/470/011 Belgium, Denmark, France, Germany, Greece, Italy, Portugal, Spain, Sweden, The Netherlands
United Kingdom
18/08/2011
Vimpat O.P.D. Laboratories Ltd
24/06/2011 50 mg Film-coated tablet 14 EU/1/08/470/001 Belgium, Denmark, France, Germany, Greece, Italy, Portugal, Spain, Sweden
United Kingdom
18/08/2011
Vimpat Swingward Ltd TA Medihealth
27/04/2011 100 mg Film-coated tablet 56 EU/1/08/470/005 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands
United Kingdom
03/05/2011
Vimpat Veron Pharma Vertriebs GmbH
23/11/2011 100 mg Film-coated tablet 56 EU/1/08/470/005 Austria, Greece Germany 22/12/2011
Vimpat Veron Pharma Vertriebs GmbH
23/11/2011 100 mg Film-coated tablet 168 EU/1/08/470/006 Austria Germany 22/12/2011
Vimpat Veron Pharma Vertriebs GmbH
23/11/2011 200 mg Film-coated tablet 168 EU/1/08/470/012 Austria Germany 22/12/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 225/255
Vimpat Veron Pharma Vertriebs GmbH
23/11/2011 200 mg Film-coated tablet 56 EU/1/08/470/011 Austria, Greece Germany 22/12/2011
Vimpat Veron Pharma Vertriebs GmbH
23/11/2011 50 mg Film-coated tablet 56 EU/1/08/470/002 Austria, Belgium, France, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom
Germany 22/12/2011
Vimpat Veron Pharma Vertriebs GmbH
23/11/2011 50 mg Film-coated tablet 168 EU/1/08/470/003 Austria Germany 22/12/2011
Vimpat Vital Supplies UK Limited
24/06/2011 100 mg Film-coated tablet 14 EU/1/08/470/004 Belgium, Denmark, France, Germany, Greece, Italy, Portugal, Spain, Sweden, The Netherlands
United Kingdom
22/08/2011
Vimpat Vital Supplies UK Limited
24/06/2011 50 mg Film-coated tablet 14 EU/1/08/470/001 Belgium, Denmark, France, Germany, Greece, Italy, Portugal, Spain, Sweden, The Netherlands
United Kingdom
22/08/2011
Vimpat Vital Supplies UK Limited
06/10/2011 150 mg Film-coated tablet 56 EU/1/08/470/008 Belgium, Denmark, France, Germany, Greece, Italy, Portugal, Spain, Sweden, The Netherlands
United Kingdom
28/11/2011
Vimpat Waymade PLC 13/07/2011 100 mg Film-coated tablet 56 EU/1/08/470/005 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
15/07/2011
Vimpat Waymade PLC 13/07/2011 50 mg Film-coated tablet 14 EU/1/08/470/001 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
15/07/2011
Vimpat Waymade PLC 22/07/2011 100 mg Film-coated tablet 14 EU/1/08/470/004 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
16/09/2011
Viramune Axicorp Pharma GmbH
17/02/2011 200 mg Tablet 120 EU/1/97/055/003 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 14/03/2011
Viramune EU-Pharma BV 10/11/2011 200 mg Tablet 60 EU/1/97/055/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
29/11/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 226/255
Viramune Orifarm OY 24/02/2011 200 mg Tablet 60 EU/1/97/055/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Finland 16/03/2011
Viramune Paranova OY 16/03/2011 200 mg Tablet 60 EU/1/97/055/001 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Finland 01/04/2011
Viread EuroPharma DK
08/07/2011 245 mg Film-coated tablet 30 EU/1/01/200/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 14/07/2011
Visudyne Orifarm AB 21/07/2011 15 mg Powder for solution for infusion
1 vial EU/1/00/140/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 26/07/2011
Volibris Haemato Pharm AG
16/02/2011 5 mg Film-coated tablet 30 EU/1/08/451/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Austria, Germany
16/03/2011
Volibris Haemato Pharm AG
21/02/2011 10 mg Film-coated tablet 30 EU/1/08/451/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Austria, Germany
16/03/2011
Votrient Emra-Med 30/08/2011 200 mg Film-coated tablet 30 EU/1/10/628/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 14/09/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 227/255
Votrient Emra-Med 30/08/2011 400 mg Film-coated tablet 30 EU/1/10/628/003 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 14/09/2011
Votrient Orifarm AB 18/11/2011 400 mg Film-coated tablet 60 EU/1/10/628/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 29/11/2011
Votrient Pharma Westen GmbH
29/08/2011 200 mg Film-coated tablet 90 EU/1/10/628/002 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 06/09/2011
Votrient Pharma Westen GmbH
07/09/2011 400 mg Film-coated tablet 60 EU/1/10/628/004 Austria, Belgium, Bulgaria, Denmark, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Germany 03/10/2011
VPRIV CC Pharma GmbH
06/12/2011 400 U Powder for solution for infusion
1 vial EU/1/10/646/002 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 08/12/2011
Xagrid 2 Care 4 08/02/2011 0.5 mg Capsule, hard 100 EU/1/04/295/001 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 23/03/2011
Xarelto Abacus Medicine A/S
29/06/2011 10 mg Film-coated tablet 30 EU/1/08/472/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 25/07/2011
Xarelto Abacus Medicine A/S
08/07/2011 10 mg Film-coated tablet 100 x 1 EU/1/08/472/008 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 25/07/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 228/255
Xarelto Clear Pharmacy
16/11/2011 10 mg Film-coated tablet 10 EU/1/08/472/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
21/11/2011
Xarelto Clear Pharmacy
16/11/2011 10 mg Film-coated tablet 30 EU/1/08/472/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
22/11/2011
Xarelto Doncaster Pharmaceuticals Group Ltd
05/10/2011 10 mg Film-coated tablet 30 EU/1/08/472/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
12/10/2011
Xarelto Doncaster Pharmaceuticals Group Ltd
05/10/2011 10 mg Film-coated tablet 10 EU/1/08/472/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
12/10/2011
Xarelto Dr Fisher Farma BV
26/08/2011 10 mg Film-coated tablet 10 EU/1/08/472/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
30/08/2011
Xarelto Emra-Med 01/02/2011 10 mg Film-coated tablet 10 EU/1/08/472/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 02/02/2011
Xarelto Emra-Med 01/02/2011 10 mg Film-coated tablet 30 EU/1/08/472/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 03/02/2011
Xarelto EU-Pharma BV 12/07/2011 10 mg Film-coated tablet 30 EU/1/08/472/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, United Kingdom
The Netherlands
12/07/2011
Xarelto EU-Pharma BV 27/09/2011 10 mg Film-coated tablet 30 EU/1/08/472/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, United Kingdom
The Netherlands
05/10/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 229/255
Xarelto Eureco-Pharma B.V.
03/01/2011 10 mg Film-coated tablet 10 EU/1/08/472/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
21/02/2011
Xarelto Eureco-Pharma B.V.
11/10/2011 10 mg Film-coated tablet 30 EU/1/08/472/007 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
03/11/2011
Xarelto EuroPharma DK
14/04/2011 10 mg Film-coated tablet 10 EU/1/08/472/006 Austria, Belgium, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Denmark 18/04/2011
Xarelto EuroPharma DK
14/04/2011 10 mg Film-coated tablet 100 x 1 EU/1/08/472/008 Austria, Belgium, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Denmark 18/04/2011
Xarelto EuroPharma DK
14/04/2011 10 mg Film-coated tablet 30 EU/1/08/472/007 Austria, Belgium, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Denmark 18/04/2011
Xarelto Medcor Pharmaceuticals BV
24/02/2011 10 mg Film-coated tablet 30 EU/1/08/472/007 Austria, Belgium, Cyprus, Denmark, Estonia, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
15/03/2011
Xarelto Medcor Pharmaceuticals BV
26/04/2011 10 mg Film-coated tablet 10 EU/1/08/472/006 Austria, Belgium, Cyprus, Denmark, Estonia, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
03/05/2011
Xeloda Axicorp Pharma GmbH
09/06/2011 500 mg Film-coated tablet 120 EU/1/00/163/002 Austria, Belgium, Bulgaria, Denmark, Estonia, Finland, France, Greece, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Germany 27/06/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 230/255
Xeloda Dr Fisher Farma BV
09/12/2010 150 mg Film-coated tablet 60 EU/1/00/163/001 Austria, Belgium, Bulgaria, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
04/01/2011
Xeloda Inopha GmbH 22/03/2011 500 mg Film-coated tablet 120 EU/1/00/163/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, United Kingdom
The Netherlands
23/03/2011
Xeloda Orifarm AB 01/02/2011 500 mg Film-coated tablet 120 EU/1/00/163/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 03/03/2011
Xeloda Orifarm AS 27/07/2011 500 mg Film-coated tablet 120 EU/1/00/163/002 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 05/08/2011
Xeloda Orifarm AS 01/09/2011 150 mg Film-coated tablet 60 EU/1/00/163/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 12/09/2011
Xeloda Pharmachim AB
26/09/2011 500 mg Film-coated tablet 120 EU/1/00/163/002 Austria, Belgium, Bulgaria, Czech Republic, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 24/10/2011
Xenical 2 Care 4 05/01/2011 120 mg Capsule, hard 42 EU/1/98/071/002 Austria, Belgium, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Denmark 13/01/2011
Xenical 2 Care 4 05/01/2011 120 mg Capsule, hard 84 EU/1/98/071/003 Austria, Belgium, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Denmark 09/02/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 231/255
Xenical Axicorp Pharma GmbH
23/09/2011 120 mg Capsule, hard 84 EU/1/98/071/003 Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Luxembourg, Norway, Portugal, Sweden, The Netherlands, United Kingdom
Germany 28/09/2011
Xenical Elpis Ltd. 03/02/2011 120 mg Capsule, hard 84 EU/1/98/071/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Liechtenstein, Lithuania, Luxembourg, Malta, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Latvia 08/09/2011
Xenical Mediwin Ltd 12/07/2011 120 mg Capsule, hard 84 EU/1/98/071/003 Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Latvia, Lithuania, Luxembourg, Malta, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Italy 01/08/2011
Xenical Parallell Pharma AB
07/02/2011 120 mg Capsule, hard 84 EU/1/98/071/003 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, The Netherlands, United Kingdom
Sweden 31/03/2011
Xenical Pretium Farm Sp. z o.o.
07/10/2011 120 mg Capsule, hard 42 EU/1/98/071/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Poland 23/11/2011
Xenical Pretium Farm Sp. z o.o.
07/10/2011 120 mg Capsule, hard 84 EU/1/98/071/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Poland 23/11/2011
Xenical SAIMA Productos Y Servicios S.L.U.
24/04/2011 120 mg Capsule, hard 84 EU/1/98/071/003 United Kingdom Spain 17/05/2011
Xenical STRATHCLYDE PHARMACEUTICALS LTD
21/11/2011 120 mg Capsule, hard 84 EU/1/98/071/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
01/12/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 232/255
Xeplion CC Pharma 09/11/2011 100 mg Suspension for injection in pre-filled syringe
1 pre-filled syringe + 2 needles
EU/1/11/672/004 Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 16/12/2011
Xeplion CC Pharma 09/11/2011 150 mg Suspension for injection in pre-filled syringe
1 pre-filled syringe + 2 needles
EU/1/11/672/005 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 16/12/2011
Xeristar BR Pharma International Ltd
10/05/2011 60 mg Gastro-resistant capsule, hard
98 EU/1/04/297/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 12/05/2011
Xeristar CC Pharma 12/04/2011 30 mg Gastro-resistant capsule, hard
28 EU/1/04/297/001 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 28/04/2011
Xeristar CC Pharma 12/04/2011 60 mg Gastro-resistant capsule, hard
28 EU/1/04/297/002 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 28/04/2011
Xeristar Euro Registratie Collectief BV
12/04/2010 30 mg Gastro-resistant capsule, hard
7 EU/1/04/297/006 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
01/06/2011
Xeristar Euro Registratie Collectief BV
12/04/2010 60 mg Gastro-resistant capsule, hard
28 EU/1/04/297/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
01/06/2011
Xeristar EuroPharma DK
14/04/2011 30 mg Gastro-resistant capsule, hard
28 EU/1/04/297/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 26/04/2011
Xeristar EuroPharma DK
14/04/2011 30 mg Gastro-resistant capsule, hard
7 EU/1/04/297/006 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 26/04/2011
Xeristar MedicoPharm AG
22/10/2010 60 mg Gastro-resistant capsule, hard
98 EU/1/04/297/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 28/03/2011
Xeristar MedicoPharm AG
20/01/2011 30 mg Gastro-resistant capsule, hard
28 EU/1/04/297/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Spain, Sweden, The Netherlands, United Kingdom
Germany 24/03/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 233/255
Xeristar NewNeopharm BV
18/05/2011 30 mg Gastro-resistant capsule, hard
28 EU/1/04/297/001 Austria, Belgium, Cyprus, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 15/06/2011
XGEVA Haemato Pharm AG
20/09/2011 120 mg Solution for injection
1 vial EU/1/11/703/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 29/09/2011
Xolair Abacus Medicine A/S
11/05/2011 150 mg Solution for injection
1 pre-filled syringe
EU/1/05/319/008 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 27/05/2011
Xolair CC Pharma 23/05/2011 150 mg Solution for injection
1 pre-filled syringe
EU/1/05/319/008 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 27/05/2011
Xolair CC Pharma 23/05/2011 75 mg Solution for injection
1 pre-filled syringe
EU/1/05/319/005 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 27/05/2011
Xolair Dr Fisher Farma BV
09/03/2011 150 mg Powder and solvent for solution for injection
1 vial + 1 ampoule
EU/1/05/319/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
14/03/2011
Xolair Medartuum AB 18/02/2011 150 mg Powder and solvent for solution for injection
1 vial + 1 ampoule
EU/1/05/319/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 14/03/2011
Xolair Orifarm AB 03/01/2011 150 mg Powder and solvent for solution for injection
1 vial + 1 ampoule
EU/1/05/319/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 03/03/2011
Xolair Pharma Westen GmbH
02/03/2011 150 mg Powder and solvent for solution for injection
10 intermediate packs (1 vial + 1 ampoule)
EU/1/05/319/004 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Sweden, The Netherlands, United Kingdom
Germany 17/03/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 234/255
Yentreve ADL Pharma GmbH
10/06/2011 40 mg Gastro-resistant capsule, hard
98 EU/1/04/280/004 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 28/06/2011
Yentreve ADL Pharma GmbH
10/06/2011 40 mg Gastro-resistant capsule, hard
28 EU/1/04/280/002 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 28/06/2011
Yentreve ADL Pharma GmbH
24/06/2011 20 mg Gastro-resistant capsule, hard
28 EU/1/04/280/007 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 07/07/2011
Yentreve ADL Pharma GmbH
24/06/2011 20 mg Gastro-resistant capsule, hard
98 EU/1/04/280/008 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Germany 07/07/2011
Yentreve Axicorp Pharma GmbH
29/08/2011 20 mg Gastro-resistant capsule, hard
98 EU/1/04/280/008 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 08/09/2011
Yentreve Axicorp Pharma GmbH
27/09/2011 40 mg Gastro-resistant capsule, hard
98 EU/1/04/280/004 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 12/10/2011
Yentreve Veron Pharma Vertriebs GmbH
31/03/2011 20 mg Gastro-resistant capsule, hard
98 EU/1/04/280/008 Austria, Belgium Germany 21/06/2011
Yentreve Veron Pharma Vertriebs GmbH
31/03/2011 20 mg Gastro-resistant capsule, hard
28 EU/1/04/280/007 Austria, Belgium Germany 21/06/2011
Yentreve Veron Pharma Vertriebs GmbH
31/03/2011 40 mg Gastro-resistant capsule, hard
98 EU/1/04/280/004 Austria, Belgium Germany 21/06/2011
Yentreve Veron Pharma Vertriebs GmbH
31/03/2011 40 mg Gastro-resistant capsule, hard
28 EU/1/04/280/002 Austria, Belgium Germany 21/06/2011
Zarzio Medartuum AB 01/07/2011 30 MU (60 MU/ml)
Solution for injection or infusion
5 pre-filled syringes with needle guard
EU/1/08/495/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 06/07/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 235/255
Zarzio Medartuum AB 01/07/2011 48 MU (96 MU/ml)
Solution for injection or infusion
5 pre-filled syringes with needle guard
EU/1/08/495/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, The Netherlands, United Kingdom
Sweden 06/07/2011
Zebinix Emra-Med 14/09/2011 800 mg Tablet 30 EU/1/09/514/017 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 06/10/2011
Zeffix Delfarma SpZoo
12/08/2011 100 mg Film-coated tablet 28 EU/1/99/114/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Poland 24/08/2011
Zeffix Euro Registratie Collectief BV
14/11/2011 100 mg Film-coated tablet 28 EU/1/99/114/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
17/11/2011
Zeffix MPT Pharma 16/12/2010 100 mg Film-coated tablet 28 EU/1/99/114/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
31/01/2011
Zeffix MPT Pharma 16/12/2010 100 mg Film-coated tablet 84 EU/1/99/114/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
31/01/2011
Ziagen Orifarm OY 15/03/2011 300 mg Film-coated tablet 60 EU/1/99/112/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Finland 10/05/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 236/255
Zometa Inopha GmbH 08/03/2011 4 mg Concentrate for solution for infusion
1 vial EU/1/01/176/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, United Kingdom
The Netherlands
28/03/2011
Zometa Paranova Danmark AS
13/07/2011 4 mg Powder and solvent for solution for infusion
1 vial + 1 ampoule
EU/1/01/176/001 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 04/08/2011
Zometa Paranova Läkemedel AB
05/07/2011 4 mg Powder and solvent for solution for infusion
1 vial + 1 ampoule
EU/1/01/176/001 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, The Netherlands, United Kingdom
Sweden 02/08/2011
Zonegran Abacus Medicine A/S
12/04/2011 100 mg Capsule, hard 56 EU/1/04/307/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 19/04/2011
Zonegran Abacus Medicine A/S
12/04/2011 50 mg Capsule, hard 56 EU/1/04/307/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 19/04/2011
Zonegran Abacus Medicine A/S
15/06/2011 100 mg Capsule, hard 98 EU/1/04/307/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 22/06/2011
Zonegran B&S Healthcare Ltd
10/05/2011 100 mg Capsule, hard 56 EU/1/04/307/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
30/05/2011
Zonegran Chemilines Ltd 27/04/2010 50 mg Capsule, hard 14 EU/1/04/307/010 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands
Ireland, United Kingdom
04/10/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 237/255
Zonegran Mediwin Ltd 04/04/2011 50 mg Capsule, hard 14 EU/1/04/307/010 Austria, Belgium, France, Germany, Greece, Italy, Malta, Portugal, Spain, The Netherlands
United Kingdom
11/05/2011
Zonegran Paranova Danmark AS
20/05/2009 100 mg Capsule, hard 98 EU/1/04/307/007 Austria, Belgium, Finland, France, Germany, Greece, Ireland, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 20/07/2011
Zonegran STRATHCLYDE PHARMACEUTICALS LTD
27/09/2011 25 mg Capsule, hard 28 EU/1/04/307/005 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
24/10/2011
Zonegran STRATHCLYDE PHARMACEUTICALS LTD
27/09/2011 50 mg Capsule, hard 28 EU/1/04/307/009 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
24/10/2011
Zonegran STRATHCLYDE PHARMACEUTICALS LTD
24/10/2011 25 mg Capsule, hard 14 EU/1/04/307/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
16/11/2011
Zutectra CC Pharma 22/08/2011 500 IU Solution for injection
5 pre-filled syringes
EU/1/09/600/001 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 23/08/2011
Zypadhera 2 Care 4 30/09/2010 210 mg Powder and solvent for prolonged release suspension for injection
1 vial + 1 vial + 1 syringe with pre-attached safety needle + 2 safety needles
EU/1/08/479/001 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 10/03/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 238/255
Zypadhera 2 Care 4 30/09/2010 300 mg Powder and solvent for prolonged release suspension for injection
1 vial + 1 vial + 1 syringe with pre-attached safety needle + 2 safety needles
EU/1/08/479/002 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 10/03/2011
Zypadhera 2 Care 4 30/09/2010 405 mg Powder and solvent for prolonged release suspension for injection
1 vial + 1 vial + 1 syringe with pre-attached safety needle + 2 safety needles
EU/1/08/479/003 Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 10/03/2011
Zypadhera CC Pharma 15/12/2011 300 mg Powder and solvent for prolonged release suspension for injection
1 vial + 1 vial + 1 syringe with pre-attached safety needle + 2 safety needles
EU/1/08/479/002 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Poland, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Germany 19/12/2011
Zypadhera CC Pharma 15/12/2011 405 mg Powder and solvent for prolonged release suspension for injection
1 vial + 1 vial + 1 syringe with pre-attached safety needle + 2 safety needles
EU/1/08/479/003 Austria, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Norway, Poland, Portugal, Romania, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Germany 20/12/2011
Zypadhera Haemato Pharm AG
26/08/2011 210 mg Powder and solvent for prolonged release suspension for injection
1 vial + 1 vial + 1 syringe with pre-attached safety needle + 2 safety needles
EU/1/08/479/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 13/09/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 239/255
Zypadhera Haemato Pharm AG
26/08/2011 300 mg Powder and solvent for prolonged release suspension for injection
1 vial + 1 vial + 1 syringe with pre-attached safety needle + 2 safety needles
EU/1/08/479/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 13/09/2011
Zypadhera Haemato Pharm AG
26/08/2011 405 mg Powder and solvent for prolonged release suspension for injection
1 vial + 1 vial + 1 syringe with pre-attached safety needle + 2 safety needles
EU/1/08/479/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 13/09/2011
Zypadhera Kohlpharma GmbH
13/09/2011 300 mg Powder and solvent for prolonged release suspension for injection
1 vial + 1 vial + 1 syringe with pre-attached safety needle + 2 safety needles
EU/1/08/479/002 Lithuania Germany 05/10/2011
Zypadhera Kohlpharma GmbH
13/09/2011 405 mg Powder and solvent for prolonged release suspension for injection
1 vial + 1 vial + 1 syringe with pre-attached safety needle + 2 safety needles
EU/1/08/479/003 Lithuania Germany 05/10/2011
Zypadhera Medcor Pharmaceuticals BV
01/06/2011 300 mg Powder and solvent for prolonged release suspension for injection
1 vial + 1 vial + 1 syringe with pre-attached safety needle + 2 safety needles
EU/1/08/479/002 Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Spain, Sweden, United Kingdom
The Netherlands
07/06/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 240/255
Zypadhera Orifarm AS 19/09/2011 300 mg Powder and solvent for prolonged release suspension for injection
1 vial + 1 vial + 1 syringe with pre-attached safety needle + 2 safety needles
EU/1/08/479/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 04/10/2011
Zypadhera Orifarm AS 23/09/2011 405 mg Powder and solvent for prolonged release suspension for injection
1 vial + 1 vial + 1 syringe with pre-attached safety needle + 2 safety needles
EU/1/08/479/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 04/10/2011
Zypadhera Orifarm AS 20/10/2011 210 mg Powder and solvent for prolonged release suspension for injection
1 vial + 1 vial + 1 syringe with pre-attached safety needle + 2 safety needles
EU/1/08/479/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Denmark 04/11/2011
Zyprexa Abacus Medicine A/S
14/01/2011 7.5 mg Coated tablet 28 EU/1/96/022/011 Austria, Belgium, Cyprus, Czech Republic, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Denmark 19/01/2011
Zyprexa ADL Pharma GmbH
30/05/2011 5 mg Coated tablet 28 EU/1/96/022/004 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 18/07/2011
Zyprexa ADL Pharma GmbH
30/05/2011 5 mg Coated tablet 70 EU/1/96/022/030 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 18/07/2011
Zyprexa ADL Pharma GmbH
30/05/2011 5 mg Coated tablet 56 EU/1/96/022/020 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 18/07/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 241/255
Zyprexa ADL Pharma GmbH
30/05/2011 5 mg Coated tablet 35 EU/1/96/022/024 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 18/07/2011
Zyprexa BB Farma s.r.l.
14/02/2011 10 mg Coated tablet 28 EU/1/96/022/009 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 09/03/2011
Zyprexa BB Farma s.r.l.
14/02/2011 10 mg Coated tablet 56 EU/1/96/022/010 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 09/03/2011
Zyprexa BB Farma s.r.l.
14/02/2011 10 mg Coated tablet 35 EU/1/96/022/026 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 09/03/2011
Zyprexa BB Farma s.r.l.
14/02/2011 10 mg Coated tablet 70 EU/1/96/022/032 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 09/03/2011
Zyprexa BB Farma s.r.l.
14/02/2011 5 mg Coated tablet 28 EU/1/96/022/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 10/03/2011
Zyprexa BB Farma s.r.l.
14/02/2011 5 mg Coated tablet 56 EU/1/96/022/020 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 10/03/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 242/255
Zyprexa BB Farma s.r.l.
14/02/2011 5 mg Coated tablet 35 EU/1/96/022/024 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 10/03/2011
Zyprexa BB Farma s.r.l.
14/02/2011 5 mg Coated tablet 70 EU/1/96/022/030 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 10/03/2011
Zyprexa BB Farma s.r.l.
21/02/2011 2.5 mg Coated tablet 28 EU/1/96/022/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 15/03/2011
Zyprexa BB Farma s.r.l.
21/02/2011 2.5 mg Coated tablet 35 EU/1/96/022/023 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 11/03/2011
Zyprexa BB Farma s.r.l.
21/02/2011 2.5 mg Coated tablet 70 EU/1/96/022/029 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 11/03/2011
Zyprexa BB Farma s.r.l.
21/02/2011 2.5 mg Coated tablet 56 EU/1/96/022/019 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 11/03/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 243/255
Zyprexa BB Farma s.r.l.
10/03/2011 7.5 mg Coated tablet 70 EU/1/96/022/031 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway,Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/03/2011
Zyprexa BB Farma s.r.l.
10/03/2011 7.5 mg Coated tablet 35 EU/1/96/022/025 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/03/2011
Zyprexa BB Farma s.r.l.
10/03/2011 7.5 mg Coated tablet 28 EU/1/96/022/011 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/03/2011
Zyprexa BB Farma s.r.l.
10/03/2011 7.5 mg Coated tablet 56 EU/1/96/022/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/03/2011
Zyprexa BB Farma s.r.l.
15/03/2011 20 mg Coated tablet 35 EU/1/96/022/028 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 29/03/2011
Zyprexa BB Farma s.r.l.
15/03/2011 20 mg Coated tablet 70 EU/1/96/022/034 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 29/03/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 244/255
Zyprexa BB Farma s.r.l.
15/03/2011 20 mg Coated tablet 28 EU/1/96/022/014 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 29/03/2011
Zyprexa BB Farma s.r.l.
15/03/2011 20 mg Coated tablet 56 EU/1/96/022/022 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 29/03/2011
Zyprexa CC Pharma 15/08/2011 2.5 mg Coated tablet 98 EU/1/96/022/035 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 22/08/2011
Zyprexa CC Pharma 16/08/2011 10 mg Coated tablet 98 EU/1/96/022/038 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 22/08/2011
Zyprexa CC Pharma 16/08/2011 15 mg Coated tablet 98 EU/1/96/022/039 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 22/08/2011
Zyprexa CC Pharma 16/08/2011 5 mg Coated tablet 98 EU/1/96/022/036 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 22/08/2011
Zyprexa CC Pharma 16/08/2011 7.5 mg Coated tablet 98 EU/1/96/022/037 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 22/08/2011
Zyprexa ChemVet Pharma ApS
08/04/2011 7.5 mg Coated tablet 56 EU/1/96/022/006 Austria, Belgium, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 16/06/2011
Zyprexa ChemVet Pharma ApS
27/07/2011 20 mg Coated tablet 28 EU/1/96/022/014 Austria, Belgium, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 04/08/2011
Zyprexa ChemVet Pharma ApS
28/07/2011 10 mg Coated tablet 28 EU/1/96/022/009 Austria, Belgium, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 16/08/2011
Zyprexa ChemVet Pharma ApS
28/07/2011 15 mg Coated tablet 28 EU/1/96/022/012 Austria, Belgium, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 05/08/2011
Zyprexa ChemVet Pharma ApS
28/07/2011 5 mg Coated tablet 28 EU/1/96/022/004 Austria, Belgium, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 16/08/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 245/255
Zyprexa Clear Pharmacy
20/12/2010 2.5 mg Coated tablet 28 EU/1/96/022/002 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Malta, Norway, Poland, Portugal, Romania, Spain, Sweden, The Netherlands, United Kingdom
Ireland, Malta, United Kingdom
11/01/2011
Zyprexa Docpharm GmbH&CoKGaA
03/05/2011 10 mg Coated tablet 98 EU/1/96/022/038 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 17/05/2011
Zyprexa Docpharm GmbH&CoKGaA
03/05/2011 15 mg Coated tablet 98 EU/1/96/022/039 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 06/07/2011
Zyprexa Docpharm GmbH&CoKGaA
03/05/2011 2.5 mg Coated tablet 98 EU/1/96/022/035 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 17/05/2011
Zyprexa Docpharm GmbH&CoKGaA
03/05/2011 5 mg Coated tablet 98 EU/1/96/022/036 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 17/05/2011
Zyprexa Docpharm GmbH&CoKGaA
03/05/2011 7.5 mg Coated tablet 98 EU/1/96/022/037 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 06/07/2011
Zyprexa Kohlpharma GmbH
19/05/2011 10 mg Coated tablet 98 EU/1/96/022/038 Finland, France, Greece, Italy, Norway, Spain, The Netherlands, United Kingdom
Germany 22/06/2011
Zyprexa Kohlpharma GmbH
19/05/2011 5 mg Coated tablet 98 EU/1/96/022/036 Finland, France, Greece, Italy, Norway, Spain, The Netherlands, United Kingdom
Germany 22/06/2011
Zyprexa Kohlpharma GmbH
01/09/2011 2.5 mg Coated tablet 56 EU/1/96/022/019 Austria, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom
Germany 29/09/2011
Zyprexa Kohlpharma GmbH
01/09/2011 2.5 mg Coated tablet 98 EU/1/96/022/035 Austria, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom
Germany 29/09/2011
Zyprexa Kohlpharma GmbH
01/09/2011 7.5 mg Coated tablet 98 EU/1/96/022/037 Finland, France, Greece, Spain, United Kingdom
Germany 29/09/2011
Zyprexa Kohlpharma GmbH
22/09/2011 15 mg Coated tablet 98 EU/1/96/022/039 Austria, Greece, The Netherlands, United Kingdom
Germany 29/09/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 246/255
Zyprexa MPT Pharma 09/06/2011 10 mg Coated tablet 28 EU/1/96/022/009 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
29/06/2011
Zyprexa MPT Pharma 09/06/2011 10 mg Coated tablet 56 EU/1/96/022/010 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
29/06/2011
Zyprexa MPT Pharma 09/06/2011 15 mg Coated tablet 28 EU/1/96/022/012 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
27/06/2011
Zyprexa MPT Pharma 09/06/2011 2.5 mg Coated tablet 28 EU/1/96/022/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
27/06/2011
Zyprexa MPT Pharma 09/06/2011 20 mg Coated tablet 28 EU/1/96/022/014 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
27/06/2011
Zyprexa MPT Pharma 09/06/2011 5 mg Coated tablet 28 EU/1/96/022/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
27/06/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 247/255
Zyprexa MPT Pharma 09/06/2011 7.5 mg Coated tablet 56 EU/1/96/022/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
29/06/2011
Zyprexa MPT Pharma 09/06/2011 7.5 mg Coated tablet 28 EU/1/96/022/011 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
29/06/2011
Zyprexa Omnia Läkemedel AB
14/06/2011 5 mg Coated tablet 28 EU/1/96/022/004 Belgium, France, Greece, Italy, Poland, Portugal, Spain, The Netherlands, United Kingdom
Sweden 26/08/2011
Zyprexa Omnia Läkemedel AB
15/06/2011 10 mg Coated tablet 56 EU/1/96/022/010 Belgium, France, Greece, Italy, Poland, Portugal, Spain, The Netherlands, United Kingdom
Sweden 17/08/2011
Zyprexa Pharma Westen GmbH
14/03/2011 15 mg Coated tablet 98 EU/1/96/022/039 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 07/04/2011
Zyprexa Pharma Westen GmbH
14/03/2011 2.5 mg Coated tablet 98 EU/1/96/022/035 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 07/04/2011
Zyprexa Pharma Westen GmbH
14/03/2011 5 mg Coated tablet 98 EU/1/96/022/036 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 07/04/2011
Zyprexa PI-Pharma N.V.
06/01/2011 10 mg Coated tablet 28 EU/1/96/022/009 Austria, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Belgium 08/03/2011
Zyprexa PI-Pharma N.V.
06/01/2011 5 mg Coated tablet 28 EU/1/96/022/004 Austria, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Belgium 08/03/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 248/255
Zyprexa Propharmed GmbH
27/04/2011 15 mg Coated tablet 35 EU/1/96/022/027 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 12/05/2011
Zyprexa Propharmed GmbH
27/04/2011 15 mg Coated tablet 70 EU/1/96/022/033 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 12/05/2011
Zyprexa Propharmed GmbH
27/04/2011 2.5 mg Coated tablet 35 EU/1/96/022/023 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 12/05/2011
Zyprexa Propharmed GmbH
27/04/2011 2.5 mg Coated tablet 70 EU/1/96/022/029 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 12/05/2011
Zyprexa Propharmed GmbH
27/04/2011 20 mg Coated tablet 35 EU/1/96/022/028 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 12/05/2011
Zyprexa Propharmed GmbH
27/04/2011 5 mg Coated tablet 35 EU/1/96/022/024 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 12/05/2011
Zyprexa Propharmed GmbH
27/04/2011 7.5 mg Coated tablet 70 EU/1/96/022/031 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 12/05/2011
Zyprexa Propharmed GmbH
28/04/2011 5 mg Coated tablet 70 EU/1/96/022/030 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 12/05/2011
Zyprexa Propharmed GmbH
28/06/2011 10 mg Coated tablet 35 EU/1/96/022/026 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/08/2011
Zyprexa Propharmed GmbH
28/06/2011 10 mg Coated tablet 70 EU/1/96/022/032 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/08/2011
Zyprexa Velotab ADL Pharma GmbH
18/05/2011 10 mg Orodispersible tablet
28 EU/1/99/125/002 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 04/07/2011
Zyprexa Velotab ADL Pharma GmbH
18/05/2011 10 mg Orodispersible tablet
35 EU/1/99/125/010 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 04/07/2011
Zyprexa Velotab ADL Pharma GmbH
18/05/2011 10 mg Orodispersible tablet
56 EU/1/99/125/006 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 04/07/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 249/255
Zyprexa Velotab ADL Pharma GmbH
18/05/2011 10 mg Orodispersible tablet
70 EU/1/99/125/014 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 04/07/2011
Zyprexa Velotab ADL Pharma GmbH
18/05/2011 20 mg Orodispersible tablet
28 EU/1/99/125/004 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 12/07/2011
Zyprexa Velotab ADL Pharma GmbH
18/05/2011 20 mg Orodispersible tablet
35 EU/1/99/125/012 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 12/07/2011
Zyprexa Velotab ADL Pharma GmbH
18/05/2011 20 mg Orodispersible tablet
56 EU/1/99/125/008 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 12/07/2011
Zyprexa Velotab ADL Pharma GmbH
18/05/2011 20 mg Orodispersible tablet
70 EU/1/99/125/016 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 12/07/2011
Zyprexa Velotab BB Farma s.r.l.
06/04/2011 5 mg Orodispersible tablet
28 EU/1/99/125/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 15/04/2011
Zyprexa Velotab BB Farma s.r.l.
06/04/2011 5 mg Orodispersible tablet
35 EU/1/99/125/009 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 15/04/2011
Zyprexa Velotab BB Farma s.r.l.
06/04/2011 5 mg Orodispersible tablet
56 EU/1/99/125/005 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 15/04/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 250/255
Zyprexa Velotab BB Farma s.r.l.
06/04/2011 5 mg Orodispersible tablet
70 EU/1/99/125/013 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 15/04/2011
Zyprexa Velotab BB Farma s.r.l.
26/04/2011 10 mg Orodispersible tablet
28 EU/1/99/125/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 13/05/2011
Zyprexa Velotab BB Farma s.r.l.
26/04/2011 10 mg Orodispersible tablet
35 EU/1/99/125/010 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 13/05/2011
Zyprexa Velotab BB Farma s.r.l.
26/04/2011 10 mg Orodispersible tablet
56 EU/1/99/125/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 13/05/2011
Zyprexa Velotab BB Farma s.r.l.
26/04/2011 10 mg Orodispersible tablet
70 EU/1/99/125/014 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 13/05/2011
Zyprexa Velotab BB Farma s.r.l.
28/04/2011 15 mg Orodispersible tablet
28 EU/1/99/125/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 13/05/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 251/255
Zyprexa Velotab BB Farma s.r.l.
28/04/2011 15 mg Orodispersible tablet
35 EU/1/99/125/011 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 13/05/2011
Zyprexa Velotab BB Farma s.r.l.
28/04/2011 15 mg Orodispersible tablet
56 EU/1/99/125/007 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 13/05/2011
Zyprexa Velotab BB Farma s.r.l.
28/04/2011 15 mg Orodispersible tablet
70 EU/1/99/125/015 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 13/05/2011
Zyprexa Velotab CC Pharma 16/08/2011 10 mg Orodispersible tablet
98 EU/1/99/125/018 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 26/08/2011
Zyprexa Velotab CC Pharma 16/08/2011 15 mg Orodispersible tablet
98 EU/1/99/125/019 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 26/08/2011
Zyprexa Velotab CC Pharma 16/08/2011 20 mg Orodispersible tablet
98 EU/1/99/125/020 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 26/08/2011
Zyprexa Velotab CC Pharma 16/08/2011 5 mg Orodispersible tablet
98 EU/1/99/125/017 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 26/08/2011
Zyprexa Velotab ChemVet Pharma ApS
29/07/2011 10 mg Orodispersible tablet
28 EU/1/99/125/002 Austria, Belgium, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 17/08/2011
Zyprexa Velotab ChemVet Pharma ApS
29/07/2011 15 mg Orodispersible tablet
28 EU/1/99/125/003 Austria, Belgium, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 17/08/2011
Zyprexa Velotab ChemVet Pharma ApS
29/07/2011 20 mg Orodispersible tablet
28 EU/1/99/125/004 Austria, Belgium, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 18/08/2011
Zyprexa Velotab ChemVet Pharma ApS
29/07/2011 5 mg Orodispersible tablet
28 EU/1/99/125/001 Austria, Belgium, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Denmark 16/08/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 252/255
Zyprexa Velotab Docpharm GmbH&CoKGaA
03/05/2011 10 mg Orodispersible tablet
98 EU/1/99/125/018 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/05/2011
Zyprexa Velotab Docpharm GmbH&CoKGaA
03/05/2011 15 mg Orodispersible tablet
98 EU/1/99/125/019 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 17/05/2011
Zyprexa Velotab Docpharm GmbH&CoKGaA
03/05/2011 20 mg Orodispersible tablet
98 EU/1/99/125/020 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 17/05/2011
Zyprexa Velotab Docpharm GmbH&CoKGaA
03/05/2011 5 mg Orodispersible tablet
98 EU/1/99/125/017 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 25/05/2011
Zyprexa Velotab Emra-Med 07/06/2011 10 mg Orodispersible tablet
98 EU/1/99/125/018 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 20/06/2011
Zyprexa Velotab Emra-Med 25/11/2011 5 mg Orodispersible tablet
98 EU/1/99/125/017 Austria, Belgium, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 30/11/2011
Zyprexa Velotab Interport Ltd 07/03/2011 20 mg Orodispersible tablet
28 EU/1/99/125/004 Austria, Belgium, France, Germany, Greece, Italy, Portugal, Spain, The Netherlands
United Kingdom
10/03/2011
Zyprexa Velotab Kohlpharma GmbH
29/03/2011 10 mg Orodispersible tablet
98 EU/1/99/125/018 Austria, Belgium, France, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom
Germany 27/04/2011
Zyprexa Velotab Kohlpharma GmbH
19/05/2011 15 mg Orodispersible tablet
98 EU/1/99/125/019 Greece, Spain, The Netherlands, United Kingdom
Germany 22/06/2011
Zyprexa Velotab Kohlpharma GmbH
19/05/2011 20 mg Orodispersible tablet
98 EU/1/99/125/020 Greece, The Netherlands, United Kingdom Germany 22/06/2011
Zyprexa Velotab Kohlpharma GmbH
19/05/2011 5 mg Orodispersible tablet
98 EU/1/99/125/017 France, Greece, Italy, Portugal, Spain, The Netherlands, United Kingdom
Germany 22/06/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 253/255
Zyprexa Velotab MPT Pharma 20/06/2011 10 mg Orodispersible tablet
28 EU/1/99/125/002 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
30/06/2011
Zyprexa Velotab MPT Pharma 20/06/2011 10 mg Orodispersible tablet
56 EU/1/99/125/006 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
30/06/2011
Zyprexa Velotab MPT Pharma 20/06/2011 15 mg Orodispersible tablet
28 EU/1/99/125/003 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
30/06/2011
Zyprexa Velotab MPT Pharma 20/06/2011 20 mg Orodispersible tablet
28 EU/1/99/125/004 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
30/06/2011
Zyprexa Velotab MPT Pharma 20/06/2011 5 mg Orodispersible tablet
28 EU/1/99/125/001 Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Ireland, United Kingdom
30/06/2011
Zyprexa Velotab Pharma Westen GmbH
14/03/2011 10 mg Orodispersible tablet
98 EU/1/99/125/018 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 08/04/2011
Zyprexa Velotab Pharma Westen GmbH
14/03/2011 15 mg Orodispersible tablet
98 EU/1/99/125/019 Austria, Belgium, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 08/04/2011
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 254/255
Initial Notices for Parallel Distribution –2011 EMA/643088/2012 Page 255/255
zyprexa velotab Pharma Westen GmbH
18/04/2011 5 mg Orodispersible tablet
98 EU/1/99/125/017 Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal, Slovak Republic, Spain, Sweden, The Netherlands, United Kingdom
Germany 24/05/2011
Zyprexa Velotab Propharmed GmbH
29/06/2011 10 mg Orodispersible tablet
70 EU/1/99/125/014 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 08/07/2011
Zyprexa Velotab Propharmed GmbH
01/07/2011 10 mg Orodispersible tablet
35 EU/1/99/125/010 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 22/07/2011
Zyprexa Velotab Propharmed GmbH
08/07/2011 15 mg Orodispersible tablet
35 EU/1/99/125/011 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 26/07/2011
Zyprexa Velotab Propharmed GmbH
08/07/2011 15 mg Orodispersible tablet
70 EU/1/99/125/015 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 26/07/2011
Zyprexa Velotab Propharmed GmbH
11/07/2011 5 mg Orodispersible tablet
35 EU/1/99/125/009 Austria, Belgium, Denmark, Finland, France, Greece, Italy, Norway, Portugal, Spain, Sweden, The Netherlands, United Kingdom
Germany 26/07/2011
Zytiga Haemato Pharm AG
25/11/2011 250 mg Tablet 120 EU/1/11/714/001 Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Norway, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, The Netherlands, United Kingdom
Germany 29/11/2011